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SUMMARY
An oxytetracycline (OTC) resistance gene, otcl. has been cloned 
previously from Streptomvces rimosus 15883, a commercial producer of 
the antibiotic. This gene confers protection to the hosts ribosomes 
from arrest of translation by OTC. The otcl gene has been sequenced 
and its transcriptional regulation pattern has been analysed.
The otcl structural gene encodes a polypeptide of 71.329KD. The
predicted amino acid (a.a.) sequence is highly homiogous with the tetM 
polypeptide, from a Streptococcal transposon Tn1545. The tetM 
polypeptide also protects the protein synthesing machinery from the 
action of tetracycline. The first 130 amino acids of each polypeptide 
are 67$ homologous and smaller regions of extensive homology are 
dispersed throughout the sequences. The amino terminal end of 
elongation factor Tu (EF-Tu) from E.coli is also homologous. It 
exhibits 36$ < homology and if chemically equivalent amino acids are 
considered, 48$ homology to the otcl polypeptide. This homology 
includes the characterised GTP binding site of EF-Tu. The
conservation of a.a. between otcl. tetM and EF-Tu suggests that the 
amino terminal end of otcl has a similar function to the amino 
terminal end of the EF-Tu. Possibly the otcl polypeptide acts as an 
alternative EF-Tu in S.rimosus which protects protein synthesis from 
the inhibitory effects of oxytetracycline.
Two transcriptional start sites have been identified for the otcl 
structural gene. Transcription initiates 129bp (otclpl) and 339-344bp 
(otclp2) upstream of the translational initiation codon. otclpl 
resembles an E.coli type consensus promoter and otclp2 has not been 
sequenced it is external to the cloned DNA. Both transcripts were
identified by S1 mapping with RNA from S.rimosus.
Six closely clustered divergent transcriptional start sites (the 
otcpA1-6 promoters) have been identified with RNA from S.lividans TK24 
containing a clone of the region 5’ to the otcl structural gene and
(x)
11$ of the coding region. These promoters overlap the otclpl start 
site and the transcript overlaps the otcZ coding region (one of the 
OTC production genes) which is transcribed in the same direction as 
otcl. Promoter activity has been recorded from promoter probe 
constructs of this region but the divergent transcriptional activity 
is repressed in constructs which contain 45$ of the otcl coding 
sequence. The transcriptional start sites of otcpA1-6 have not been 
identified with RNA from S.rimosus which is consistent with the 
promoter probe data. In promoter probe constructs otclpl is 
partially repressed by promoter activity from otcpA1-6. otcpAI is 
very similar to a group of streptomycete promoters which are probably 
transcribed by core RNA polymerase in association with sigma factor 
49. The otcpA1-5 promoters show no homology to any recognized 
promoter sequence.
The transcriptional complexity of this region indicates several levels 
of regulation • i.e. the number and variety of promoter signals, 
repression of the divergent transcript by sequences within the coding 
region of otcl (possibly the otcl polypeptide itself) and partial 
repression of otclpl by the transcriptional activity of overlapping 
promoters otcpA1-6. The function of the divergent transcript is 
unknown but it is possible that it regulates the expression of otcZ. 
This regulation might be mediated by an anti-sense RNA or if the 
transcript is translated, by the polypeptide. Such control of the 
expression of an OTC biosynthetic gene would ensure that a cell was 
expressing otcl and therefore resistant to OTC before the onset of OTC 
production.
CHAPTER 1 
INTRODUCTION
1.1 GENERAL INTRODUCTION
Streptomycetes form a genus of gram-positive soil bacteria which
!
contains many dfferent species. Historically S.ooelicolor has been 
studied most but the vast range of secondary metabolites produced by 
all streptomycetes has stimulated interest in a large number of
species. S.coelicolor has an estimated genome size of approximately 
10** kilobases (kb) (Antonov e£ al 1978) and exhibits a complex 
growth cycle involving spore germination, growth to substrate
mycelium, production of aerial mycelium and spore formation (Chater 
and Merrick 1979). The range of secondary metabolites produced by 
streptomycetes includes more than 60$ of the known natural
antibiotics, anti-cancer agents, anti-heliminthics, growth promotants 
and herbicides. Antibiotic production has been correlated with the 
development of aerial mycelium and spore formation and both processes 
indicate the need for the differential regulation of gene expression. 
The industrial potential of Streptomvces has stimulated interest in 
understanding the processes of cellular differentiation and secondary 
metabolite production, though many aspects of Streptomvces biology are 
of general interest. In comparison to other prokaryotic organisms, 
streptomycetes have a large genome size and they exhibit gross DNA 
macrolesions. Streptomycete DNA has an average G+C content of 72$ 
(Enquist and Bradley 1971)» which differs substantially from the DNA 
of more intensely studied prokaryotes e.g. E.coli-51% (Singer and Ames
1970) and B.subtilis-40$ (Singer and Ames 1970).
Streptomvces have unusually plastic genomes and extensive genome 
alterations have been observed in many strains. Amplifications of 
100-500 copies per chromosome of DNA segments ranging from 5-20kb have 
been recorded (Robinson et al 1981) and some of the amplifiable units 
are sandwiched between directly repeated sequences (Fishman and 
Hershberger 1983). The stability of amplified sequences varies from 
stably maintained amplifications to those which progressively 
deamplify during growth (Hershberger and Fishman 1985). Deletions of 
various sizes have also been observed, ranging from 0.3kb (Fisher jet 
al 1987) to greater than 100kb (Hasegawa et al 1985). Deletions are 
often found in association with amplifications (Schrempf 1983) but
they also occur independently. Some deletions result in the loss of 
phenotypic markers. For example the argG phenotype in S.lividans is 
due to a deletion, with an associated amplification of neighbouring 
DNA (Piendl et al 1987). However, two independent deletions of 
greater than 100kb and greater than 70kb analysed in S.glaucbens did 
not affect the prototrophy of the strain (Hasegawa et al 1985). Young
and Cullum (1987) have proposed a hypothetical mechanism for the large
scale deletions which occur. Their model requires that the 
amplifiable unit is bordered by directly repeated sequences and 
predicts that deletion events could occur at either end of the
amplified unit. The model suggests that the units are amplified by a 
rolling circle replication mechanism after a recombination event 
between the directly repeated sequences. The replication structure 
may be resolved by homologous recombination or illegitimate 
recombination which would lead to a deletion occuring on one side of 
the amplified sequence. The stimuli responsible for these major
genome alterations are unknown but the majority of genome alterations 
have been observed after stressing cells by protoplasting, protoplast 
fusion or treatment with DNA intercalating dyes. A direct 
relationship between these events and the DNA rearrangements has yet 
to be demonstrated. A wide variety of gross genome alterations have 
been analysed, many of which have no adverse effect on the cell but 
the function of such a fluid genome has yet to be determined.
Circular chromosome maps have been obtained for several Streptomvces 
strains. The most complete linkage map is of S.ooelicolor (Chater
1984) but the less extensive linkage maps of other strains show many 
similarities with the S.ooelicolor linkage map (Friend and Hopwood
1971). The vast majority of markers map in two large clusters, 
diametrically opposed, which flank two silent regions. Some 
functionally related genes map at diametrically opposed positions and 
it has been suggested that a chromosomal duplication occurred in an 
evolutionary ancestor of the streptomycetes. Streptomvces genomes 
have considerably greater coding capacity than E.coli and B.subtilis. 
but it is unclear what the functions of the extra 6000 kilobase pairs 
are.
Streptomvces DNA has a high G+C content (72$) in common with other
bacteria such as, Micromonospora (72%), Mvxococcus (68$), Actinoplanes 
(74$), Nocardia (70$) ( Singer and Ames 1970). G+C content varies 
widely among bacterial species, from 25$ to 75$, and it is likely that 
these differences have been caused by mutation pressure. Singer and 
Ames (1970) propose that bacterial species exposed to sunlight evolve
high G+C contents to avoid thymine specific damage from the
ultraviolet (UV) radiation from sunlight. They cite many cases of 
bacteria which reproduce aerially, aquatic bacteria and bacteria 
protected by carotenoids, that have a high G+C content and there is a 
strong positive correlation of G+C content with exposure to sunlight. 
However other protection mechanisms to UV damage exist. UV light is 
absorbed by cellular constituents such as tryptophan and RNA and cells 
with greater cellular mass will screen out more UV light. DNA repair 
mechanisms also play a major role in repairing damaged DNA. It is 
difficult to assess the efficency of these mechanisms particularly as 
the repair systems of many bacteria are poorly understood. Singer and 
Ames (1970) have proposed that another factor, the evolution of the
base ratio of the DNA, such that fewer targets are exposed to the
mutagen.
The codon usage of any species reflects the relative abundance of G+C 
base pairs to A+T base pairs (Muto and Asawa 1987). Species with high 
A+T contents preferentially select synonomous codons with A/T in the 
third degenerate position of a codon. Mycoplasma capricolum (29$ G+C) 
has a 10$ G+C content at the third position of codons and Micrococcus 
luteus (75$ G+C) a 90$ G+C content. Streptomvces coding regions have 
a similar skewed occurrence of G or C base pairs, which makes a coding 
region instantly recognizable (Bibb et al 1984).
1.2 Developments in the molecular biology of Streptomvces
Hopwood's group at the John Innes Institute have pioneered both the 
genetical and molecular biological research in Streptomyces. The 
development of protoplasting and regeneration techniques enabled 
transformation of Streptomvces species (Bibb et ^1 1978). A gene
conferring resistance to methylenomycin (Mm) from S.coelicolor was 
the first gene cloned from a streptomycete (Bibb it al 1980). Total 
DNA from S.coelicolor A3(2) was ligated to the low copy number vectors
Spores of each transformed strain were tested for resistance to Mm and 
the ability to elicit lethal zygosis (a small area of growth 
inhibition due to the presence of a plasmid containing cell on a 
plasmid free lawn). More sophisticated vectors are now available 
which have antibiotic resistance genes to select transformants and 
positive cloning vectors which select for transformants containing 
inserts. Many of the low copy number vectors now used in cloning, 
such as pIJ6l and pIJ922 are derived from the early cloning vectors, 
SLP1.2 and SCP2 respectively. pIJ101 is a high copy-number vector 
isolated from S.violaceroruber (Kieser .§£ al 1982) which has been used 
to produce a large number of wide host range cloning vectors. Many 
phages have been isolated from different Streptomvces species and one
et al 1981). 0C31 has the ability to form lysogens or undergo a lytic
life cycle after entering a cell. Lysogeny follows a similar pattern 
to phage lambda in E.coli. There is a specific integration site in 
the chromosome (attB) and a specific site (attP) in the phage genome 
which interacts with the chromosomal attachment site. The 
establishment and maintenance of lysogeny requires the c-gene product 
which also represses lytic phage functions. 0C31 has been developed 
extensively as a cloning vector. Recombinant phages deleted for attP 
can integrate into an $C31 lysogen by recombination to form double 
lysogens or by homologous recombination between the chromosome and DNA 
cloned in the 0C31 vector. Vectors deleted for the c-gene can 
accommodate larger inserts, of up to 8kb, and may be used in the 
double lysogen system. 0C31 vectors are useful for the functional 
: analysis of DNA by the insertions! inactivation of transcription units 
(Seno .et al 1984) and in mutational cloning (Chater and Bruton 1983). 
Mutational cloning is a useful technique as it circumvents the need to 
isolate mutants in order to screen for a cloned gene. The mutations 
arise when the insert DNA in 0C31 is completely internal to the 
transcription unit and recombination between the insert DNA and 
chromosomal DNA disrupts the transcription unit.
Great advances have been made since the early gene cloning reports and 
large numbers of antibiotic resistance genes, some nutritional 
requirement genes, developmental genes, a few genes coding for
of the most developed is the broad host (Chater
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Fig 1.1 Structures of the antibiotics: actinorhodin, medermycin, 
and dihydrograticin and the hybrid antibiotics mederrhodin and 
dihydrogranaticin.
for antibiotic production have been cloned. Both bovine and human 
genes have been expressed in S.lividans. Gray et al (1984) expressed 
bovine growth hormone using the promoter of the S.fradiae aph gene and 
Pulido et al, (1986) expressed a biologically active form of human 
interferon ^ 2 also controlled by the aph promoter but using the 
ribosome binding site of E.coli membrane lipoprotein. The expression 
of heterologous genes in S.lividans indicates the potential of 
Streptomvces as hosts for the production of commercially useful 
proteins.
1.3 Characterization of antibiotic pathways and production of novel 
compounds.
The demand for antibiotics has stimulated antibiotic research in two 
directions: the characterisation of cloned antibiotic pathways and the 
production of new antibiotics. Novel structures produced to date have 
depended on the alteration of existing compounds, for example 
penicillin G and penicillin V are manufactured by feeding analogs of 
normal precursors to the production process. More modern methods of 
producing hybrid structures involve introducing cloned antibiotic 
pathways or individual genes from antibiotic pathways into strains 
producing related antibiotics. Medermycin and actinohordin (Act) are 
structurally related but different compounds and are both classified 
as isochromane quinone antibiotics. The Streptomvces strain AM-7161, 
which produces medermycin, was transformed with subclones of the act 
gene cluster. Some of the transformants analysed continued to produce 
medermycin and in addition a new compound named, mederrhodin A (Fig 
1.1) (Hopwood .et a.JL 1 985). Another novel product
dihydrogranatirhodin was produced in a similar experiment (Hopwood .et 
al 1985). S.violaceroruber. the producer of dihydrogranaticin (an 
isochromane quinone), was transformed with the complete act 
biosynthetic pathway. Transformants produced actinohordin and the 
novel compound dihydrogranatirhodin (Fig 1.1). The novel products 
mederrhodin A and dihydrogranatirhodin have minor alterations to their 
structures. Large scale screening programmes would be necessary to 
identify hybrid compounds with commercially useful structures. The 
screening factor limits the usefulness of this strategy but a more
6
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Fig 1.2 Diagram of the actinorhodin and tetracenomycin biosynthetic 
gene clusters, displaying the similarities in gene organization.
complete biochemical and genetical understanding of antibiotic 
biosythesis will identify the most suitable approaches for the 
directed generation of novel antibiotics and overproduction of 
existing antibiotics. The general genetic engineering approach 
discussed above may be refined by altering steps in the biosynthetic 
pathway e.g. by directed mutagenesis of cloned production genes and 
manipulation of regulatory mechanisms. This new approach to 
developing novel antibiotics still depends on existing structures but 
the versatility of the system should enable it to produce radically 
different structures in the future.
To date eight complete or partial antibiotic pathways have been cloned 
i.e. pathways synthesizing actinohordin (Malpartida and Hopwood 198*0, 
methylenomycin (Chater and Bruton 1985), streptomycin (Ohnuki et .§1,
1985), undecylprodigiosin (Feitelson .et al, 1985), biolaphos (Murakami 
et al. 1986), erythromycin (Stanzak et al. 1986), oxytetracycline 
(Butler .gt. al, 1986) and tetracenomycin (Motamedi and Hutchinson 
1987). The cloning of these pathways has been facilitated by the 
clustering of the genes for antibiotic biosynthesis. The organization 
of the gene clusters for actinorhodin (Malpartida and Hopwood 1986) 
and tetracenomycin biosynthesis (Motamedi and Hutchinson 1987) has 
been analysed in detail and share some features. The early steps of 
actinohordin biosynthesis actlf actlll. actVII. aotIV and actVb are 
located on the right side of the cluster and the late genes actVa. 
actVI on the left side separated by the regulatory gene actll. The 
early genes of the tetracenomycin biosynthetic pathway tomla. tcmld 
and tcmVi are centrally located and flanked on the left by tcmll. 
tcmlV and tcmV which mediate reactions in the middle of the pathway 
and on the right by the late genes tcmVII and tcmlll (Fig 1.2). 
Preliminary evidence suggests there is a regulatory gene between the 
early and late genes. Motamedi and Hutchinson (1987) propose that 
there is a functional advantage to this type of architecture. They 
suggest that as antibiotic synthesis occurs through a multistep 
biochemical pathway, sequential expression of the enzymes in the 
pathway should help efficient synthesis of an antibiotic. Their 
hypothesis is supported by Malpartida and Hopwood (1986), who 
demonstrated that the early and late act genes are transcribed by two 
polycistronic messages (Fig 1.2). The architecture of the OTC
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pathways (Butler e£ .al 1986), supporting the observation that the 
organization of genes in these pathways has been conserved. These 
three antibiotics are part of the polyketide group and the proposed 
polyketide synthase genes of the Tcm and OTC pathways share homology 
as judged by DNA hybridisation to the actl probe whose gene product 
encodes the synthase enzyme (Malpartida et. al 1987). DNA from many 
other polyketide producing species hybridise to the actl probe as do 
some non-producer strains which may contain a cryptic copy of a 
polyketide antibiotic pathway. These cross hybridization studies 
will facilitate the cloning of most polyketide antibiotics whether 
expressed or cryptic and it seems plausible to extend this cloning 
technology to other antibiotic groups such as B-lactams and 
aminoglycosides.
1.4 Gene Expression in Streptomvces
Gene expression is controlled by transcription and translation 
signals, usually 51 to the coding sequence. These control elements 
have been studied extensively in E.coli and a consensus sequence 
established which core RNA polymerase (RNAP) recognizes in association 
with sigma factor-70. Sigma factor-70 is the major factor used to 
direct transcription from E.coli promoters but it is not the only 
species. Two other minor species have been identfied. Sigma 32, 
recognizes a small set of promoters involved in the heat shock 
response of E.coli (Grossman 1984) and the ntrA gene product is a 
sigma factor which directs RNAP to bind to the glnA promoter 
(Hirschman et &X 1985). Gene expression may also be positively or 
negatively controlled by activator or repressor proteins which act on 
specific or small subsets of genes (Raibaud and Schartz 1984). Five 
bacterial and two phage encoded sigma factors have been identified in 
B.subtilis (Losick and Pero 1981). The B.subtilis sigma factor 43 in 
association with core RNAP recognizes promoter sequences with the same 
conserved elements as the E.coli consensus sequence recognized by 
sigma 70. The remaining sigma factors in assosiation with core RNAP 
all direct transcription initiation from different sequences but very 
little sequence data is available to establish any real consensus. 
Many of the sigma factors are expressed during vegetative cell growth
8
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(Grossman and Losick 1986). However the specifc role of these sigma 
species in vegetative and sporulative gene expression have not yet 
been investigated.
The first studies on gene expression in Streptomvces demonstrated that 
the E.coli recA. E.coli lacUV5. S.marcesens trp and the B.subtilis 
penP promoters were expressed in S.lividans (Bibb and Cohen 1982). 
The reciprocal experiment i.e. cloning of fragments of Streptomvces 
DNA in E.coli demonstrated that Streptomvces transcriptional control 
signals were rarely recognized in E.coli. Jaurin and Cohen (1985) 
have carried out a more comprehensive analysis of Streptomvces 
promoters which function in both E.coli and Streptomvces. They 
analysed the sequence and transcriptional activity of five such 
promoters, named Streptomvces-E.coli-type promoters (SEP). These 
promoters were selected for their activity in E.coli and compared well 
with the wild type E.coli amoC average strength promoter. However 
transcription activity measurements of SEP in Streptomvces indicate 
they are poorly expressed. The wild type E.coli amoC promoter has a 
20-fold greater expression level in Streptomvces than the SEP. As the 
SEP -10 and -35 sequences match the E.coli consensus promoter sequence 
well, the evidence suggests that the SEP sequences have regulatory 
elements, absent in ampCf which are recognized in S.lividans. The 
transcriptional start points of three SEP were determined in E.coli 
and multiple direct repeats and a conserved hexameric sequence were 
found in the sequence upstream from the start point, which may play a 
regulatory role. Statistical analysis of the pool of clones which 
yielded the five SEP analysed, estimates there are approximately 200 
SEP in the S.lividans genome. This suggests they form a minority of 
promoter signals in S.lividans.
Other Streptomvces promoters which are expressed in E.coli include 
three promoters from the plasmid pIJ101 (Buttner and Brown 1987* Deng 
et al 1986). Promoters pIJ101A and pIJ101C initiate transcription at 
the same start point in E.coli and Streptomvces. indicating that the 
same transcriptional signals are recognized in both genera. Jaurin 
and Cohen (1984) demonstrated that Streptomvces RNAP responds to up- 
promoter mutations of the E.coli ampC promoter. However, the degree
9
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the RNA polymerases have different specificties for the same promoter 
sequence. The evidence suggests that the basic prokaryotic consensus 
sequence recognized by E.coli sigma factor 70 and B.subtilis sigma 
factor 43 exists in Streptomvces. However, these sequences are not 
ubiquitious as in E.coli and the Streptomvces RNAP hoioenzyme does not 
have exactly the same recognition specificity.
Other Streptomvces promoters which are not functional in E.coli show 
little or no homology to the E.coli consensus sequence. A group of 
these promoters exhibit homology to the sequence recognized by sigma 
factor 37 from B.subtilis. Two sigma factors have been identified in 
S.coelicolor (Westpheling £t al 1985). One of these factors specified 
transcription from the etc promoter of B.subtilis. usually transcribed 
by E-sigma 37 and also specified transcription from the endoH promoter 
of S.plicatus which exhibits homology to the etc promoter. The second 
sigma factor specified transcription of the B.subtilis veg promoter, 
which has the general E.coli consensus sequence. No other sigma 
factors have been isolated but it appears probable that Streptomvces 
has an analogous system, of multiple sigma factors, to B.subtilis.
One of the more unusual properties of Streptomvces promoters is the 
high frequency of tandem promoters and the preponderance of multiple 
transcription start sites. Many of the genes analysed to date, have 
two transcription start points separated by up to 300bp. Other genes 
have multiple transcription start points. The dag promoter exhibits 
four distinct transcription starts (Buttner et al. 1986) and an open 
reading frame associated with erythromycin resistance gene has three 
transcription start sites (Bibb and Janssen 1987). This variety of 
control signals may help to regulate the expression of these genes 
which code for antibiotic resistance, an extracellular agarase and 
glycerol and galactose utilization genes. These genes are all good 
candidates for differential expression.
Translational initiation has also revealed some unusual facets in 
Streptomvces. Translational initiation depends on an ATG or GTG start 
codon, and usually the ribosomal complex recognizes a region 5f to the 
start codon called the ribosome binding site (RBS) which displays
10
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Fig 1.3 (A) Diagram of the biosynthesis of oxytetracycline. The 
Dositions of the blocked mutants are indicated.
(B) The location of OTC negative mutations on the genetic map of 
S.rimosus. Tne loci are arbitrarily spaced at equal intervals
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B.subtilis and Staphylococcus a high degree of homology is required. 
However, E.coli and Streptomvces are not so stringent in their 
requirements. The aph and sta genes have identical transcriptional 
and translational start sites and the ermEPI initiates trancription 
one base before the translational start site. The requirement for a 
ribosome binding site, in these examples, appears to be non-existent 
but the role of sequences 3f to the translational start site may be 
important (Scherer et al 1980, Gold et al 1981). This appears to be a 
rare event amongst other bacterial species and it is difficult to 
assess its significance in Streptomvces until a larger spectrum of 
cloned Streptomvces genes have been studied.
1.5 Cloning and characterisation of the oxytetracycline (OTC) 
biosynthetic pathway from S. rimosus
The pathway has been partially characterised both genetically and 
biochemically by Rhodes et il (1981). They produced blocked mutants 
in the pathway by NTG and UV mutagensis and classified these mutants 
by cosynthesis tests and feeding intermediates of the OTC pathway to 
blocked mutant strains. These techniques defined the organization of 
6 mutants in OTC biosynthesis. Two of the blocked mutants were 
assigned to specific steps in the conversion of anhydrotetracycline 
(ATC) to OTC and the other four mutants were blocked before ATC. The 
order of otcX. otcY and otcZ has not been determined but otcD is 
blocked in the conversion of 4-amino-ATC to ATC (Fig 1.3). The 
mutants were mapped to diametrically opposite clusters on the 
S.rimosus linkage map (Fig 1.3). Two OTC resistance genes map with 
the early gene cluster.
OTC resistance clones were isolated by screening a gene library made 
in an OTC sensitive host, S.rimosus M15883 (Rhodes et. al 1984). Two 
unrelated clones were isolated, as judged by restriction analysis and 
DNA/DNA hybridisation. This suggested that there were two resistance 
genes and possibly two mechanisms of resistance. Several antibiotic 
producers have two resistant genes: S.fradiae. a neomycin producer, 
has two enzymes to inactivate the antibiotic (Davies et al 1979) and 
S.vinaoeus. a viomycin producer, has an inactivating enzyme and
11
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S.kanamvceticus. a kanamyein producer (Nakano .et al 1984). The 
resistance genes otcl and otcll are closely linked and also map with 
the early gene cluster making them useful as probes to clone this 
cluster. A cosmid library of S.rimosus was constructed in a 
bifunctional Streptomvces/E.coli cosmid vector pPZ74 (Chambers and 
Hunter 1984) in E.coli LE3Q2 and probed with otcl (pPZ24) and otcll 
(pPZ57). Two cosmid clones pPZ499 and pPZ500 were isolated. Analysis 
of these clones, which are overlapping, mapped the otcl and otcll 
clones to the ends of the gene cluster (Fig 1.4). Subclones of the 
cosmid inserts were made in high copy-number vectors and transfomed 
into a restriction deficient S.rimosus strain (Hunter and Friend 
1984). Some of these subclones caused repression of OTC production 
possibly indicating the presence of regulatory elements which when 
present on high copy number vectors repress the pathway. When inserts 
were cloned on low copy number vectors they did not affect OTC 
production in the restriction deficient S.rimosus and were therefore 
used to complement the four blocked mutants otc-D4.otc-X20.otc-Y90 and 
otc-Z151 (Fig 1.4) (Butler £t al 1986). Regulatory regions have been 
defined by further subcloning and are localized between otcZ and otcX 
and between otcD and otcY (Fig. 1.4). A third regulatory element was 
isolated with the initial otcl clone. pPZ24 encodes for otcl and otcZ 
but does not complement otc-Z151 unless the insert is cloned on a low 
copy number vector. pPZ19 contains the pPZ24 insert and an additional 
4.7KB fragment (also cloned independently in pPZ15) which is not 
contiguous on the chromosome (Fig 1.5). pPZ19 complements the mutant 
otc-151 and therefore it has been suggested that this 4.7KB insert 
moderates the effect of the regulatory element found between otd and 
otcZ. The 4.7KB fragment also segregates with a brown pigmented 
phenotype and has not yet been assigned a chromosomal map position.
1.6 Mechanism of tetracycline resistance and tetracyclines mode of 
action
Two OTC resistance genes have been cloned independently by Ohnuki .et 
al (1985), from a S.rimosus ATCC 10970 strain and by Rhodes et .al 
(1984) from S.rimosus 15883. Drocourt (pers. comm. 1987) has also 
cloned an OTC resistance gene from S.rimosus and S.aureofaciens.
production of OTC as have the strains used by Drocourt whereas 
/  S.rimosus ATCC 10970 is a soil isolate. A comparison of the OTC
resistance genes from all strains may identify some effects of 
mutagenesis. Ohnuki et .al (1985) have designated the genes tetA and 
tetB. which are homologous to otcl and otcll respectively, as judged 
by restriction analysis. Drocourt (pers. comm. 1987) has named the 
resistance clone tet347 and it is homologous to tetB and otcll. judged 
by restriction analysis. Ohnuki jet al. (1985) have further 
characterised tetA and tetB according to their level of tetracycline 
resistance and possible resistance mechanisms in the heterologous host 
S.griseus. tetA permitted growth at a tetracycline concentration of 
250ug/ml, after preexposure to 50ug/ml tetracycline and tetB permitted 
growth at 300ug/ml also after preexposure to 50ug/ml. Further 
increased pre-exposure levels did not increase the maximal inhibitory 
concentration of tetracycline. The parent strain permitted growth at 
800ug/ml after pre-exposure to 50ug/ml of tetracycline and this 
concentration could be raised to 1200ug/ml after pre-exposure to 
100ug/ml of tetracycline. Growth was recorded as an increase in the 
OD62JO the culture. The expression of both resistance genes appeared 
to be induced 2-fold in the presence of tetracycline but it is 
difficult to relate the concentration of tetracycline adminstered to 
the culture to the normal levels of intracellular tetracycline present 
in a cell, which are unknown. Therefore it remains difficult to 
assess what effect tetracycline has on the expression of the 
resistance genes in their natural environment.
Analysis of the mechanisms of resistance has indicated that tetA 
protects protein synthesis from tetracycline and tetB mediates reduced 
accumulation of tetracycline. Benveniste and Davies (1973) proposed 
an evolutionary relationship between the aminoglycoside inactivating 
enzymes in bacteria containing R-factors and similar enzymes found in 
Streptomvces. suggesting that genetic information for antibiotic 
resistance has been transferred from streptomycetes to non-antibiotic 
producing bacteria accounting for their antibiotic resistance 
phenotypes. According to the Benveniste and Davies (1973) hypothesis 
the tetB resistant mechanism could be the common ancestor of the 
tetracycline resistance mechanism employed by many plasmids and
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mechanism of these plasmids and transposons is active efflux of the 
antibiotic across the membrane. The mechanism is under the control of 
a repressor protein which prevents transcription of the tetracycline 
resistance gene, from both its promoters. In the presence of 
tetracycline, the antibiotic binds to the repressor, outcompeting the 
operator sites and releases the resistance gene from repression 
(Hillen gt aJL 1984). The mechanism of tetB control has yet to be 
established but it is involved in reducing the accumulation of 
tetracycline in the cell.
tetA resistance was localized .in vitro to the crude ribosome fraction 
with some slight activity in the S150 (cytoplasmic) fraction (Ohnuki 
et ii! 1985). However crude ribosomes washed with 1M ammonium chloride 
were no longer resistant to tetracycline indicating the resistance was 
not mediated by modified ribosomal proteins or rRNA. Antibiotic 
resistant protein synthesis has been associated with tight ribosomes 
in vitro (Cimdliffe and Thompson 1979* Skinner and Cundliffe 1982), 
however the data suggests that tetA mediates its resistance through an 
unidentified association with the ribosome. Tetracycline resistance 
determinants from Streptococcus, tetM and tetN also mediate resistance 
at the level of protein synthesis (Burdett 1986). Mikulik et al. 
(1971) have examined the interaction of tetracycline with the protein 
synthesing system of S.aureofaciens. also a producer of tetracycline. 
The protein synthesising machinery of S.aureofaciens is more resistant 
to tetracycline in vitro than that of E.coli. exhibiting 30% 
inhibition of translation at 10ug/ml while E.coli was inhibited 80$ at 
this tetracycline level. They also observed tetracycline-ribosome 
aggregates and the highest level of binding was equivalent to 320 
molecules of tetracycline per ribosome. Tetracycline binds all over 
the ribosome though much of this binding is reversible. One strong 
binding site has been located on the 50S subunit and three on the 30S 
subunit (Fey et. al 1973). The mode of action of tetracycline is to 
inhibit the binding of aminoacyl(AA)-tRNA.EF-Tu.GTP ternary complex to 
the 30S.mRNA complex and this implies that the 30S subunit may play a 
role in the action of the drug. Williams and Smith (1979) have 
isolated chromosomal mutants in B.subtilis causing resistance to 
tetracycline. One of these mutations maps to the ribosomal protein
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altered electrophoretic mobility in the mutant strain. Ribosomes from 
the mutant strain show an increased level of resistance to 
tetracycline during in vitro translation. These studies have been 
followed up by Mikulik ejt al (1983) who demonstrated that tetracyclne 
producing strains of S.aureofaciens have altered electrophoretic 
mobility of the S10, S2 and L19 ribosomal proteins. Reconstitution 
studies with E.coli 30S ribosomal subunits lacking S10, have shown 
that these particles bind tRNA less efficently than complete particles 
(Nomura jet ajL 1969* Lake 1985). S10 and tetracycline both play a
role in the binding of AA-tRNA.EF-Tu.GTP to the ribosome, however S10 
is required for the complexes to bind and tetracycline prevents 
binding. The interaction of the 16SrRNA molecule with tetracycline 
has also been examined (Moazed and Noller 1987). The anticodon of A 
site bound AA-tRNA is spatially proximal to residues in the 1400 
region of l6SrRNA. Experimental results demonstrate that cleavage at 
residue 1493 is blocked by bound AA.tRNA, as expected and it is also 
blocked in the presence of tetracycline. This result indicates that 
tetracycline interacts with the ribosome at some of the sites usually 
occupied by AA-tRNA. Residue 892 also exhibited strong protection 
against DMS modification in the presence of tetracycline, the authors 
suggested that this interaction reflects the folding of the 16S rRNA 
molecule.
The aims of this project were to characterise the transcriptional 
control mechanism of the otcl gene and to sequence the gene with a 
view to gaining a better understanding of its mechanism of resistance.
Promoter probe vectors have been used to identify promoter activity 5* 
to the otcl structural gene and the transcriptional start sites have 
been identified by high resolution S1 mapping. The results of these 
experiments were compared to other sequenced streptomycete promoters 
and the promoter structure of other streptomycete genes, specifically 
antibiotic resistance genes.
The otcl gene has been sequenced and compared with the DNA sequence of 
tetM from Streptococcus, which also confers resistance to ribosomes. 
The DNA and predicted amino acid sequence have been analysed for any
15
sites and homology to other genes in an attempt to predict the 
mechanism of ribosomal protection.
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CHAPTER 2 
MATERIALS AND METHODS
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2.1 Bacterial Strains
The E.coli strains used were all derivatives of E.coli K12. The 
Streptomvces strains used were from Pfizer or John Innes Institute, 
Norwich. All strains are listed below.
NAME GENOTYPE REFERENCE/SOURCE
JM101 s u p E . thi. (lac proA.B)/F% f Yanisch-Perron
traD36, proA.B. lacIAZ M15 (1985)
DS903 nec.F143, ProA7. str31. thr 1, DaveSherratt
leu6. tsx33, mt!2. his4. argE3. 
lacvl. galK2. aral4. supE44. xv!5 
DS941 DS903 but lad , lacZAM15, lacY* Dave Sherratt
CB51 • dam“, ara. thi. (lac.pro) Chris Boyd
S.rimosus derived from a w.t. S.rimosus G7 Pfizer
4018 by strain improvement for OTC
production.
S.rimosus OTC sensitive, in vivo deletion of Pfizer
M15883S M15883 which is derived from S.rimosus
G7 by strain improvement for OTC 
production.
S.lividans str-6 John Innes
Institute
2.2 Plasmids and bacteriophages
The plasmids and bacteriophages used in this study including those 
whoseconstructionis described in the thesis,are listed inTable 2.1.
2.3 Chemicals
CHEMICALS SOURCE
General chemicals B.D.H., HopkinsandWilliams,
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PLASMID/
BACTERIOPHAGE
DESCRIPTION SOURCE/REFERENCE
pGLVJ7
pPZ46
PUC18/19 
M13mp18/19 
pIJ486/487 
PDM101
pDM102
pDM103
pDM104
pDM105
pDM106
pDM112/3
pDM122/3
pDM152/3
pDM172/3
pDM182/3
pDM192/3 
PDM1721-3
2.6kb BamHI/SstI fragment 
encoding otcl in pT7-2 
6kb SstI fragment encoding 
encoding otcl in pPZ34
2l6bp BamHI/BclI fragment 
from pGLW7 cloned into pUCl8 
357bp Bcll/Smal fragment Chapter 3
from pGLVJ7 cloned into pUCl8 
573’op BamHI/Smal fragment Chapter 4
from pGLW7 cloned into pUClB 
1229'PP Bcll/Bcll fragment Chapter 4
from pGLW7 cloned into pUCl8 
277op Smal/SstI fragment Chapter 3
from pGLW7 cloned into pUCl8 
1234bp BamHI/Sall fragment Chapter 4
from pGLW7 cloned into pUCl8 
the pDM101 insert cloned Chapter 3
into M13mpl8/19
the pDM102 insert cloned Chapter 3
into M13mpl8/19
the pDM105 insert cloned Chapter 3
into M13mpl8
746bp Smal fragment from Chapter 3
pGLW7 cloned in both orientations 
in M13mpl3
1056bp Smal fragment from Chapter 3
pGLW7 cloned in both orentations 
in M13mpl8
149obp BamHI/SphI fragment Chapter3
from pGLW7 cloned into M13mpl8/19 
ExoIII- deletion derivatives Chapter 3
of pDM172
Iain Hunter
Iain Hunter
Yanisch-Perron (1985) 
Yanisch-Perron (1985) 
V/ard et al (1986) 
Chapter 3/4
PLASMID/
BACTERIOPHAGE
DESCRIPTION SOURCE/REFERENCE
PDM1731-3 
pDM1821 -4 
pDM1831-4 
PDM110/1 
PDM130/1 
pDM141 
PDM160/1
ExoIII deletion derivatives 
of pDM173
ExoIII deletion derivatives 
of pDM182
ExoIII deletion derivatives 
of pDMI33
the pDM101 insert cloned
into pIJ486/7 
the pDM103 insert cloned 
into pIJ486/7
the pDM104 insert cloned
into pIJ487
the pDM106 insert cloned 
into pIJ486/7
Chapter 3 
Chapter 3 
Chapter 3 
Chapter 4 
Chapter 4 
Chapter 4 
Chapter 4
Kochiight Laboratories, May and 
Baker.
Media
Hydrazine 
Dimethyl sulphate
General Biochemicals
Difco, Oxoid
Sigma, Pharamacia, B.R.L
Kodak
Aldridge
Piperidine
Agarose
Fluka
B. R • L.
Acrylamide 
Radiochemicals
Electran
N.E.N
Antibiotics Sigma, Squibb and Sons
2.4 Culture Media
L-Broth: 10g tryptone, 5g yeast extract, 5g NaCl, 1g glucose, 20mg 
thymine, made up to 1 litre in distilled water and adjusted to pH7.0 
with NaOH
L-agar: As L-broth without glucose and the addition of 15g/l agar
2YT Broth: 10g bacto-tryptone, 10g yeast extract, 5g NaCl made up to 1 
litre in distilled water.
Minimal Agar: 7g K2HP0^, 2g KH2P0i|, 4g NH^SO^, 0.25 trisodium citrate, 
0.1g MgS0^.7H20, 17.5g agar made up to 1 litre in distilled water.
Davis and Mingoli (D&M) salts (X4): 28g K2HP0jj, 8g KH2P0jj, 4g
(NHj^SOjp 1g sodium citrate, 0.4g MgS0^.7H20, made up to 1 litre with 
distilled water.
Supplonents: When required supplements were added to the above
minimal medium at the following concentrations:
glucose 2mg/ml thiamine vitamin B1 20ug/ml
amino acids 40ug/ml
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Tryptone Soya Broth (T.S.B.): 30g of Oxoid tryptone soya broth powder
made up to 1 litre in distilled water.
Yeast extact-Malt extract (Y.E.M.E.): 3g Difco yeast extract, 5g
Difco bacto peptone, 3g Oxoid malt extract, 10g glucose, 340g sucrose 
made up to 1 litre in distilled water. After autoclaving add 1/20 
volume of 100mM MgCl2. For preparing protoplasts also add 1/20 volume 
of 10% glycine.
R2 Medium: R2A- M g  agar, 0.5g KgSO^, 20.2g MgCl2.6H20, 5.9g
CaCl2.2H20, 20g glucose, 6g proline, 0.2g casamino acids, 4ml trace
elements solution, made up to 1 litre in distilled water.
R2B- 11.5g Mops, 10g yeast extract, 203g sucrose, adjusted to pH 7.4 
with NaOH, made up to 1 litre in distilled water.
Combine equal volumes of R2A (melted and cooled to 55°C) and R2B plus 
1ml of 1$KH2P0jj prior to use.
R9 Medium: R9A- 20g glucose, 0.5g K2S0jj, 8.2g MgCl2, 4.7g of CaCl2,
4g sodium nitrate, 1g potassium chloride, 0.4g magnesium sulphate, 
0.8g casamino acids, 2ml of \% FeSOj^ , 4ml trace element solution, M g  
agar, made up to 1 litre in distilled water.
R9B- 11.5g Mops, 10g yeast extract, 4l0g sucrose, adjusted to pH 7.4
with NaOH and made up to 1 litre in distilled water.
Combine equal volumes of R9A (melted and cooled to 55°C) and R9B prior 
to use.
Trace Element Solution: Mrag ZnCl2, 200mg FeClg6H20, 10mg CuCl22H20,
10mg MnCl24H20, 10mg Na2Bi|0^10^0, 10mg (NH^)gM0Y02i}4H20, made up to 1 
litre in distilled water.
MM Medium: 10g agar, 0.5g 1-asparagine, 0.5g K2P0ij, 0.2g MgS0ij.7H20,
0.01g FeSO^ made up to 1 litre with distilled water and adjusted to pH 
7.0-7.2 with NaOH.
MMT Medium: Supplement 200ml MM medium with 4ml of 30^ Difco casamino
acids and 1.5ml of the following solution - 1000mg 1-arginine, 750mg
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1-cystine, 750mg 1-histidine, 750mg 1-phenylalanine, 750mg 1-proline, 
150mg adenine, 150mg uracil, 10mg nicotinamide in 100ml of distilled 
water.
2.5 Sterilization: All growth media were sterilized by autoclaving at
120°C for 15mins; supplements and buffer solutions at 108°C and CaCl2 
at 11l|°C for 10mins. Amino acid and other heat sensitive solutions 
were filter sterilized.
2.6 Buffers and Solutions:
Electrophoresis
10X TBE Buffer pH 8.3: 109g tris, 55g boric acid, 9.3g Na2EDTA.2H20
made up to 1 litre in distilled water, pH is 8.3«
Agarose gel loading buffer: 0.025/6 bromophenol blue, 0.025$ xylene
cyanol, 25$ ficoll, 0.5$ S.D.S., 50mM EDTA.
Sequencing gel loading buffer: 0.1$ bromophenol blue, 0.1$ xylene
cyanol, 10raM Na2EDTA, 95$ formamide (de-ionized with a mixed-bed 
resin).
DNA Manipulations
10X Core Buffer: 500mM Tris-HCl (pH 8.0), 100mM MgCl2, 500mM NaCl.
Stored at 4°C.
10X Sph1 Buffer: 500mM Tris-HCl (pH 7.5), 60mM MgCl2 , 500mM NaCl,
60mM 2-mercaptoethanol. Stored at 4°C.
10X Smal Buffer: 150mM Tris-HCl (pH 8.0), 60mM MgCl2, 150mM KC1.
Stored at ii°C.
10X Ligation Buffer: 660mM Tris-HCl (pH 7.6), 66mM MgCl2, 100mM DTT.
Stored at -20°C.
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ATP Stock Solution 10mM: Dissolve 6mg of ATP in 0.8ml of dH20.
Adjusted to pH 7.0 with NaOH and adjusted the volume to 1ral with dH20. 
Dispensed the solution into 10ul aliquots and stored at -70°C.
TE Buffer: 10mM Tris-HCl (pH 7.0-8.0), 1mM EDTA (pH 8.0).
TES Buffer: 20mM Tris-HCl (pH 7.5), 10mM NaCl, 0.1mM EDTA
10X Sequencing Buffer: 70mM Tris-HCl (pH 7.5), 70mM MgCl2. Stored at
-20°C.
10X Annealing Buffer: 100mM Tris-HCl (pH 7.5), 100mM MgCl2.
10X Kinase Buffer: 500mM Tris-HCl (pH 7.6), 100mM MgCl2, 50mM DTT,
1mM spermidine, 1mM EDTA. Store at -20°C.
10X Klenow Buffer: lOOmM Tris-HCl (pH 7.5), 100mM MgCl2, 500mM NaCl.
Stored at 4°C.
1X Exonuclease III Digestion Buffer: 66mM Tris-HCl (pH 8.0), 0.66mM
MgCl2. Stored at 4°C.
1X Exonuclease III Stop Buffer: 0.2M NaCl, 5mM EDTA (pH 8.0). Stored
at 4°C.
Low Salt Buffer: 0.2M NaCl, 20mM Tris-HCl (pH 7.4), 1mM EDTA.
High Salt Buffer: 1M NaCl, 20mM Tris-HCl (pH 7.4), 1mM EDTA.
Maxam and Gilbert Sequencing Solutions
DMS Buffer: 50mM Sodium cacodylate (pH 8.0), 1raM EDTA.
DMS Stop Solution: 1.5M NaOAc (pH 7.0), 1M mercaptoethanol, 100ug/ml
tRNA.
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Hydrazine Stop Solution: 0.3M NaOAe, 0.1M EDTA, 25ug/ml tRNA.
S1 Nuclease Mapping Solutions
Hybridization Solution: 40mM PIPES adjusted to pH 7.4 with NaOH,
400raM NaCl, 1mM EDTA, 80% formamide (de-ionized with mixed-bed resin). 
Stored at -70°C.
5X Digestion Buffer: 280mM NaCl, 30raM NaOAe (pH 4.4), 4.5mM Zn(0Ac)2.
Stored at -70°C.
Termination Solution: 2.5M NH^OAc, 50mM EDTA. Stored at 4°C.
Phenol: All phenol used in the purification of DNA or RNA contained
0.1% 8-hydroxyquinoline and was buffered against 0.5M Tris-HCl (pH 
8.0)
Phenol/Chloroform: 50 parts phenol, 49 parts chloroform, 1 part
isoamyl alcohol.
Birnboim Doly I (BDI): 50mM glucose, 25mM Tris-HCl (pH 8.0), 10mM
EDTA. Add lysozyme to 1mg/ml immediatley before use, if necessary.
Birnboim Doly II (BDII): 0.2M NaOH, 1% S.D.S., stored in a plastic
container.
Birnboim Doly III (BDIII): 5M KOAc (pH 4.8); mix equal volumes of 3M
CH3COOK and 2M CH3COOH, pH should be 4.8.
STET Buffer: 8% Sucrose, 5% Triton X-100, 50mM EDTA, 50mM Tris-HCl
(pH 8.0).
PEG Solution: 20% PEG 8000, 2.5M NaCl.
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Kirby Mix: 1g Tri-iso propylnapthalenesulphonate, 6g 4-amino
salycilate (Na salt), 50mM Tris-HCl (pH 8.3)» 6mls phenol, made up to 
100mls in distilled water.
Streptomvces Transformation Solutions:
Transformation Mix (T-Mix): 2.5? sucrose, 100mM CaCl2, 2.5mM K2S0jj,
1ml trace elements, 50mM maleic acic, adjust to pH 8.0 with 1M Tris. 
Add 25? (w/v) PEG 1000 before use.
Medium P: 5.73g TES, 103g sucrose, 2.93g MgCl2.7H20, 0.5g K2S0]|,
3.68g CaCl2.2H20, 2ml trace element solution. Adjust to pH 7.4 with 
NaOH and make up to 1 litre in distilled water.
Lysozyme Solution: 10? sucrose, 25mM TES buffer (pH 7.2), 2.5mM
k2S04» 2ml trace elements, 2.5mM MgCl2, 2.5mM CaCl2. Add 0.3mg/ml 
lysozyme and 0 .5ml of KH2P02|/100ml solution immediatley before use.
2.7 Antibiotics and Indicators: The antibiotic concentrations used
throughtout for both liquid and plate selection were as follows:
NAME SELECTIVE STOCK SOLUTION STORAGE
Stock solutions were added to molten agar, cooled to 55°C.
X-gal (5-bromo-4-chloro-3-indolyl-B-galactosidase) was used in 
conjunction with the host strains JM101 and DS941 and the pUC and 
M13mp vectors providing a screen for plasmids with inserts in the 
polylinker region. Clones containing inserts are generally white and
CONCENTRATION TEMPERATURE
Ampicillin 
Kanamycin 
Oxy-tetracycline 
Thiostrepton
50ug/ml 20rag/ml (water) -20°C
5-250ug/ml 20mg/ml (water) -20°C
50ug/ml 5mg/ml (10mM HC1) fresh
25ug/ml or 10mg/ml (DMS0) 4°C
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clones lacking inserts are blue. X-gal was stored at a concentration 
of 20mg/ml in DMF at -20° and added to L-agar plates to a final 
concentration of 20ug/ml.
2.8 E.coli Growth Conditions:
Liquid culture for transformation and DNA preparations were routinely 
grown in L-broth at 37° with vigourous shaking. JH101 liquid cultures 
for ssDNA preparations were grown in 2YT at 37° in a rollerdrum for 5- 
6hrs.
Growth on plates was on L-agar or minimal media plus supplemnts; 
antibiotics were added as required. Plates contained 25mls of agar 
solution and were incubated overnight. All dilutions were carried out 
in L-broth. Strains were stored in 20% glycerol and 1% peptone at - 
70°C. Innocula from these stocks were streaked out on L-agar plates, 
incubated and single colonies were re-streaked on selective plates.
2*9 Streptomvces Growth Conditions:
Liquid culture for protoplasting, DNA and RNA preparations were grown 
in Y.E.M.E. for S.lividans strains and T.S.B. for S.rimosus strains. 
Cultures were incubated at 30°C with vigourous shaking for 
approximatley 2 days. The cultures were innoculated from slopes 
stored at -20°C or spore suspensions also stored at -20°C.
Strains were stored on agar slopes (15mls) which were germinated for
4—5 days and then frozen at -20°C. Spore suspensions in 80% dH20 and 
20% glycerol were also stored at -20°C.
Growth on protoplast regeneration plates was at 30°C and antibiotics 
were overlayed on plates after l6-2Mhrs of incubation. Plates were 
further incubated for 3-4 days. S.lividans protoplasts were 
regenerated on R2 agar plates and S.rimosus on R9 agar plates.
2.10 E.coli in vivo Techniques:
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Ethanol precipitation of DNA: The DNA solution was made 0.3M in NaOAe
and 2 volumes of cold ethanol added. After mixing, the DNA was 
precipitated by cooling on ice for up to 1 hour and pelleted by 
centrifugation (27000g, 15min, 4°C for large volumes or 12000g, 15min, 
1}°C for small volumes in eppendorf centrifuge tubes). The pellet was 
usually washed in 70% ethanol and dried briefly in a vacuum drier.
Restriction of DNA: Restrictions were usually performed in a total
volume of 20ul containing between 0.25ug and 1ug of DNA, 2ul of 10X 
restriction buffer and 1 unit/ug DNA of enzyme, the volume being made 
up with distilled water. For larger scale restrictions the volumes 
were scaled up accordingly. The reactions were allowed to proceed for 
1 to 2 hours at the appropriate temperature. Reactions were stopped 
either by the addition of gel loading buffer or by rapid heating to 
70°C for 5 min followed by rapid cooling on ice.
Ligation of DNA fragments: The restriction fragments to be ligated
were mixed such that the insert was in 3 times excess over the vector 
(10 times excess for blunt end ligations) and made up to 20ul by the 
addition of 2ul 10 X ligation buffer, 2ul *imM ATP and distilled water. 
T4 DNA ligase was added (0.01 units/ug DNA for 'sticky1 end ligation 
and 1 unit/ug DNA for 'Blunt* end ligation) and the solution ligated 
for 1 hour at room temperature (overnight at 16°C for 'blunt* end 
ligations). Aliquots of the ligation mix were used to transform 
competent cells.
Calf Intestinal Phosphatase (CIP) treatment: To increase cloning
efficiency, CIP was used to remove the 5'-terminal phosphate groups 
from the linearised vector to prevent recircularisation of the vector. 
This technique is particularly useful if there is no direct selection 
for the insert. CIP works in core buffer and was used at a 
concentration of 1-2 units/ug DNA. It was added directly to the 
restriction digest for the final 15min of the incubation and was heat 
killed in the manner described for restriction enzymes. If the DNA was 
been prepared for kinase end labelling, it was also phenol extracted.
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Transformation with plasmid DNA: Plasmids were introduced to
different strains by genetic transformation. An overnight culture of 
the recipient was diluted 1 in 100 into 100ml L-broth and was grown to 
a density of approximately 10® cel Is/ml (about 90min - 2 hours). The 
cells were harvested (12000g, 5min, 4°C) and resuspended in 50ml of 
cold 50mM CaC^. The cells were pelleted again, resuspended in 5ml of 
cold 50mM CaC^ and kept on ice for at least 15min before use. 200ul 
aliquots of the competent cells were added to the plasmid DNA, mixed 
gently and left on ice for up to 1 hour. The cells were heat shocked 
(2min, 42°C) and returned to the ice for a further 15min. The cells 
were plated out on the appropriate selections. For transformation to 
ampicillin resistance, no expression time was necessary. Unused cells 
were frozen at -70°C in 20$ glycerol.
2.11 Streptomvces in vivo Techniques:
Preparation of Protoplasts: 25ml cultures were grown in the
appropriate medium for 30-36hrs. Mycelia were pelleted at 12100g for 
10 mins and washed twice in 10.3$ sucrose. The mycelia were 
resuspended in Jjml of lysozyme solution and incubated at 37°C for 15- 
30 mins. The mycelia were examined microscopically to monitor 
protoplast formation. Add 5mls of P medium, triturate a couple of 
times and filter the protoplasts through cotton wool. Pellet the 
protoplasts at 12100g for 10 mins and wash twice in P medium. 
Resuspend protoplasts in 4mls, dispense into 200ul aliquots and freeze 
at -70°C.
Transformation of Protoplasts: Add DNA to protoplasts and within 
30secs add 0.5mls T-mix. Dilute protoplasts in medium P to 2mls after 
10sec. Plate out on regeneration plates which have been dried 
overnight.
2.12 In Vitro Techniques:
Plasmid DNA preparation: Two methods were used to obtain DNA from
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cells.
Birmboin and Doly (1979) DNA preparation: 200 ml cultures of
stationary phase cells were harvested by centrifugation (12000g, 5min 
at 4°C). The pellet was resuspended in 4ml of Birmboin-Doly I
solution and incubated on ice for 5min for E.coli cultures and 
incubated at 37°C for 15min with 100ug/ml lysozyme for Streptomvces 
cultures. 8ml of Birmboin-Doly II solution were added and the 
solution left on ice for 5min before 6ml of cold Birmboin-Doly III 
solution was added, gently mixed and left on ice for a further 5min. 
The cell debris and most chromosomal DNA was removed by centrifugation 
(32000g, 5min at 4°C) and the plasmid DNA precipitated by addition of 
an equal volume of isopropanol followed by centrifugation at 39200g 
for 15min. This DNA was further purified by banding on a CsCl/EtBr 
gradient. The DNA was resuspended in 1ml of TE and 4.5g of CsCl 
dissolved in 3.5ml of TE. The DNA and CsCl solutions were added 
together with 250ul of EtBr (10mg/ml). The gradients were centrifuged 
in a Beckman VTi65 vertical rotor at 289,000g for 4hrs at 20°C. Two 
band were visible, a lower supercoiled plasmid band and an upper 
chromosomal and relaxed plasmid DNA band. The lower band was removed 
using a 1ml syringe and the EtBr removed by repeated butanol 
extractions (using water saturated butanol). The salts were removed 
by dialysis in 2 X 500ral 1 X TE. The DNA was then ready for use.
Mini DNA preparation using the method of Holmes and Quigley (1981): 
1.5ml of an overnight culture containing the plasmid of interest was 
harvested by centrifugation in a 1.5ml eppendorf tube and resuspended 
in 350ul of STET buffer. 25ul of STET buffer containing lysozyme at a 
concentration of 10mg/ml was added and the tube vortexed briefly. 
This solution was boiled for 40sec and centrifuged in an eppendorf 
microfuge for 15min at 4°C. The pellet was discarded using a 
toothpick and 40ul of 3M NaAc and 400ul of cold isopropanol was added, 
followed by microcentrifugation for 7min which precipitated the 
nucleic acid. The pellet was washed twice in 70% ethanol and dried 
briefly in a vacuum drier before being resuspended in 20ul - 50ul 1 X 
TE. This DNA was suitable for digestion and other in. vitro
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manipulations.
Total RNA Preparation (Hopvood et .&1 1985a): RNase is a very
persistent enzyme and precautions were taken against contamination of 
equipment and solutions. All glassware was incubated overnight at 
300°C. Distilled water was treated with DEPC (0.1$ of total volume) 
overnight and autoclaved. All solutions were made up from DEPC 
treated water and using previously unused chemicals.
100ml cultures of Streitomvces mycelia were harvested by filtration.
The mycelia were resupended in 12g of 0.45mm glass beads, 5mls of
Kirby mix and vortexed for 2 mins and centrifuged at 6000g for 5 mins.
The supernatant was poured off into an equal volume of
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phenol/chloroform, vortexed and centrifuged at 6000g for mins. The 
aqueous phase was removed and again added to an equal volume of 
phenol/chloroform, vortexed and centrifuged at 6000g for 5 mins. The 
aqueous phase was removed and precipitated in an equal volume of 
isopropanol and 1/10 volume of 3M NaOAe. The isopropanol solution was 
centrifuged at 121 OOg for 5 mins and the pellet resuspended in 1ml of 
DEPC treated d^O.
The RNA preparation at this stage consists of total nucleic acid. The 
DNA and small ribosomal RNA species were largely removed from the 
preparation by sucessive salt precipitations. 3mls of 4M NaOAe were 
added to 1ml of the RNA preparation, incubated at -20°C for 1hr and 
centrifuged at 11400g for 5mins. The pellet was washed in 3M NaOAe, 
centrifuged at 11400g for 5mins, washed in 100$ EtOH and re­
centrifuged at 1l400g for 5mins. The pellet was dried and resuspended 
in 1ml of DEPC treated water and the salt precipitation repeated. The 
final resuspended pellet was added to 1ml of isopropanol and stored at 
-70°C.
The concentration and purity of the RNA preparation were checked by 
taking O.D. readings at 260nm and 280nm.
1 0.D.(260nm)= 40ug/ml
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260/280 = 2.1 Indicates a preparation almost completely free of 
protein.
Preparation of Labelled DNA Probes:
Filling recessed 3* Ends of Double Stranded DNA with Klenow Fragment 
of E.coli DNA Polymerase I:
The DNA was restricted with the appropriate enzyme, precipitated and 
resuspended in dH20. The reaction contained DNA at a concentration of 
1-500ug/ml, unlabelled 1mM nucleotides, 25-50uCi of labelled 
nucleotides, 1/10 volume of 10X klenow buffer and 1U/ug DNA of Klenow. 
The reaction was incubated at r.t. for 15mins and heat killed at 70°C 
for 10mins.
Labelling the 5* Ends of DNA with T4 Polynucleotide Kinase:
The DNA was restricted at the appropriate restriction site, 
phosphatased, phenol extracted, precipitated and resuspended in dH20. 
The reaction contained DNA (1-50pM of 5* ends), 50uCi of <^2p>ATP, 
20U T4 polynucleotide kinase and made up to a final volume of 50ul 
with dH20. The reaction was incubated at 37°C for 30mins, stopped by 
the addition of 200ul of 2.5M NH^OAc, 1ul tRNA (1 mg/ml), 750ul 95$ 
EtOH and precipitated. The pellet was washed in 70$ EtOH, dried and 
resuspended in dH20.
2.13 Gel Electrophoresis
Both DNA and RNA were visualized on horizontal neutral agarose gels. 
0.8$ (w/v) gels were most commonly used and 1-2$ (w/v) gels were used 
for fragments of < 1.5KB.
Mini gels were used for fast analysis of DNA digested with restriction 
enzymes or precipitated. A BRL model H6 gel kit was used. 0.16g 
agarose was added to 20ml of TBE, boiled and cooled to 60°C. 200ng/ml
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EtBr was added and the molten agarose poured into a 7.6cm X 5.1cm gel 
caster and a 8 well slot former (4.1 X 0.8 mm wells) was placed in 
position. After the gel had set the slot former was removed and the 
gel paced in the tank with 500ml of TBE. The gel was electrophoresed 
for 30-45mins at 100V. The separated DNA molecules were visualized on 
a 254nM UV transilluminator.
Full size gels were used to isolate and size DNA molecules. A Yale 
gel tank (23cm X 12.5cm) was used. 150-200mls of agarose made up in 
TBE as before, was poured into the gel apparatus with the required 
slot former in place. When the gel was set, the slot former was 
removed and TBE overlayed on the gel to prevent it drying out during 
electrophoresis. The gel was loaded with samples and electrophoresed 
overnight at 70V or at 200V for 3-4hrs. The seperated DNA molecules 
to be isolated from the gel were visualized with a 302nM hand held UV 
lamp or on «the 254nM UV transilluminator.
Alkaline agarose gels: 2.4g of agarose was added to 200mls of 50mM
NaCl, and 1mM EDTA. The solution was boiled and cooled to 50°C before 
pouring the gel. After the gel had set it was soaked in alkaline gel 
electrophoresis buffer (30raM NaOH, 1mM EDTA) for 30mins. Samples to 
be electrophoresedwere resuspended in alkaline loading buffer (50mM 
NaOH, 1mM EDTA, 2.5/6 Ficoll, 0.02556 bromocresol green). The gel was 
electrophoresed at 70V overnight.
Photographing Gels:
EtBr gels were viewed on a 254nM UV transilluminator and photographed 
using a Polaroid MP.4 Land camera and Polaroid Type 667 film or 
Polaroid pos-neg film. The camera was fitted with a Kodak Wratten 
filter no.9.
Sizing of Restriction Fragments:
The size of linear restriction fragments was estimated from graphs of 
the log-jQ molecular size plotted against the distance travelled of the
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standards on the gel, according to the formula
logM = C X 1/D (Helling et 3I  1974)
M = Molecular size in base pairs 
C = Constant 
D = Distance Migrated
Molecular weight standards were obtained by restriction of lambda 
cl857i>am7 (Philippsen et. al 1978; Haggerty and Sheif 1976), the pUC 
plasmids (Yanisch-Perron .et al, 1985) and 0X174 RF DNA ( Sanger et alf 
1977).
Sequencing Gels: 6% (w/v) denaturing polyacrylamide gels were most
commonly used and made up from the following stocks- 40% acrylamide 
stock (acrylamide: bisacrylamide ; 19:1), urea, 10X TBE.
6% Acrylamide Gel 6% Acrylamide. 30% Formamide Gel
15ml 40% acrylamide 
54g urea 
10ml 10X TBE 
30ml formamide
Made up to a final volume of 100mls in dH20. The urea was dissolved 
by heating at 37°C and the sequencing gel solution stored at 4°C. 
Before pouring the gel 300ul of 10% APS and 50ul of TEMED were added 
to 50ml of the stock solution.
Prerparation of Glass Plates and Pouring the Gel: The plates (40cm X
20cm) were cleaned thoroughly with alcohol and water and assembled 
using two (40cm X 20cm X 0.4mm) spacers and taped together. The gel 
solution was poured from a beaker down one edge of the plates while 
tilting the plates at an angle of about 30°C. The gel was laid at an 
angle of 5°C and the comb inserted to the top of the well teeth. The 
gel polymerized at R.T. usually within 30mins but formamide gels took
15ml 40% acrylamide 
54g urea 
10ml 10X TBE
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at least 1hr.
Electrophoresis of Sequencing Gels: The gel was pre-electrophoresed
for 30min at a constant power of 40W. Prior to loading the samples, 
they were heated to 95°C for 5mins, placed on ice and loaded on to the 
gel. 655 gels were electrophoresed for -1.75-2hrs to read the first 100 
nucleotides and for 4.5-5hrs to read up to *100 nucleotides. 655 (w/v) 
polyacryamide 25$ (v/v) formamide gels were electrophoresed for 2.5- 
3hrs to read the first 100 nucleotides on a gel.
Isolation of DNA from Agarose Gels:
The DNA fragments isolated were visualized with a hand held 302nM UV 
lamp and a small well the width of the band and 1-0.5cm long was cut 
out of the agarose just below the DNA band. A piece of dialysis 
tubing (washed in TBE) the width of the band and 2.5cm long was used 
to line the well and secured in place by tucking it underneath the 
gel. The well was filled with TBE and the gel electrophoresed at 200V 
for 10-20mins. The power was shut down and the TBE in the well and 
the dialysis tubing removed into an eppendorf. The dialysis tubing 
was washed down with the TBE to remove DNA adhering to it and removed 
from the eppendorf.
Removing Impurities from DNA after Isolation from Agarose: 2mls of
high salt buffer was passed through an elutip, followed by 5mls of low 
salt buffer. The DNA in TBE was passed through the elutip , followed 
by 3mls of low salt buffer and then 0.2mls of high salt buffer. 
0.2mls of dHgO was added to the eluate from the high salt wash and 
precipitated with two volumes of EtOH. The sample was resuspended in 
a small volume of dH20, 10-50ul of dH20. The yield was checked by 
looking at the sample on a mini-gel.
2.14 DNA Sequencing:
M13 dideoxy sequencing (Sanger et al 1977a) and Maxam and Gilbert 
(1977) chemical sequencing methods were both used.
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2.14.1 HI3 Dideoxy Sequencing:
Preparation of s.s. Template DNA: An overnight JM101 culture diluted
1:10 in 2TY was innoculated with a white plaque and grown at 37°C for
5-6hrs. The culture was transferred to a 1.5ml eppendorf and 
centrifuged in a microfuge for 5mins. The supernatant was transferred 
to another 1.5ml eppendorf and re-centrifuged. The supernatant was 
transferred again to a 1.5ml eppendorf containing 300ul of PEG 
solution, vortexed and let stand at R.T. for 15mins. The eppendorf 
was centrifuged for 10mins and the supernatant discarded. The 
eppendorf was respun to remove all traces of PEG and the viral pellet 
resuspended in 100ul of TES buffer. 50ul of phenol was added to the 
sarapLe which was vortexed for 15-20secs and centrifuged for 3mins. 
90ul of the aqueous phase was transferred to another eppendorf, 
extracted'with 50ul of chloroform, centrifuged for 3mins and 70ul of 
the aqueous phase removed to a fresh eppendorf to be precipitated. 
The s.s.DNA template was resuspended in 20ul of dH20.
Annealing Primer to Template DNA:
The annealing reaction is performed in a 500ul eppendorf, placed in a
water filled test tube which was in a small water bath at 95°C. The
reaction was incubated for 5mins, the water bath turned off and the 
temperature allowed to equilibrate to R.T.. Oligonucleotides specific 
to insert sequences were annealed at 60°C for 2hrs.
Annealing reaction mix:
5ul s.s.DNA template 
1ul M13 primer (2ng)
1.5ul 10X klenow buffer
2.5ul dH20
Nucleotide Stocks for Sequencing Reactions: dNTP and ddNTP solutions
were made up from 10mM stock solutions. The dNTP mixes (N°) were made 
up as follows:
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A° C° G° ■^O
0.5mM dCTP 20ul 1ul 20ul 20ul
0.5mM dGTP 20ul 20ul 1ul 20ul
0.5mM dTTP 20ul 20ul 20ul lul
10X polymerase 20ul 20ul 20ul 20ul
reaction buffer
The ddNTPs were made up at the following concentrations; 0.1 mM ddATP, 
0.4mM ddTTP, 0.1 mM ddCTP, 0.1 mM ddGTP. Equal volumes of N° mixes and 
ddNTP were combined e.g. 10ul A° mix and 10ul ddATP were added 
together, stored at -20°C and termed the A mix.
Sequencing Reaction: 2ul of A mix was added to the A reaction tube
and so forth for the T, C and G reaction tubes. 2ul -355 d^TP, 1ul 
0.1 mM DTT and 1ul of Klenow fragment (1.5U/ul) were added to the 
annealed primer template sample, mixed gently and 3ul aliquots 
dispensed to each of the reaction tubes A, T, C and G which contained 
the appropriate N mix. The reactions were incubated at 37°C for 
20mins, 1ul of 0.5mM dATP was added to each tube and the incubation 
continued for a further J5mins. The reaction was stopped by the 
addition of 4ul of formamide dye, if the sample was to be 
electrophoresed immediatley, otherwise the sample was stored at -20°C.
2.14.2 Maxam and Gilbert Chemical Sequencing:
32P end labelled DNA fragments ( about 10^ cpm) were used in the 
reactions. The four reactions employed cleaved the DNA specifically at 
1) G residues 2) G+A residues 3) C+T residues 4) C residues. The 
modification and cleavage steps are tabulated below.
A+G G C+T T
1ul carrier DNA 200ul S.C. £Otv*H 10ul dH20 15ul 5M NaCl
(1 mg/ml) 5ul 32P-DNA 10ul 32P-DNA 5ul 32P-DNA
8ul Sod. Cit.
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10ul 32p-dna 
4ul dH20
Add 1ul DMS Add 30ul HZ Add 30ul HZ
80°C for 8min R.T. for 1.5 rain R.T. for 2.5rain
Add 50ul DMS stop Add 200ul HZ stop
250ul 0.3M NaOAc 
2ul tRNA (1mg/ml)
750ul 9556 EtOH (0°C)
750ul EtOH
precipitate 
1ml EtOH wash
precipitate 
250ul 0.3M NaOAc, 750ul 95$ EtOH
vaccura dry
precipitate 
1ml EtOH wash 
vaccura dry
Add to all tubes 100ul of 1M piperidine, resuspend pellet and heat at 
90°C for 30rains. Add 500ul EtOH, 20ul 3M NaOAc, 5ul carrier DNA, 
100ul dH20 and precipitate. The pellet was washed in 70$ EtOH, vaccum 
dried and resuspended in form amide dye.
2.15 S1 nuclease mapping (Hopwood et al 1985a):
Hybridisation: 1-100ng of DNA (in a small volume) was added to JJOug
of RNA, stored as an isopropanol suspension (50$ isopropanol, 0.3M 
NaOAc). The sample was centrifuged for 10min and the pellet dried in 
a vacuum desicator. The pellet was resuspended throughly in 10ul of 
hybridisation solution and incubated for 10rain at 85°C in a dri-block. 
The temperature was reduced to the appropriate hybribisation 
temperature (5°C above the Tm[DNA/DNA]) and the samples incubated for 
3 hours.
S1 nuclease digestion: 300ul of chilled (0°C) S1 nuclease digestion
solution containing 50-100 units of S1 nuclease was added to each 
sample. The samples were vortexed and placed on ice imediately. 
After processing, all the samples were incubated at 37°C for 30min.
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75ul of S1 termination solution and 7.5ul of tRNA (1 mg/ml) was added 
to each sample and mixed by vortexing. MOOul of isopropanol was added 
and the nucleic acid precipitated by centrifugation for 10mins after 
being chilled on ice for 5min. The pellets were vacuum dried and 
resuspended in the appropriate gel loading buffer prior to 
electrophoresis on alkaline agarose gels or denaturing polyacrylamide 
gels.
2.16 Unidirectional digestion with exonuclease III to create targeted 
deletion derivatives of M13 clones
10ug of double stranded RF DNA was digested with PstI and BamHI. The 
sample was precipitated and resuspended in 50ul of ExoIII digestion 
buffer. 67 units of ExoIII were added and digestion proceded at room 
temperature. 2.5ul aliquots were removed at 3min intervals and mixed 
with 7.5ul of ExoIII stop buffer and incubated at 70°C for 10min. The 
samples were precipitated, dried and resuspended in 50ul S1 digestion 
buffer containing 15 units of S1 nuclease and incubated at 37°C for 
30min. 6ul of S1 termination buffer was added to each sample and the 
aliquots extracted with 25ul Phenol followed by 25ul Chloroform. The 
samples were precipitated and resuspended in 10ul of a 10raM Tris.HCl 
(pH8.0), 7mM M g C ^  solution. 0.1 unit of Klenow was added and the 
samples incubated for 10min at 37°C. 1ul of a 0.1 mM mix of the four 
deoxyribonucleotideswas added and the incubation continued for a 
further 2min. 40ul of 1X ligation buffer with 1 unit of T4 DNA ligase 
was added and incubated at room temperature for 3-6 hours. 20ul of 
each time point sample was transformed into DS9^1 competent cells . 
Plaques resulting from the transformation were screened for deleted 
derivatives. The ExoIII digestion was found to proceed at about 
50bp/min.
37
CHAPTER 3
Sequence of the BamHI/SstI fragment which encodes otcl
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Two OTC resistance genes have been cloned from S.rimosus. otcl and 
otcll (Rhodes et al 1984). Alleles of these genes have been cloned 
independently by Ohnuki et al (1985) and named tetA and tetB, 
equivalent to otcl and otcll respectively. A third group have also 
cloned an OTC resistance gene from S.rimosusr named tet347, which is 
equivalent to otcll and tetB (Drocourt pers. comm. 1987). tetA and 
otcl were shown to mediate tetracycline resistance at the level of 
protein synthesis (Ohnuki et al 1985, Doyle et al 1986) and tetB 
functions by reducing the accumulation of tetracycline in the cell 
(Ohnuki et al 1985). Studies of tetracycline resistance in gram 
negative bacteria have revealed five classes of tetracycline 
resistance determinants as judged by DNA/DNA hybridisation and levels 
of tetracycline and minocycline resistance. However all classes 
mediate tetracycline resistance by active efflux of the drug out of 
the cell (Mendrez et al 1980). Three other resistance determinants 
designated tetL. tetM and tetN have been identified in Streptococcus. 
They can also be distinguished by*DNA/DNA hybridisation and levels of 
sensitivity to tetracycline antibiotics (Burdett et al 1982). The 
tetL determinant probably mediates resistance to tetracycline by 
active efflux as cells containing this determinant do not accumulate 
tetracycline (Burdett 1986). Both tetM and tetN determinants have no 
effect on the accumulation of tetracycline in cells but their protein 
synthesizing machinery is resistant to tetracycline (Burdett 1986). 
The tetM determinant has been sequenced and encodes a protein with a 
predicted molecular weight of 72.574KD (Martin et al 1986). The 
calculated hydropathy value of the tetM gene product would predict 
that it is a soluble protein. In vitro transcription/translation of 
DNA expressing the otc-1 gene product predicted that it encodes a 70KD 
protein (Doyle et al 1986).
The DNA sequence of the otc-1 gene would enable a direct comparison of 
these two proteins to be made. Both proteins mediate tetracycline 
resistance by interacting with the ribosome. However it is not known 
if the resistance mechanism is the same. An analysis of DNA and amino 
acid homologies should indicate if there is any functional homology 
between the two gene products. The sequence 5* to the coding region,
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identify regulatory sequences controlling the expression of otc-1. 
Therefore the 2657bp BamHI/SstI DNA fragment which encodes otc-1 has 
been sequenced.
Sequencing strategies have been widely developed since the original 
random or shotgun approachs were used. Unidirectional digestion with 
exonuclease III (ExoIII) of large clones produces a set of nested 
deletions suitable for sequencing (Henikoff 1984). M13 dideoxy
sequencing of deletions produced in this way is a very efficent method 
of sequencing large fragments of DNA. This method was used to 
sequence segments of DNA which did not contain any convenient 
restriction sites for subcloning and the remainder of the sequence was 
derived from subclones.
DNA with a high $GC (72$ for streptomycetes) content is intrinsically
more difficult to sequence. Inverted repeat sequences occur
(
frequently and can hybridise to form secondary structures such as 
hairpin loops. G-C base pairing involves three hydrogen bonds which 
forms a stronger bond than A-T base pairing, involving two hydrogen 
bonds. The large fragment of DNA polymerase I (Klenow enzyme) 
commonly used for M13 dideoxy sequencing can exhibit some difficulty 
in reading through regions of secondary structure and may produce 
artifactual bands in all four sequencing tracks. Secondly the product 
of the sequencing reaction may form regions of secondary structure 
which produce compressions of bands on the sequencing gel and result 
in part of the sequence being unreadable. Strategies to overcome 
these problems, including formamide gels and Maxam and Gilbert (1977) 
sequencing, were employed and are discussed in the results and 
discussion sections.
3-2 Sequencing Strategy
Ten subclones of the BamHI/SstI DNA fragment containing the otcl gene 
(Fig 3.1a: pDM112, pDM113, PDM122, pDM123, PDM172, pDM173, PDM182,
PDM183, pDM152 and pDM153) served as templates in dideoxy sequencing 
reactions. Approximatley 60$ of the BamHI/SstI fragment was sequenced 
in this way. Deletion derivatives of pDM172, pDM173» PDM182 and
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Fig 3.1 M13 Clones and Sequencing Strategy
(A) n 13 clones constructed to sequence the Ba;nM1/Sst1 fragment. The 
arrowheads indicate the orientation with respect to the sequencing 
primer.
(B) Restriction map of the relevant restriction sites for subcloning 
the 2657bp BamHI/SstI fragment.
(C) Sequencing strategy.
PDM183 (Fig 3.1a: pDM1721, pDM1722, PDM1723, PDM1731, PDM1732,
PDM1733, PDM1821, PDM1822, PDM1823, PDM1824, PDM1831, PDM1832, PDM1833 
and PDM1834) were constructed by exonuclease III digestion and used 
to determine the remainder of the sequence. Upon completion of this 
work, four non-overlapping regions of the sequence remained at 
restriction site boundaries. These four boundary regions occured at a 
Bell site at 216bp, a Smal site at 573bp, a Smal site at 1319bp and a 
Smal site at 2375bp. The Bell (2l6bp) and Smal (573bp) junctions were 
sequenced using oligonucleotides which primed the sequencing reactions 
at 383bp and 371 bp respectively and pDM192 and pDM193 served as 
templates. The junction at the Smal site at 1319bp was sequenced 
across using the Sphl/BamHI clone pDM192. The junction at the Smal 
site at 2375bp was sequenced by chemical sequencing of a 362bp Dde1 
fragment from 2062bp-2427bp.
3-2.1 Construction of subclones from the BamHI/SstI fragment in M13
All clones are diagrammed in Fig 3.1. pDM112 and pDM113 were derived 
from pDM101. The BamHI/BclI insert from pDM101 (Section 4.2.1) was 
subcloned as a Hindlll/EcoRI fragment in M13mpl8 and M13mp19 vectors, 
giving pDM112 and pDM113 respectively. pDM122 and pDM123 were derived 
from pDM102. pDM102 was constructed by subcloning the 357bp Bell/Smal 
fragment into pUCl8. The Bcll/Smal insert was subcloned on a 
Hindlll/EcoRI fragment in M13mpl8 and M13mp19 vectors, giving pDM122 
and pDM123 respectively. pDM172 and pDM173 were constructed by 
subcloning the 746bp Smal fragment from pGLW7 into M13mp18 in both 
orientations. PDM182 and PDM183 were constructed by subcloning the 
1056bp Smal fragment from pGLW7 into M13mpl8 in both orientations. 
PDM152 and pDM153 were derived from pDM105. pDM105 was constructed by 
subcloning the 277bp Smal/SstI fragment in pUCl8. The Smal/SstI 
insert from pDM105 was subcloned on a Hindlll/EcoRI fragment in 
M13mpl8 and M13mp19 vectors, giving pDM152 and pDM153 respectively. 
pDM192 and pDM193 were constructed by subcloning the BamHI/SphI 
fragment from pPZ24 into M13mpl8 and M13mp19 respectively.
3-2.2 Construction of ExoIII deletions from pDM172, pDH173, PDM182
and PDM183
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Fig 3.2 Analysis of ExoIII Deletion Clones
(A) Plasmid map of pDM182.- -Restriction sites used Jto analyse the 
size of the deletion, EcoRI and Bglll. and to confirm the U.P. site 
is intact, Hindlll and BgHI, are indicated. -
(3) Lane 1: Hindlll/EcoRI lambda DNA markers.
Lane 2: Hindlll/Bglll restriction digest of pDMl82
Lane 3: EcoRI/Bglll restriction digest of pDMl82
Lane A,6,8,10: Hindlll/Bglll restriction digest of pDMl82
derivatives a,b,c and d respectively, digested for Amin with
exoIII at R.T.
Lane 5,7,9,11: EcoRI/Bglll restriction digest of pDMl82
derivatives a,b,c and d respectively.
(C) All lanes identical except that the pDhl32 derivatives were 
treated with exoIII for 8mins at R.T.
The exoIII digestion procedure (2.16) was followed and several plaques 
were screened from each time point. The DNA was restricted and
examined by agarose gel electrophoresis to determine the size of the 
deletion and confirm the presence of the universal priming site. Fig
3.2 shows a typical example of the deletions recovered. The majority 
of the deletions were in the expected size range assuming a digestion 
rate of approximately 50 bases per minute. Two random size classes 
were also observed:
(a) deletions which had proceeded in both directions and therefore
appeared to have progressed beyond the expected size for a particular 
time point. Incomplete digestion with the enzyme used to produce the 
3* overhang probably caused these deletions and they were discarded 
because they had lost the universal priming site.
(b) a second class of deletions was observed which had an intact
universal priming site but had progressed further than expected for a 
particular time point. Henikoff (1984) suggests that these deletions 
result from random degradation prior to ligation possibly caused by 
preexisting nicks in the RF DNA, by restriction enzyme impurities or 
by breaks occurring during S1 nuclease digestion. These clones v/ere 
still useful as alternative deletions not included in the experimental 
design. The selected ExoIII deletion clones pDM1721-3> pDM1731-3»
PDM1821-4 and pDM1831-4 are shown in Fig 3.1.
3.3 Sequencing Methods
The M13 dideoxy sequencing method was employed almost exclusively and 
was carried out as described in section 2.14.1. Minor alterations of 
the method described in the B.R.L. sequencing handbook were required 
due to the high G+C content of the DNA.
3.3.1 Dideoxy Concentrations
The B.R.L. M13 sequencing handbook recommended concentrations of 0.1mM 
ddATP, 1.0mM ddTTP, 0.3mM ddCTP and 0.5niM ddGTP were used. However 
this protocol produced premature termination in the T, C and G tracks 
using streptomyete DNA templates. G tracks were particularly
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Fig 3-3 Sequence primed from oligo-86 and oligo-89 on template DNA 
from pDM193 and pDM192 respectively.
problematic failing to produce sequence beyond 150-200 bases. The 
concentrations of ddTTP, ddCTP and ddGTP were reduced to 0.4mM, 0.1mM 
and 0.1mM respectively. At these concentrations, C and G tracks ran 
out before the A and T tracks but sequences of up to 300 bases were 
readable and the conditions were not optimized further.
3*3*2 Annealing of oligonucleotides
The universal 17>p primer was sucessfully annealed by incubation at 
90°C for 5min followed by gradual cooling to room temperature. The 
oligonucleotides 86 and 89 were annealed to the sequencing template by 
the same method.
T
Te-SC-TT&CCG ^C&TC. 
oligo-86 * ' ^
, oligo-89 AAGCTGAATCTGGGCAT 
355 371
The sequence derived from the oligonucleotide primers was unreadable 
(Fig 3.3(a)), producing many spurious bands. The banding pattern 
indicated that the oligonucleotides might be hybridizing to more than 
one site on the template DNA. The annealing temperature was raised 
from R.T. to 60°C to increase the stringency of the annealing reaction 
and the sequencing reaction was carried out at 37 °C as before. The 
sequence primed from oligo-89 was readable but many spurious bands 
remained in the sequence primed from oligo-86 (Fig 3.3(b)). Oligo-86 
was again annealed to the template DNA at 60°C and the sequencing 
reactions carried out at 60°C for 1min followed by a 3min chase, to 
eliminate any secondary annealing during the sequencing reaction. 
This procedure produced an unambiguous sequence pattern (Fig 3.3(c)).
3*4 Trouble Shooting
Some regions of the sequence were difficult to read, due to areas of 
compression on gels or simply small regions of sequence which were 
ambiguous after sequencing both strands. These problems were overcome 
with formamide gels, which help to denature secondary structures which
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(A) Sequence of pDM1733 electrophoresed on a 6% polyacrylamide 
(p.a.) gel
(B) Sequence of pDM1733 electrophoresed on a 25% formamide, 6% p.a 
gel
(C) Sequence of pDM1722 electrophoresed on 6% p.a. gel
(D) Sequence of pDM1722 electrophoresed on a 40% formamide, 6% p.a 
gel
— ^ - indicates regions of compression 
— - indicates opened out compressed regions
used as an additional tool to clarify any ambiguous sequence. Reverse 
transcriptase was used in place of Klenow enzyme and 7 de aza-G in 
place of dGTP but neither of these alterations had any significant 
effect on resolving ambiguous sequence.
3.4.1 Formamide Gels
Formamide increases the denaturing capacity of a gel and is useful for 
analysing sequence compressions caused by secondary structure. 
Various concentrations of formamide were tested for the clarity of the 
sequence obtained. Formamide increases the electrophoresis time of a 
gel and can decrease the resolution. 40$(v/v) formamide sequencing 
gels were electrophoresed for twice the usual time and produced rather 
fuzzy bands. 25^(v/v) formamide sequencing gels gave good resolution 
though the electrophoresis time was increased by approximately one 
third. Fig 3.4 shows three areas of sequence where compressions were 
observed. In pDM1733 two areas of compression were observed on a 6% 
(w/v) sequencing gel at 1116-1124 and at 1153-1165 (Fig 3.4(a)). The 
sequence was run on a 255&(v/v) formamide sequencing gel which 
completely resolved the compression at bases 1153-1165 and partially 
resolved the compression at bases 1116-1124 (the sequence was 
confirmed on the other strand). In pDM1722 a compression of 16 bases 
from 867-882 was resolved on a 40? formamide sequencing gel (Fig 
3.4(b)).
3.4.2MaxamandGilbertchemical sequencing
Two regions of ambiguous sequence were not completely resolved by the 
incorporation of formamide in the sequencing gels. The C at 845bp was 
unclear on both strands and the sequence from 2100-2124bp was 
difficult to interpret. These regions were subsequently sequenced by 
the Maxam and Gilbert chemical sequencing method. The C at 845bp was 
confirmed when a 475bp XhoII/BstEII(776-1251bp) fragment, 51 end- 
labelled at the XhoII site, was sequenced. The second region from 
2100-2124bp is within a 365bp Ddel fragment at 2026-2427bp. This 
fragment was isolated from an agarose gel, 5f end-labelled and the 
strands separated on a 5% (w/v) non-denaturing polyacrylamide gel.
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2100-2124 resolved the ambiguities encountered in the dideoxy 
sequence. The sequence from the second strand provided sequence 
across the Smal junction at 2375bp and confirmed the sequence already 
established.
3.5 Confirmation of sequence by analysis of predicted restriction 
sites
The following restriction sites predicted from the DNA sequence were 
confirmed by analysis of restriction digests on agarose and acrylamide 
gels.
Bst Eli - 1251 bp, 1375bp, I887bp
Dde I - 327bp,2062bp, 2427bp, 2620bp
Hae III - 50bp, 199bp, 528bp
Hinf I - 296bp, 478bp
Mlu I - 923bp, 1103bp
Sst I - 58bp, 225bp
Taa I - 84bp, 566bp
These sites were identified by restriction of the BamHI/SstI fragment
while preparing probes for S1 analysis described in chapter 5 and
preparing DNA for chemical sequencing and confirm the sequence at 
these sites. A complete list of restriction sites is included in the 
appendix.
3.6 Discusssion
3.6.1 Sequence Methodology for streptomycete DNA
Both dideoxy and chemical sequencing methods have been used. The M13 
dideoxy system is quicker than the chemical sequencing procedure and 
does not use any of the hazardous chemicals required for chemical 
sequencing. The dideoxy system is also more versatile. It does not 
depend on restriction sites to create clones, demonstrated by the 
production of deletion clones with ExoIII and it can employ 
oligonucleotides homologous to sequences, but internal to the cloned
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without any subcloning. The dideoxy concentrations in the reaction 
have been manipulated to sequence streptoraycete DNA. The high G+C 
content of the DNA causes premature termination when the normal 
dideoxy concentrations are used because although the incorporation of 
ddG and ddC occurs at the same frequency there is an increased 
concentration of C and G residues. A decrease in the concentration of 
dideoxy nucleotides, decreases the rate of incorporation and therefore 
extends the length of the sequence. However if the concentrations of 
dideoxy nucleotides is too low sequence information may be lost from 
the shorter fragments. Intermediate dideoxy concentrations were 
established for sequencing streptomycete DNA which resulted on average 
in 250-300 bases of sequence per clone. If longer sequences were 
required from a clone two sets of dideoxy concentrations might be used 
to extend the range of sequence available.
Secondary structure causes two types of problems when sequencing by 
the dideoxy method. The first problem is independent of the 
sequencing method and occurs when the labelled DNA forms secondary 
structures which are not denatured in the gel system. This problem 
can be overcome by including formamide in the gel, which increases its 
denaturing capacity. The results in 3.4.1 demonstrate the efficency 
of the system. However, not all ambiguities were completely resolved 
on formamide gels (Fig 3.4(b)).
The second sequencing problem is a consequence of the dideoxy 
sequencing system. Some DNA sequences, for example consecutive G 
residues, prevent the Klenow enzyme from reading through the sequence 
and usually intense bands appear in all four tracks followed by faint 
sequence if any at all. Runs of G residues (up to 5) were 
sucessfully sequenced but it was noticeable that bands sometimes 
occurred in all four lanes at specific bases and at low intensity 
which indicates that the Klenow enzyme was having some difficulty 
reading through these regions. The sequence from bases 2100-2124 was 
not completely resolved on formamide gels but compressed regions were 
apparent from the spacing of the bands. Further ambiguities arose 
from extra bands which were unevenly spaced even in relation to the 
compressed areas. It appeared that the Klenow enzyme found it
2109 2119 5115 5125
M13mpie TGACCCCGTTAAAACTT M13mpl8 CTGGTGAATCTGCCAAT
#« « «  ««« — « — — — — **
oligo-86 <6- TGACGCCGGCAAGACCA oligo-89 AAGCTGAATCTGGGCAT
3' 5 5' .3'
6670 6680
M13mpl8 TGGCTACAGGAAGGCCA
oligo-86 «- TGACGCCGGCAAGACCA 
3' 5'
493 503
otcl GAGCGGCAGCGCGGCAT
# # #  * * *
oligo-89 AAGCTGAATCTGGGCAT —
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Fig 3-5 Diagram displaying the mismatch homology of Aoligo-86, 
oligo-89 and the universal 17bp sequencing primer with the M13mpl8 
DNA sequence and the DNA sequence of the pDM192 insert.
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at bases 212^-2128) and that the formation of secondary structures 
was causing compressions. The chemical sequencing method is less 
affected by the secondary structure of the DNA to be sequenced, 
because it modifies and cleaves each base randomly. The chemical 
sequence of this region was much clearer with no spurious extra bands, 
though as expected the compressions were still visible. Chemical 
sequencing is a useful alternative to resolve sequence which Klenow 
enzyme is unable to elucidate. Other strategies for resolving 
secondary structure compressions, which have not been investigated, 
include the use of dITP as a substitute for dGTP in the dideoxy mix 
and the elimination of cytosine rings after the chemical reactions are 
complete. The inosine base forms weaker secondary structures than 
guanine (Amersham Sequencing Manual) and removal of the cytosine ring 
in chemical reactions prevents any G:C secondary structures forming 
(Ambartsumyan and Mazo 1980).
Sequencing with custom-built oligonucleotides as primers enables the 
extension of a sequence from any part of a clone without resorting to 
further subcloning. The results in section 3-3*2 indicate that the 
oligonucleotides must be designed with care to avoid annealing to 
alternative primer sites. The banding patterns in Fig 3-3(a) 
suggested that the oligonucleotides were partly homologous to more 
than one sequence in the clone. Analysis of the homologies between 
the oligonucleotides and the sequence of pDM192 revealed sequences 
which were up to 76$ (13/17 bases) homologous (Fig 3-5). Although 
oligonucleotides may anneal to regions with which they have less than 
100/6 homology, in order to prime the sequencing reaction efficently 
they should be completely homlogous at the 3f end of the 
oligonucleotide. Oligo-86 has 13/17 bp matched with the insert 
sequence from il56-*l72bp and has ten consecutive matched base pairs to 
within one base of the 31 end. It also has a 12/17 bp match with two 
other regions in the insert and a 11/17 bp match to two regions of the 
M13 vetor sequence which includes the base at the 3* end (Fig 3-5). 
Oligo-89 has a 11/17 bp match with three regions of the insert DNA and 
has eight consecutive base pairs of homology at one of these regions 
which includes the 31 end of the oligonucleotide. It also has a 11/17 
bp match with two regions of the M13 vector sequence, again including
*17
the 31 end of the oligonucleotide (Fig 3.5). The universal primer 
(U.P.) has a 10/17 bp match with the insert DNA at four places but 
only in one case does the homology extend to the 3’ end. The U.P. has 
a 11/17 bp match with a region of M13 vector sequence. The homology 
in this case is dispersed along the oligonucleotide and includes the 
3* end (Fig 3.5).
The U.P. does not anneal erroneously to the M13 sequence even though 
it has a 11/17 bp match to one region, but oligo-89 which also has 
11/17 bp matchs to pDM192, produced a shadow sequence superimposed on 
the correctly primed sequence. However one of the homologous regions, 
at 694-710bp, has eight base pairs of consecutive homology starting at 
the 3f end. It is possible that the stability created by the 
consecutive homologous base pairs, which is 62$ GC rich, enabled a 
sequencing reaction to be initiated from this hybrid. It was not 
possible to ascertain which secondary priming site oligo-89 annealed 
to at room temperature because the signals were too weak and probably 
masked by the more intense correctly primed sequence. Therefore it 
was not possible to confirm from which site the shadow sequence was 
initiated but when oligo-89 was annealed at 60°C, a clean sequencing 
pattern was produced (Fig 3.3b). Presumably, at the elevated 
temperature the hybrids formed between oligo-89 and the alternative 
priming sites were destabilized. Oligo-86 has a 13/17 bp match to a 
secondary priming site and has a long run of consecutive homologous 
base pairs. The ten consecutive base pair homology stretches from the 
middle of the oligonucleotide to within one base pair of the 31 end. 
One would not expect a sequencing reaction to be primed from this 
hybrid but the mismatched bases are G and T residues and therefore it 
is possible that they form a bond. The sequence obtained after a 
60°C annealing was still contaminated with spurious bands but 
annealing at higher temperatures such as 65°C, produced no sequence, 
probably because no stable hybrids were formed. The possibility that 
oligo-86 was annealing to secondary sites during the sequencing 
reaction was investigated by conducting the sequence reaction at 60°C 
also. Fig 3.3(c) indicates that this strategy was sucessful, 
suggesting that oligo-86 annealed to the alternative sites while the 
reaction was prepared and/or while the reaction was incubating.
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' D P A T T T V H D V L Q H L I! H G L I R
> -GGittCCd6t:tlACCACGACGGTGCACGACGTACTGCAACGGCTCAACCACGGCCTCATCCG
10 20 30 40 50 60
G D T S S S S' V E E Y E A E I E E A G F
> CGGCGACACGTCGTCCAGCAGCGTCGAGGAGTACCGCGCGGAGATCGAGGAGGCCGGCTT
70 80 90 100 110 120
R V R Q A E R I D E  L L G D W L I ¥ A V
> CCGGGTGCGGCAGGCGGAGCGCATCGACAACCTCCTCGGTGACTGGCTGATAGTCGCCGT
130 140 150 160 170 180
K P *
> CAAGCCCTGACCCTGCGTGGCCGCCCTTGCTAGGGTGATCATGCCCGCGGGTGTGTTCCC
190 200 210 220 230 ,240
> GCCGGGCGGATCACAGCGACGTCAGAGAGGGCGGAACGATGCGGCAGGCGACCACGAATC
250 260 270 280 290 300
M N K L
> CGGCAGGAAAGGTCCGCATCACGACGCTAAGGAATC(:GAACCCCCTCCATG'AACAAGCTG:
310 320 330 340 350 360
N L G I L A H V D A G K T S L T E R L L
> AATCTGGGCATCCTGGCCCACGTTGACGCCGGCAAGACCAGCCTCACCGAGCGCCTGCTG
370 380 390 400 410 420
• - *
H R T G V I D E V  G S V D A G T T T T D
> CACCGCACCGGTGTGATCGACGAGGTCGGCAGCGTGGACGCCGGCACCACGACGACCGAC
,430 440 450 460 470 480
S H E L E R Q R G I T.I R S A V A T F V
> TCGATGGAGCTGGAGCGGCAGCGCGGCATCACCATCCGGTCCGCCGTGGCCACGTTCGTC
490 500 510 520 530 540
, L D D L  K ¥, U L I D T P G H S D F I S E
> CTGGACGATCTCAAGGTCAACCTCATCGACACCCCGGGCCACTCCGACTTCATCTCCGAG-
550 560 570 580 590 600
V E R - A L G V L D C- A ¥ L V ¥ S A V E G
> GTCGAGCGGGCGCTCGGGGTGCTCGACGGCGCGGTCCTGGTGGTCTCGGCCGTCGAGGGC
610 620 630 640 '650 660
V Q P Q T R I L M R T L R R L G I P T L
> GTCCAGCCGCAGACCCGCATCCTGATGCGGACCCTGCGCAGGCTGGGCATTCCCACGCTG
670 680 690 700 710 720
V F V N K I D R G G A R P D G V L R E I
> GTCTTCGTCAACAAGATCGACCGGGGCGGCGCGCGTCCCGACGGTGTGCTGCGGGAGATC
730 740 750 760 770 780
R D R L T P A A V A L S A V A D A G T P
> CGCGACCGGCTCACCCCCGCCGCGGTGGCACTGTCCGCCGTGGCGGACGCCGGCACGCCG
790 800 810 820 830 840
R A R A I A L G P D T D P D F A V R V G
> CGGGCCCGCGCGATCGCGCTCGGCCCGGACACCGACCCGGACTTCGCCGTCCGGGTCGGT
850 860 870 880 890 900
E L L  A D H D D A F L T A Y L D E E H V
> GAGCTGCTGGCCGACCACGACGACGCGTTCCTCACCGCCTACCTGGACGAGGAACACGTA
910 920 930 940 950 960
L T E I C E Y A E E L A A Q  T A R G  L V H
> CTGACCGAGAAGGAGTACGCGGAGGAACTGGCCGCGCAGACCGCGCGCGGTCTGGTGCAC
970 980 990 1000 1010 1020
' P V Y F G S A L  T G S G L D H L V H G I
> CCGGTGTACTTCGGGTCCGCGCTGACCGGCGAGGGCCTGGACCATCTGGTGCACGGCATC
1030 1040 1050 1060 1070 1080
R E L L P S V H A S -  Q D A P L R A T V F
> CGGGAGTTGCTGCCGTCCGTGCACGCGTCGCAGGACGCGCCGCTGCGGGCCACCGTGTTC
1090 . 1100 1110 ' 1120 1130 1140
K V D R G A R G E A V A Y L R L ¥ S G T
> AAGGTGGACCGTGGCGCGCGCGGCGAGGCCGTCGCGTACCTGCGGCTGGTCTCCGGCACG
1150 1160 1170 1180 ' 1190 1200
* ‘ * , '
L G  T R D S V T L H R V D H T G R V T E
> CTGGGCACCCGCGATTCGGTGACGCTGCACCGCGTCGACCACACCGGCCGGGTCACCGAG
1210 1220 1230 1240 1250 1260
H A G R I T A L R V F E H G S A T S E T
> CACGCCGGACGCATCACCGCGCTGCGGGTCTTCGAGCACGGGTCGGCCACCAGCGAGACC
1270 1280 1290 1300 1310 1320
R A T A C- D I A Q A W , G L 1C D V' R" *V ‘ G. D
> CGGGCSACCGCCGGGGACATCGCGCAGGCGTGC-GGCCTGAAGGACGTACGGGTCGGTGAC
1330 1340 1350 1360 1370 1380
R ' A G H L D G P P P R H F F A P P S L E
> CGGGCCGGGCACCTCGACC-GTCCCCCGCCGCGCAACTTCTTCGCGCCGCCCAGCCTGGAG
1390 1400 1410 1420 1430 1440
' T V I R  P E R P E E A G R L H A A L R  M
> ACCGTGATCAGGCCGGAGCGCCCGGAGGAAGCGGGACGGCTGCACGCCGCGCTGCGCATG
1450 1460 1470 1480 1490 1500
L D E Q D P S I D L R Q D E E N A A C- A
> CTGGACGAGCAGGACCCCTCGATCGACCTGCGGCAGGACGAGGAGAACGCGGCCGGCGCG
1510 1520 1530 ’ 1540 1550 1560
V V H L Y G E V Q K E I L G S T L A E S
> GTGGTCCGCCTCTACGGGGAGGTC-CAGAAGGAGATCCTCGGCAGCACGCTCGCGGAGTCC
1570 1530 1590 1600 1610 1620
F G V R V R F D P T R T V C I E K P V G
> TTCGC-CGTACGGGTGCGCTTCGACCCGACCCGTACGGTCTGCATCGAAAAGCCCGTGGGG
1630 1640 1650 1660 1670 1680
T G E A L I E L D T R T H N Y F U G A P
> ACCGGCGAGGCGCTGATCGAGCTGGACACGCGGACGCACAACTACTTCTGGGGCGCACCG
1690 1700 1710 1720 1730 1740
W V C A S D R P S P A R A I T F R L A V
> TGGGTCTGCGCGTCGGACCGGCCGAGCCCGGCGCOGGCGATCACGTTCCGTTTGGCGCTG
1750 1760 1770 1780 1790 1800
E L G S L P L A F K K ' A I E E T V H T T
> GAACTGGGCTCGCTCCCCCTGGCCTTCCACAAGGCCATCGAGGAGACGGTGCACACCACC
1810 1820 1830 1840 1850 1860
L R  H G L Y G W Q V T D C A V T L T R T
> CTGCGGCACGGTCTGTACGGCTGGCAGGTCACCGACTGCGCCGTCACCCTGACCCGTACC
1870 1880 1890 1900 1910 1920
G V R S P . V S A A D D F R K A N A R L V
> GGCGTTCGCAGTCCGGTCAGCGCGGCCGACGACTTCCGCAAC-GCCAACGCGCGCTTGGTC
1930 1940 1950 1960 1970 1980
L M D A L G R A G T - E V H E P V S S F E
> CTGATGGACGCGCTCGGCAGGGCCGGTACGGAGGTGCACGAGCCGGTCAGCTCCTTCGAA
1990 2000 2010 2020 2030 20*10
L E V  P A A R L S P V L A K L A E L G A
> CTGGAGGTGCCCGCCGCCCGGCTCAGCCCGGTACTTGCGAAACTCGCGGAACTGGGCGCG
2050 2060 2070 2080 2090 2100
T P G V P T A E G D V F R L E G T M P -  T
> ACGCCCGGTGTGCCCACGGCCGAGGGGGACGTCTTCCGCCTGGAGGGCACGATC-CCGACC
2110 2120 2130 21*10 2150 2160
S L V H D F H Q R V P C- L T Q G E C- V F
> AGCCTCGTGCACGACTTCAACCAGCGGGTTCCCGGACTGACCCAGGGCGAGGGCGTGTTC
2170 2180 2190 2200 2210 2220
L ' A E H R G Y R P  A V G Q P P V R P R P
> CTGGCCGAGCACCGGGGCTACCGGCCCGCCGTCGGACAGCCGCCCGTGCGGCCGCGGCCC
2230 22*10 2250 2260 22?0 2280
E G  P M P L II Pi I) E Y I L H V L K R V
> GAGGGGCCCAACCCGCTCAACCGCGACGAGTACATCCTGCACGTC-CTCAAGCGCGTGTGA
2290 2300 2310 2320 2330 23*10
> ACCGGCACCGGACCGCGCCCCGCGCGGATTTCCGCCCGGGGCGCGGTCCGGTGGTTTCAG
2350 2360 2370 2380 2390 2*100
> GTGCCGGCCTGTACCTGGAGGCGGACCTCAGGCCGTGGATACGGGCTGTCCTGCCGTGCG
2*110 2*120 2430 2440 2450 2460
> TACGGGCCGGTGTTCCGGGAGATTCCGAGGATCAGCATGGATTTCGCCTTGTTCACGGCA
2470 2480 2490 2500 2510 2520
> TCGATCCGGGAAACCGCGCCCAGCTTTTCGAAAACATTGCTCAAATGGCC-TTTCACGGTC
2530 2540 2550 2560 2570 2580
> GCTTCGGTGATGGTGAGCCGGGCGGCGATCTGGCTGTTGCTCAGCCCGCGCGCCACGTTC
2590 . 2600 2610 2620 2630 2640
> TCCATTATCTGGAGCTCGC-ATCCGGCCACCACGACGCTGCACGACGTACTCCAACGGCTC
2650
Fig 3.6 DNA Sequence and predicted amino acid sequence of the 
BamHI/SstI fragment.
Oligonucleotides synthesized as sequencing primers should be designed 
with these problems in mind especially for streptomycete DNA which 
contains many of repeated sequences. If the whole sequence is 
available it is possible to search for mismatch homology to a proposed 
oligonucleotide primer. However in most cases this approach would not 
be possible. To maximize the uniqueness of the primer a long 
oligonucleotide with a low GC content (50-55$) should be chosen for 
sequencing streptomycete DNA. The examples of oligo-89 (47$ G+C) and 
oligo-86 (64$ G+C) demonstrate that an oligo with a high G+C content 
forms more stable hybrids.
3.6.2 Analysis of Sequence
The sequence has been analysed by two methods to identify open reading 
frames (orf's) which encode proteins. Orf's were identified using the 
university computer by translating the DNA sequence and searching the 
3 possible reading frames for translational stop codons, TAA, TAG and 
TGA. Two orf's were identified. Orf 1 occurs at the 5f end of the 
sequence and terminates at a TGA codon at 190bp (Fig 3*6). Orf 2 
starts at an ATG at 349bp and terminates at a TGA codon at 2340bp, 
with the potential to encode a protein of 71.392KD (Fig 3.6). The 
potential of the orf's to code for proteins was assessed by two 
computer analyses, Fickett (Fickett 1982) and Frame (Bibb et al 1984). 
Fickett measures the asymmetry in the distribution of each base among 
the three coding positions and the overall A, C, G and T content. The 
analysis then weights each of these 8 parameters on their ability to 
predict coding sequence in isolation and uses all this information to 
predict if a sequence is coding or non-coding. The second computer 
analysis called Frame, simply measures the frequency of G and C bases 
in each of the positions within a codon (Bibb ejb aJL 1984). Frame is 
particlarly relevant to DNA sequences with extremely high or low $GC 
contents because it is also possible to determine the coding strand of 
such sequences.
The Fickett analysis indicated that both orf's were coding and that 
the intervening sequence between the open reading frames from 191- 
348bp was non-coding. The analysis also indicated a third potential 
coding sequence at the extreme 31 end of the sequence (Fig 3-7). A
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Fig 3-7 Graphical representation of Fickett analysis. Values 
plotted between the horizontal lines at 0.75 and 0.95 are not 
assigned as coding or non-coding sequence. Values above the 0.95 
line represent coding sequence and values below the 0.75 line 
represent non-coding sequence as predicted by the Fickett analysis. 
The diagram below the graph represents the three open reading 
frames. Complete vertical lines indicate translational stop codons. 
Small vertical lines indicate translational start codons, descending 
lines represent.an ATG codon and ascending lines represent a GTG 
codon.
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Fig 3.8 Frame analyses.
In the open reading frame analyses , arrowheads (> and <) indicate 
translational start codons and their orientation; vertical bars (I) 
represent translational stop codons. In the graphical analysis of G+C 
distribution the first triplet position and its associated reading 
frames are represented by a line marked N1> and H2<; the second 
triplet position and its associated reading frames are represented by 
a line marked N2> and N3<; the third triplet position and its 
associated reading frames are represented by a line narked ?J3> and
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Frame analysis indicated the same open reading frames and also showed 
that the potential orf 3* to otc would be transcribed from the 
complementary strand (Fig 3.8). 0rf1 spans the BamHI site and 
probably encodes the 3* end of the otcZ (Fig 1.4) gene product. 
otcZ151 requires sequences 5' to the BamHI §ite for complementation 
indicating that the coding sequence crosses this restriction site. 
There is no evidence of a transcriptional terminator downstream of the 
TGA codon at nt 190. It is predicted that orf2 encodes the otcl gene 
product. It is the only orf in the sequence with an in frame start 
and stop codon and it encodes a protein of 71.392KD which correlates 
very well with the predicted size of the protein, 70K, from in vitro 
transcription/translation assays (Doyle et. al. 1986). The only in 
frame ATG translational start codon between the stop codon at 190bp 
and the coding sequence of orf2, as predicted by computer analysis, 
occurs at 349bp. A comparison of the coding sequence of tetM and otd 
also suggests that the ATG at 349bp is the initiation codon due to the 
amino acid homology at the 5f end of both proteins (discussed in more 
detail below). A poor ribosome binding site (RBS) occurs 9bp from 
this ATG codon with a potentially stronger RBS 15bp from the start 
codon.
AAGGAATCCGAA 
329 3^0
However this is unusually distant from the initiation codon and it is 
unlikely to be utilized. It is possible that translation initiation 
occurs in the absence of a RBS. Three streptomycete genes are known 
to initiate translation in the absence of RBS’s but in these cases 
transcription initiated at or very near the translation initiation 
site (Bibb and Janssen 1987, Horinouchi et al 1987).
The TGA translational stop codon at 2340bp is folowed by a 21 bp 
inverted repeat spanning nucleotides 2346-2393bp (Fig 3.6). The 
theoretical free energy of formation (AG) of the hairpin-loop 
structure was calculated as -70kcal, according to the specifications 
of Tinoco .et ajL (1973). The predicted hairpin -loop structure is 
followed by a short run of T residues, which is usually indicative of 
a terminator structure in the more intensely studied bacteria e.g. 
E.coli. Low resolution S1 mapping of the 3* end of the gene,
s U m C X A X G X
U x Phe 0 x Ser 0 t Tyr 0 X Cys 0 x U
x Phe 1 X Ser 1 X Tyr 1 X Cys 0 X C
x Lqu 0 X Ser 0 X Ter 0 x Ter 1 X A
t Leu 0 X Ser 1 X Tor 0 X Trp 1 X G
C s Lq u 0 x Pro 0 X His 0 x Arg 0 x U
x Lqu 4 x Pro 1 X His 2 x Arg 3 x C
x Lqu 0 x Pro G x Gin 1 X Arg 0 x A
s Lqu 2  x Pro 1 X Gin 1 X Arg 3 x G
A t I1q 0 x Thr 0 x Asn 0 X Ser G x U
t I 1q 3 x Thr 1 X Asn 2 x Ser 2  x C
lie 1 X Thr 0 x Lys 0 x Arg 0 x A
s Mot 0 x Thr 3 x Lys 1 X Arg 0 x G
G : Val 0 x Ala 0 x Asp 1 t Gly 1 X U
X Val 3 x Ala 3 x Asp 4 x Gly 3 x C
• Val 1 X Ala 0 t Glu 0 x Gly G x A
X Val 2 x Ala 2 x Glu 6 x Gly G x G
Percentage base usage in each codon position -
U C A G
3 . 2 9. 5 6 . 9 13. 8
9. 0 6 . 9 10. 1 7. 4
1. 1 1 8 . 0 2. 1 1 2 . 2
Fig 3.9 Codon usage and percentage base usage in each position of a 
codon of orf1, proposed 3* end of otcZ.
8 u 3 c 8 A s G
u 3 Phe 0 3 Ser 0 ft Tyr 0 3 Cys 0 U
8 Phe 20 8 Ser 9 3 Tyr 9 3 Cys 3 C
8 Leu 0 8 Ser 0 ft Ter 0 3 Ter 1 A
3 Leu 3 3 Ser 8 ft Ter 0 3 Trp 4 G
c * Leu 1 ft Pro 0 3 His 1 3 Arg 5 U
3 Leu 19 8 Pro 16 ftft His 22 3 Arg 23 C
•• Leu 0 8 Pro 0 3 Gin 0 3 Arg 0 A
8 Leu 50 ft Pro 24 8 Gin 13 8 Arg 30 G
A 8 lie 1 3 Thr 0 3 Asn 1 ftft Ser 1 U
8 lie 21 3 Thr 34 3 Asn 10 8 Ser 10 C
3 lie 0 ftft Thr 0 8 Lys 1 3 Arg 0 A
3 Met 6 3 Thr 17 ft Lys 12 ft Arg 3 G
G ft• Val 3 8 Ala 0 ft Asp 2 3 Gly 9 U
8 Val 28 ftft Ala 33 3 Asp 41 3 Gly 36 C
8 Val 4 3 Ala 2 ftft Glu 7 3 Gly 4 A
3 Val 30 ft Ala 37 ftft Glu 41 3 Gly 9 G
Percentage base usage in each codon position
U C A G
2. 9 10. 2 5.9 14. 4
9. 3 9. 0 8.0 6. 9
1. 2 16. 8 1.0 14. 4
Fig 3.10 Codon usage and percentage base usage in each position of a 
codon of orf2, proposed otc.1 gene.
approximately 250bp from the SstI site i.e. at approximately nt 2*100, 
which correlates well with the proposed terminator structure.
The otcl coding sequence is 72/6 G+C rich, the 3’end of otcZ is 68% G+C 
rich and the intervening sequence between these protein coding 
sequence is 66% G+C, as expected for streptomycete DNA which is on 
average 72% G+C rich. However the sequence from 2*170-2590 has an 
unusually low G+C content of 54%. A second unusual feature of this 
sequence is that the A and T residues are grouped together in short 
runs of three or four residues (Fig 3.6). The significance of these 
features remains undetermined but similar clusters of T residues have 
been found 3* to the carboxy terminus of tet347 (Drocourt pers. 
comm. 1987).
The codon usage of both orf's is in good agreement with other 
streptomycete coding sequences. As expected, an extremely biased 
choice of synonomous codons is observed. The average % of GC residues 
found in the 1st, 2nd and 3rd positions of a codon in otc-1 are 74%, 
48% and 97% respectively. These figures are reflected in the choice 
of synonomous codons (Fig 3.9, Fig 3.10).
The sequence has been analysed at the DNA level for the presence of 
direct and inverted repeats and the predicted amino acid sequence has 
been analysed for DNA binding motifs and mononucleotide binding 
motifs. No direct or inverted repeat strucures were found apart from 
the proposed terminator sequence at nt 2346-2393. The amino acid 
sequence was analysed according to the method of Dodd and Egan (1987) 
but no potential DNA-binding regions were discovered. A potential 
nucleotide binding site was located at amino acid residues 1-20. This 
conserved site usually occurs, as in this case, at the NH2 terminal 
end of a protein (Moller and Amons 1985). The conserved nucleotide 
binding site of otcl exhibited most homology with the guanine 
nucleotide binding proteins and especially the translational 
elongation factors, indicating that the otcl gene product has the 
potential to bind GTP.
The predicted amino acid (a.a.) sequence of otc-1 has been compared to
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Fig 3.11 A dotmatrix representation of homology at the 35% level, 
between the amino acid sequence of otcl (x-axis) and tetM (y-axis)
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Fig 3.12 A dotmatrix representation of homology at the 70% level 
between the amino acid sequences otcl (x-axis) and tetM (y-axis)
the ammo acid of tetM from Streptococcus. tetC from pBR322 and tets47 
(equivalent to atcll) from S.rimosus. No significant amino acid 
homology was observed between tetC and otc-1 or between tet~347 and 
otcl. which is predictable considering that their mechanisms of 
resistance to tetracycline are quite different. The tetM resistance 
determinant confers resistance to the protein synthesizing machinery 
as does otc-1. A comparison of these two amino acid sequences reveals 
good homology at the 3556 level which is concentrated predominately at 
the amino and carboxy termini (Fig 3.11). No further significant 
homology was discovered by considering the chemical equivalence of 
some amino acids. The NH2 terminal regions of the proteins are very 
highly conserved. Fig 3.12 indicates substantial homology at the 70% 
level. The first 130 amino acids are 6756 homologous. Three other 
regions are highly homologous when the sequences are aligned such that 
two deletions of 10 amino acids are created in the otcl sequence 
between a.a. 170-200 and 300-350. A deletion of one a.a. at 538-540 
aligns the carboxy terminal ends of otcl and tetM to increase the 
homology between these two sequences. These deletions are represented 
in Fig 3.11 and Fig 3.12 by lines which are slightly displaced from 
the diagonal. This level of amino acid sequence homology is highly 
significant. The base compositions of the two genes are radically 
different (tetM - 37% GC : otc-1 - 72^ GC). However the DNA sequences 
are 60% homologous over 400bp at the amino termini of the genes. This 
region shows 67% homology at the amino acid level. No other 
significant homology at the DNA level was apparent.
The predicted amino acid sequences of otcl and tetM have been compared 
with the amino acid sequence of EF-Tu, a translational elongation 
factor from E.coli (Arai ejt al 1980). Fig. 3.13 represents the 
homology between otcl and EF-Tu at the 3556 level. The pattern is very 
similar to Fig 3.11 where homologous regions are concentrated at the 
NH2 terminal ends of the proteins. All three proteins show homology 
over the first 150 amino acids (Fig 3.14). otcl and tetM are 6556 
homologous over this region and EF-Tu exhibits 3656 homology with the 
other two sequences. If chemically equivalent amino acids are 
considered homologous, EF-Tu exhibits 4856 homology with the NH2 
termini of otcl and tetM but there is little effect on the homology 
levels of the less or non-homologous regions. During peptide
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Fig 3-13 A dotmatrix representation of homology at the 35% level 
between the amino acid sequence of otcl (x-axis) and FF-Tu (y-axis
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F ig  3-14 Amino acid sequence of EF-Tu (residues 9 -1 5 8 ), otcl
(residues 1-150) and tetM (residues 1 -150 ). Identical amino 3cids 
have been enclosed in boxes to indicate homology and the chemically 
equivalent amino acids (K,R), (I,L) and (D,E) have also been 
enclosed in boxes.
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the ternary complex AA-tRNA.EF-Tu.GTP. The ternary complex binds to 
ribosomes at the vacant A site, the GTP is hydrolyzed, EF-Tu.GDP is 
released and AA-tRNA is oriented on the ribosome so that peptide bond 
formation can occur (Arai et al 1980). Tetracycline disrupts protein 
synthesis by interfering with the binding of the ternary complex, AA- 
tRNA.EF-TU.GTP, to the A site of the ribosome, otcl and tetM are 
approximately twice the size of EF-TU and have some other conserved 
regions not shared by EF-Tu.
5? homology at the amino acid level may be considered to occur 
randomly, and therefore homology at the 35? level indicates a possible 
evolutionary relationship (Doolittle 1981). The NH2 ends of the otcl 
and tetM gene products are very highly conserved which indicates that 
these two proteins have the same mechanism of resistance and that the 
130a.a. at the NH2 terminal region are essential to the function of 
both proteins. The sequence homology between these two sequences may 
have occurred by divergent or convergent evolutionary processes. 
However all suggested cases of convergent evolution result in 
similarties of function without extensive amino acid homology 
(Bannister and Parker 1985) suggesting a case here of divergent 
evolution. The Benveniste and Davies (1973) hypothesis suggests that 
the plasmid and transposon resistance determinants are derived from 
the resistance determinants of antibiotic-producing species. This 
hypothesis has been tested by comparing the a.a. sequences of 
resistant determinants from antibiotic producing species with their 
functional counterparts on plasmids and transposons. The 
aminoglycoside phosphotransferase (aph) present in S.fradiae has been 
compared to the aph gene of bacterial transposons Tn903 and Tn5 
(Thompson and Gray 1983). The a.a. sequences exhibit an overall 
homology of 36?-40? with more highly conserved regions in the carboxy 
termini. Less extensive a.a. sequence homology has been reported 
between the N-methyl transferases (erm) from S.ervthraeus and the 
plasmid borne erm genes from S.aureus. S.sanguis and B.lichenformis 
(Uchiyama and Weisblum 1985). Similarly tet3*!7 from S.rimosus and the 
plasmid borne tet resistant determinants in S.aureus and tetC from 
pBR322 show less extensive amino acid homology (Drocourt pers. comm. 
1987). These reports support the hypothesis that resistant
53
determinants found on plasmids and transposons in pathogenic Daeteria 
might have originated from the determinants of antibiotic producing 
bacteria where resistance is obligatory for survival. The homology 
between otcl and tetM further supports this hypothesis. The tetM 
protein is 23a.a. shorter than the corresponding otcl sequence, but 
the sequences can be aligned Tor maximal homology by deleting 21 a.a. 
from the otcl sequence. The unusually high levels of homology at the 
NH2 termini suggest this region has a functional role.
The homology between the OTC resistance genes otcl and tetM, and EF-Tu 
is very interesting. It indicates a functional relationship between 
the resistance genes and EF-Tu suggesting that these proteins have GTP 
binding sites and that they may even act as elongation factors, otcl 
and tetM proteins are approximately twice the size of the EF-Tu 
protein and have some conserved regions not shared by EF-Tu, 
indicating that these proteins may have other functional properties, 
probably involved in preventing tetracycline interfering with protein 
synthesis. Based on the homology between the proteins, a plausible 
. hypothesis for the resistance mechanism of otcl and tetM is that they 
act as alternative tetracycline resistant elongation factors, possibly 
by substituting for the usual EF-Tu factors, which are inhibited by 
tetracycline. This would be the first example of an antibiotic 
resistance mechanism which is not mediated by inactivation of the 
drug, modification of the ribosomal target or efflux of the drug out 
of the cell.
5%
CHAPTER 4
Promoter Probe Analysis of the otd Clone
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4.1 Introduction—
A 2.65Kb BamHI/SstI clone encodes otcl (Butter et al 1986). This DNA 
fragment is situated at one end of the OTC biosynthetic early gene 
cluster (Fig 1.4). DNA sequencing data suggested that the otcl gene 
was transcribed from right to left (Fig 4.1, Section 3.6.2) and 
promoter probe vectors have been used to identify promoter activity in 
this clone. Subsequent dissection of the larger fragments exhibiting 
promoter activity by subcloning further defined the location of the 
presumptive promoters and indicated that transcription from these 
promoters is regulated. The S1 analysis data, presented and discussed 
in chapter 5, are consistent with the results discussed in this 
chapter and are discussed in conjunction with the data derived from 
the promoter probe constructs.
Two types of promoter-probe vectors are currently being used in 
Streptomvces. A low copy-number vector pARC1, which contains a 
promoterless gene directing synthesis of a brown pigment, has been 
used to identify promoter activity (Horinouchi and Beppu 1985). The 
advantages of this vector are the non-selective manner of identifying 
promoter activity and the low copy-number which partially recreates 
the natural environment of the promoter. However, pARC1 has only one 
restriction site for inserting fragments to test for promoter 
activity. The second vector system is based on a high copy-number 
vector pIJ101 (V/ard et. ail 1986). Several useful features have been 
incorporated into the promoter-probe plasmids pIJ486 and pIJ487. A 
polylinker 5* to the promoterless neo gene from Tn5 facilitates the 
insertion and excision of fragments being tested. A terminator from 
E.coli phage fd has been incorporated 5* to the polylinker preventing 
any detectable transcriptional read through from vector promoters. A 
translational stop codon, 3’ to the polylinker but in frame and 5f to 
the neo coding region has been included to prevent translational 
fusions which could alter the stability and/or the specific activity 
of the neo gene product. pIJJ|86 and pIJ*l87 differ only in having 
their polylinkers in opposite orientations. These vectors were chosen 
to analyse the potential promoter activity of subclones of the
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Fig 4.1 Diagram of promoter probe constructs based on the pIJ486/487 
vectors. The arrows indicate the orientation of an insert with 
respect to the promoterless Tn5 neo gene. The otcl and otcZ coding 
sequences are denoted by hatched boxes and the arrows above the 
boxes indicate the direction of transcription.
--------- BamHI/SstI fragment because they are well characterised and are more
versatile as cloning vectors.
4.2 Results
4.2.1 Construction of promoter probe clones in pIJ486 and pIJ487
The fragments to be analysed in promoter probe vectors were initially 
subcloned in pUCl8 and subsequently subcloned on Hindlll/EcoRI 
fragments into pIJ486 and pIJ487. This approach was taken because the 
analysis of ligation products is quicker in E.coli than Streptomvces 
and the subsequent subcloning steps into Streptomvces vectors were 
simplified.
The 216bp BamHI/BclI. 573bp BamHI/Smal, 1229bp Bcll/Bcll and 1234bp 
Sall/BamHI fragments from pGLW7 were subcloned into pUCl8 to produce 
pDM101, pDM103» pDM104 and pDM106 respectively. The cloned fragments 
in pDM101 and pDM104 were orientated such that the intact BamHI site 
was nearest the Hindlll site in the polylinker and the Sail site 
within the right end of the Bcll/Bcll fragment was nearest the EcoRI 
site (Fig 4.1).
Hindlll/EcoRI fragments from these clones were subcloned into pIJ486 
and pIJ487 vectors and transformed into TK24 to derive pDM110 and 
pDM 111 from pDM'101, pDM130 and pDM131 from pDM103, PDM141 from pDM104 
and pDMl60 and PDM161 from pDM106. The even numbered clones denote 
PIJ486 constructs and odd numbered clones pIJ487 constructs. All the 
Streptomvces constructs and their orientation with respect to the 
promoterless neo gene are diagrammed in Fig 4.1.
4.2.2 Assay of promoter activity from promoter probe constructs
Spores from TK24 containing each of the constructs including TK24 
containing pIJ486 and pIJ487 as controls, were plated in a dilution 
series on emerson (Em) agar with thiostrepton (tsr) to assess the 
spore count. Approximately equal numbers of spores of each construct
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were subsequently plated on Em plates with tsr at a concentration of 
25ug/ml and kanamycin (km) at concentrations ranging from 100ug/ml to 
900ug/ml. Several independent clones of each construct were tested 
for promoter activity.
No promoter activity was detected from pDMl60 but pDM111 and pDM131 
were both resistant to km at high levels (Table 4.1). The maximal 
level of resistance to kanamycin by pDM131 was not assessed because it 
showed no indication of being inhibited at 900ug/ml km. The inserts in 
pDM111 and pDM131 are subclones of pDMl60 and because of the 
apparently anomalous results, a further 8 independent isolates of 
PDM160 were tested and the km concentration was lowered to 20ug/ml. 
All isolates were analysed by restriction enzyme mapping to ensure 
that no gross structural changes had occurred in the clones. No 
activity was detected from any of these further isolates of PDM160 or 
from the pDMl41 construct.
Both pDM110 and PDM161 were resistant to km indicating promoter 
activity, but PDM161 was more resistant than pDM110 (Table 4.1). 
Independent isolates of pDM130 were found to be both resistant and 
sensitive to km. 18 independent isolates were tested on Em agar with 
tsr and km at a concentration of 20ug/ml. 9 isolates of pDM130 were 
sensitive and 9 isolates were resistant to km at this concentration. 
The 9 resistant isolates were tested at higher km concentrations and 
were resistant to kra concentrations similar to pDM110. To test the 
stability of the resistant and sensitive phenotypes, plasmid DNA was 
isolated from these strains and used to transform S.lividans TK24. 
Secondary transformants were plated on Em agar with tsr and km. 
Sensitivity to km was stably maintained but secondary transformants 
from 3 of the isolates which were resistant to km became sensitive.
Plasmid DNA from sensitive and resistant isolates was resticted with 
PstI and SphI (Fig 4.2). Plasmid DNA from isolates 1, 4, 6, 7, 8, 10, 
11, 12, 13, 15, 16, 17, and 18 showed no structural changes had 
occurred within the limits of resolution on a 1.2$ (w/v) agarose gel. 
The above isolates include all of the resistant isolates and 4 of the
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Sph 1^  
BamHI
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Fig 4.2
(A) Restriction map of pD.*1130, denoting the PstI. SphI. 3mal and 
BamHI restriction sites.
(B) PstI and SphI restriction digests of independent isolates of 
pDM130 to confirm the status of the insert. pDM130 isolates 
4,6,7,8,10,11,15,16 and 18 were resistant to km and 
1,2,3,5,9,12,13,14 and 1? were sensitive.
(B) Lane 1: Hindlll/EcoRI DNA marker
Lane 2, 4, 6, 8, 10, 12, 14, 16 and 18: pDM130 isolate^. 1-9
digested with PstI
Lane 3, 5, 7, 9, 11, 13, 15, 17 and 19: pDM130 isolates 1-9 
digested with SphI
(C) As above except pDM130 isolates 10-18 replace isolates 1-9
2 4 6 8 10 12 14 16 18 
1 3 5 7 9 11 13 15 17 19
sensitive isolates. Plasmid DNA from sensitive isolates 3» 5, 9 and 
14, form mixed populations of intact and deleted derivatives of 
pDM130. The intensity of the approximately 830bp PstI fragment (which 
includes the insert) varies with respect to the three plasmid derived 
PstI fragments, which indicates that the deletions are occurring 
within the insert, and several other smaller bands appeared (Fig 4.2). 
The 830bp PstI fragment in isolates 9 and 14 is very faint indicating 
that the majority of the plasmid population is composed of deletion 
derivatives. The deleted derivatives form a minority within the 
plasmid populations of isolates 3 and 5, especially 5 (Fig 4.2). 
Plasmid DNA from isolate 2 appears to have more complex rearrangments 
involving one of the plasmid derived PstI fragments as well. The most 
predominant deletion derivatives of plasmid DNA isolates 3, 5, 9 and 
14 have deleted a fragment of approximately 300bp, smaller deletions 
of less than 100bp have also been observed in samples 3 and 5 (Fig 
4.2).
4.3 Discussion
The smallest DNA fragment to exhibit promoter activity was the 2l6bp 
BamHI/BclI fragment in pDM110 and pDM111. The promoter activity in 
pDM110 will be referred to as the rightward transcriptional activity 
(towards the otcl structural gene) and the promoter activity from 
PDM111 as the leftward transcriptional activity (transcribing a mRNA 
of unknown function) (Fig 4.1). The presence of other promoters to 
the right of the Bell site cannot be ruled out because the promoter 
probe clones form a set of nested deletions. The S1 mapping analysis, 
presented in chapter 4, identified transcriptional start sites for the 
rightward transcript within the BamHI/BclI fragment and 
transcriptional start sites for the leftward transcript were clustered 
on either side of the Bell site, extending 10bp to the left of the 
Bell site and 40bp to the right of the Bell site. No other 
transcription starts were detected suggesting that promoter activity 
51 to the otcl gene resides within and very close to BamHI/BclI 
fragment.
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The km resistance levels of pDM111 and pDM131 are consistent with 
either a promoter to the left of the Bell site which has been 
partially disrupted by subcloning the BamHI/BclI fragment but still 
retains some promoter activity or with intact promoters on either side 
of the Bell site. Both possibilities would explain the increased 
resistance to km recorded with pDM131. S1 mapping results, presented 
and discussed in Chapter JJ support both of these hypotheses. 6 
transcriptional start sites have been identified, one of which is 10bp 
to the left of the Bell site (named otcpAI) and therefore promoter 
motifs preceeding this start site are likely to have been partially 
disrupted. Part of the promoter has been replaced by vector 
polylinker sequences (Table 5.2), which disrupts a potential -10 
prokaryotic consensus sequence and a potential consensus similar to 
the B.subtilis etc promoter. However the km resistance levels 
indicate that this partially disrupted region is still functional as a 
promoter, so it is possible that the sequence just upstream of the 
transcription start is of more significance to promoter activity 
and/or that the polylinker sequence fortuitously provides the 
necessary additional sequence information for transcription 
initiation.
5 other transcriptional start sites involved in leftward transcription 
have been identified to the right of the Bell site, named otcpA2-6. 
These transcriptional starts could account for the increased km 
resistance levels recorded for pDM131 or the increase may simply be 
due to the undisrupted promoter sequence o_tcpA1, directing 
transcription from the transcriptional start to the left of the Bell 
site.
PDM160 clones were inhibited at concentrations as low as 20ug/ml of 
km. 10 independent isolates of pDMl60 were tested for km resistance, 
all of which failed to grow. T£e plasmid DNA was analysed by 
restriction enzyme digestion and electrophoresis on agarose gels but 
no gross DNA rearrangements were found. This evidence suggests that 
PDM160 which is 66lbp longer than pDM131 is somehow repressing the 
promoter activity recorded from pDM111 and pDM131. All of the extra
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DNA in pDMl60 is part of the coding region of otcl. pDMl60 encodes 
295 a.a. of the otcl protein, which is approximately 45$ of the total 
protein. pDM131 encodes 75 a.a. and pDM111 is not within the coding 
region of otcl (see Chapter 3). The S1 mapping data discussed in 
chapter 4 supports these promoter probe results. The six 
transcription start sites identified for the leftward transcribing 
activity with RNA from S.lividans TK24 (pDM131) were not present with 
RNA from S.rimosus 4018 which contains the complete chromosomal copy 
of the otcl gene.
The mechanism of repression of the pDMl60 construct could be due to a 
cis-acting regulatory sequence or a trans-acting repressor function. 
A cis.-acting regulatory sequence seems unlikely because the target 
site would be a minimum of 3^0bp from the regulatory sequence which 
would be within the coding region of otcl. Enhancer sequences found 
5' and 3' to eukaryotic promoters are known to positively regulate 
expression over large distance but there is no precedent for such 
sequences in prokaryotic organisms (Serfling .et al, 1 985). The 
alternative mechanisms of repression would involve the otcl 
transcriptional product or the translational product (or at least the 
N terminal end of the polypeptide) repressing transcription from 
these promoters. There is no evidence that mRNA species which are 
translated can also act as antisense mRNA regulators (Green et. al. 
1986), therefore the most likely mechanism of repression would be at 
the polypeptide level.
Both the function and length of the leftward transcript are unknown. 
The transcription unit overlaps the coding region of the 31 end of the 
otcZ gene which terminates 190bp to the right of the BamHI site. The 
distribution of bases in the otcZ coding region concurs with the 
asymmetric distribution of bases expected for Streptomvces coding 
regions (Thompson and Gray et. al. 1982), which implies that if the 
leftward transcript is translated its codon usage would be affected by 
that of otcZ. Analysis of the sequence indicates it is feasible that 
this transcript is translated ; . ,. An ATG translational
initiation codon occurs I44bp from the BamHI site and it is prece ded
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by a potential ribosome binding site 6bp upstream. No translational 
stop codons occur in this frame before the BamHI site. An analysis of 
the codon usage of this potential coding region indicates that most 
synonomous codons generally used by the streptomycete coding regions 
are selected and the G/C base usage in the 1s ,^ 2nc* and 3r(* codon 
positions would be 45?, 70? and 95?, respectively.
It is likely that this transcript plays some role in the regulation of 
the OTC biosynthetic pathway because it is regulated by DNA sequences 
in the coding region of otcl or by the otcl polypeptide itself. The 
question of whether the transcript is translated and functions at the 
protein level or plays a role as an anti-sense RNA regulator remains 
to be answered.
PDM110 and pDM130 are resistant to lower levels of km than pDM111 and 
PDM131, but the resistance level appears to increase with PDM161. S1 
mapping with RNA derived from S.lividans TK24 containing pDM130 
identified one transcription start point within or one base to the 
right of the Bell site, named otclpl. This result is consistent with 
the fact that there is no increased resistance to km between pDM110 
and pDM130. The increase in kmr of PDM161 may be explained if otclpl 
activity is repressed by the overlapping leftward transcriptional 
activity from otcpAI-6. It might be predicted that PDM161 will 
repress leftward transcription as does pDMl60 and therefore any 
repression of .otclpl activity by leftward transcription will be 
relieved in the PDM161 construct.
PDM130 clones display a curious instability with respect to kmr. Half 
of the original clones analysed were sensitive to km and a further 30? 
of the resistant clones became sensitive after re-transformation. No 
sensitive isolates have been observed reverting to kmr, suggesting 
that the change in phenotype is irreversible. Plasmid DNA from 4 of 
the 9 sensitve isolates showed no evidence of gross DNA rearrangments 
within the limits of detection on a 1.2? (w/v) agarose gel. This 
suggests that fine structural changes such as small deletions, point 
mutations or inversions may be responsible for the switch to km
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sensitivity. Large deletions (approximately 100-300bp) have been 
observed in the plasmid isolates 2, 3, 5, 9 and 14, which are all 
sensitive to km. The plasmid populations of these isolates are mixed 
with respect to intact and deleted derivatives, therefore one would 
expect some resistance to km. As stated above these mixed populations 
of plasmid are all sensitive to km, suggesting that the intact insert 
fragment is rearranged in an unknown fashion probably similar to the 
rearrangements of the 4 sensitive isolates which exhibit no gross 
rearrangments.
Whatever rearrangments are occurring they appear not to affect the
promoter activity of the leftward transcribing promoters, as the kmr
phenotype of pDM131 displays no sign of instability. It is possible
that the rearrangements are occurring due to the orientation of the
insert in the vector. No gross rearrangments e.g. detectable
deletions, were observed with plasmid DNA of pDM131 however relatively
few isolates were analysed in comparison to isolates of pDM130 and it
is possible that deletions were occurring but were not detected.
Possible sites for the rearrangements may be deduced, if they are not
orientation specific. Any rearrangments within 20bp of either side of
the Bell site would be likely to disrupt the promoter activity of
pDM131 unless a point mutation is occurring in the otclpl consensus
sequence. Rearrangments of the otclpl consensus sequence would also
affect pDM110, which exhibited no instability with its kmr phenotype.
It would appear that the Bcll/Smal fragment is the only plausible site
u
for rearrangments. However unless a terminator struc; tre is created, 
a rearrangment is unlikely to have a direct affect on transcription. 
Alternatively the stability of the mRNA or polypeptide could be 
altered by a rearrangment in the 5* end of the mRNA. A 170bp deletion 
within the untranslated leader sequence of afsB resulted in failure to 
confer the afsB+ phenotype to host strains (Horinouchi et. al. 1986) 
indicating that sequences 31 to the transcriptional start point have a 
role to play in the control of gene expression. Experiments to 
elucidate the cause of this effect have not been pursued. A direct 
approach to solving the nature of this mutation would be to 1) isolate 
an insert from a sensitive pDM130 clone and insert it into pIJ487, to
6 3
confirm that the 1e f t ward promoter activty is not affected 2) to 
sequence the relevant part of the insert, looking for a small 
deletion, insertion or point mutation present in the sensitive 
isolates.
Results from the promoter-probe constructs in conjunction with S1 
mapping data suggest that overlapping divergent promoters are located 
at the Bell site 5* to to the otcl structural gene. Promoter-probe 
constructs have indicated that the leftward transcriptional activity 
is repressed by a factor to the right of the Smal site, possibly by 
the NH2 terminal end of the otcl polypeptide. To test if the 
repression is trans mediated it will be necessary to subclone the 
BamHI/Sall fragment onto a compatible plasmid and transform this 
plasmid into S.lividans containing pDM111 and pDM131. The effect of 
the otcl polypeptide in trans on the promoter activity of pDM111 and 
pDM131 could then be assayed.
The function of the leftward transcript is unknown but it is clear 
that the expression of this transcript is regulated. A possible 
function for this transcript indicated by the data, is that it acts as 
an anti-sense mRNA regulator of the production pathway. This 
transcript could bind to the otcZ mRNA and possibly other production 
gene transcripts depending on the length of the message and disrupt 
the expression of the OTC production genes. Anti-sense RNA has been 
found to play an important role in gene regulation of prokaryotes. 
The first E.coli antisense RNA regulation mechanism to be identified, 
controlled the expression of OmpF expression (Mizuno et al 1984). 
Several other examples have since been identified involving control 
of plasmid replication, Tn10 transposition, expression of crp in 
E.coli and expression of Q protein (Green et al 1986). All of these 
anti-sense regulators are small transcripts which interact with the 5* 
end of the message. Antisense RNA regulation has also been 
demonstrated in artificial systems in both prokaryotes and eukaryotes. 
An artificial anti-sense regulator which is complementary to lacZ mRNA 
from sequence encoding amino acid 8-1007, inhibits expression of lacZ
•N
(Ellison el al, 1 985). However the importance of complementarity to
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the leader sequence, in some cases, is demonstrated by a series of 
experiments on the inhibition of ompC (Coleman et al 1984). No 
natural antisense RNA regulator has been found which is complementary 
to the full length of the target transcript or interacts only with the 
31 end of the target mRNA.
The size of the leftward trancript has not been established so it is 
possible that it terminates before the transcriptional start site of 
otcZ. It is also possible that otcZ is transcribed as part of a 
polycistronic transcript. In this case the leftward transcript would 
need to be transcribed the full length of such a polycistronic message 
to interact with the 51 end. It will be necssary to determine the 
transcrition termination point of the leftward transcript and the 
transcriptional start site of the otcZ transcript before the anti­
sense regulator hypothesis can be further tested. If the function of 
the leftward transcript is mediated through antisense RNA regulation, 
the structure of the regulator would be unique amongst natural anti­
sense RNA transcripts previously studied. The anti-sense RNA 
regulation hypothesis or a regulation hypothesis involving a possible 
translation product of the leftward transcript provides a mechanism of 
controlling the expression of the production pathway which would 
ensure that a cell was expressing otcl and therefore resistant to 
OTC, before the onset of OTC production.
CHAPTER 5
S1 Nuclease Mapping of Divergent Promoters 5* to the otc-1 Gene
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5.1 Introduction
Relatively few sequences controlling transcription and translation of 
Streptomvces genes have been studied in detail. Expectations of 
discovering novel promoter features have arisen for two reasons. 
Streptomycetes express genes differentially throughout their complex 
life cycle and the expression of many of these genes will probably be 
controlled at the level of transcription. Streptomycete DNA has a 
72% G+C content but most prokaryotic promoters have a high A+T content
and the effect of an overall high G+C content on promoter structure
and function is been investigated.
S1 mapping of the sequence upstream of the otcl structural gene has
identified divergent transcriptional activity. The transcriptional 
start sites identified upstream of the structural gene will be 
discussed in relation to the promoter probe studies in Chapter 4 and 
the published data on sequence, expression and organization of 
Streptomvces promoters. The approximate location of the 
transcriptional stop site of the otcl gene has been identified by low 
resolution S1 mapping.
5.1.1 Streptomvces Promoter Sequences
Streptomycete promoter sequences have been reviewed recently by 
Hopwood .et al (1986). The promoters were divided into three classes 
based on their homologies to other prokaryotic consensus promoter 
sequences. Recent publications have considerably increased the number 
of sequenced streptomycete promoters (Table 5.1) but they may still be 
divided into three distinct classes.
(1) those with homology with the E.coli consensus sequence
(2) sequences exhibiting homology with the B.subtilis etc promoter
(3) a miscellaneous group, showing no significant homology with a 
recognized consensus sequence.
This categorization is somewhat arbitrary because the transcriptional
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Table 5.1 The sequences around the -10 and -35 regions of a 
promoter have been displayed. Mo attempt has been made to align 
theses sequences for maximum homology. An * denotes promoter 
sequences identified only by S1 mapping, with no supporting evidence 
to indicate promoter actvity.
(A) Group 1 promoters
(B) Group 2 promoters. The consensus sequence is underlined.
(C) Group 3 promoters. Homology between AfsBp and aohol is denoted
by a line between the sequences. The 6bp homology between hv'gp and
orfp2 and other sequences which are partly homologous, are 
underlined.
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cuiaj.y £>is aata are not ruiiy comparable. For example, not all 
predicted promoters have been tested in promoter probe vectors. S1 
analysis can occasionally result in artefacts due to the secondary 
structure of the region being analysed or mRNA processing may result 
in processed transcripts being identified. Therefore it is possible 
that some of the promoter sequences tabulated in Table 5.1, which have 
being identified by only one technique, are not functional in vivo. 
Any transcriptional start sites which have no additional evidence to 
suggest they are preceeded by functional promoters have been marked 
with an asterisk in Table 5.1.
The class 1 promoters, comprises of 15 of the 40 promoters sequenced 
to date (Table 5.1). A variety of gene functions are included in 
this group e.g. an antibiotic resistance gene, genes for glycerol 
utilization, plasmid encoded genes, an extracellular agarase gene and 
several genes of unknown function. These promoters exhibit 
significant homology with the most highly conserved bases in the 
E.coli consensus promoter sequence (Hawley and McClure 1983). Adenine 
occurs in 14 out of 15 cases at position 2 of the -10 region and 
thymine also occurs in 14/15 at position 6. The first three positions 
of the -35 region in prokaryotic consensus are TTG and these bases are 
conserved in 12/15, 13/15 and 15/15 cases respectively in these 
Streptomvces promoters. Mutation of the thymine at position 6 in the 
-10 region of ermEpI, essentially abolished all transcription from the 
promoter (Bibb and Janssen 1987). This T is the most highly conserved 
base in the E.coli consensus sequence (Hawley and McClure 1983) and 
would also appear essential to Streptomvces promoters in this group.
The class 2 promoters exhibit homology with the B.subtilis etc 
promoter. The etc promoter sequence is recognized by a minor form of 
sigma factor (sigma 37) in association with B.subtilis core RNA 
polymerase (Moran et. al. 1986). The five promoters in this group 
direct the transcription of genes encoding kanamycin (kan) resistance, 
viomycin (vph) resistance, streptothricin (sta) resistance, the 
endoglycosidase-H (endo-H) gene and an open reading frame (orflpD 
associated with the streptomycin (sph) resistance gene. The vphol and 
endo-H promoters have an eight consecutive base pair homology between 
the -12 and -21 region. The staP. kanPI and orflpl have 5/8, 4/8 and
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Three consecutive G residues, which occur between -13 and -17 
depending on the promoter, are conserved among all five Streptomvces 
promoters and also conserved in the etc promoter.
Methylation protection experiments on the etc promoter indicate 6 
bases at -9,-14,-15,-16,-33 and -36 which are protected by E-sigma 37 
(core RNAP-sigma37) (Moran et al 1982) and base substitutions at these 
bases defined the G at -36, G at -14, G at -15 and G at -16 as most 
important in promoter recognition in vitro bv E-sigma 37 (Tatti and 
Moran 1984). RNAP from S.rimosus transcribes in vitro the base 
substitution mutants at -14, -15 and -16 at approximately 30%, 5/6 and 
10? respectively, of the wild type etc promoter activity suggesting 
that these conserved bases are also important for promoter recognition 
in S.rimosus (Craig Binnie pers. comm.). Transcription of the s p o VG 
promoter, from B.subtilis. is also directed by E-sigma37 (Moran et al 
1981) and the sequence conserved between these two promoters is 
displayed in Table 5.1. The -10 and -35 regions of these promoters 
are similar, unlike the 5 class 2 promoters where the most highly 
conserved sequences are situated between the -12 and -20 region. 
Sigma factor 37 is expressed in vegetatively growing cells but E-sigma 
37 transcribes in. vitro s p o VG and etc, which are expressed at the 
onset of sporulation and at the end of exponential growth phase (in 
non sporulating conditions), respectively. Expression of s p o VG als 
depends on the s p o O class of regulatory genes (Zuber and Losick 1983) 
indicating there is more than one factor involved in the control of 
expression.
RNAP heterogeneity has been demonstrated in S.coelicolor (Westpheling 
et.aJL 1985). Two sigma factors were identified, sigma 49 and sigma 
35, which confer specificity for transcription of the B.subtilis etc 
and veg promoters respectively. The veg promoter is transcribed in 
B.subtilis by E-sigma 43 which is functionally equivalent to the major 
E.coli sigma factor; sigma 70. The endo-H promoter from S.plicatus is 
also differentially transcribed by these sigma factors, utilizing E- 
sigma 49 but not E-sigma 35. The evidence suggests that a sigma 
factor with a similar recognition specificity to sigma 37 exists in 
Streptomvces and in association with core RNA polymerase recognises
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the five genes m  this class. The conserved sequences of the class 2 
promoters and the spoVG/ctc promoters (with_the_ exception of the G 
residue at -36, -14, -15 and -16) suggest that there are also major 
differences between the promoter structures, which are possibly 
required for recognition of the promoter by other regulatory factors.
The remaining 20 promoters have been assigned to the third class. For 
eleven of these promoters the two most highly conserved bases in the - 
10 region of the E.coli consensus sequence are present but they 
display little homology at the -35 region. In E.coli. poor 
conservation of the -35 region has been correlated with promoters 
which are positively regulated by activator proteins (Raibaud and 
Schartz 1984). The regulation of these promoters, apart from those 
controlling the galactose operon (Fornwald et al 1986), has not been 
studied. This makes it difficult to infer any analogy with the E.coli 
data. The galactose operon has two promoters, galpl which is 
regulated positively by galactose and galp2 which is expressed 
constitutively. Interestingly, the galpl -35 region has an almost 
perfect E.coli consensus sequence but galp2 displays little homology 
to the consensus which suggests that the presence or absence of 
positive regulation has little effect on the sequence at -35 in this 
case. The vital importance of the consensus T in the -10 region of 
aphpl was demonstrated by elimination of promoter activity after 
substitution of this T (Bibb and Janssen 1987). These data suggest 
that the sigma factor which is involved in specifing the transcription 
of aphpl recognized this residue which is also the most conserved 
residue of the E.coli consensus sequence. The importance of the 
conserved A and T residues in the other promoters, especially those 
which are unusually close to the transcriptional start site, remains 
undetermined (Table 5.1). These promoters may also represent a new 
class or several new classes of promoters recognized by alternative 
sigma factors. The -35 regions of the 20 promoters have very little 
homology to each other and no consensus sequence is obvious. The -10 
regions of hygp and orfp2 (associated with ermE) have 6bp of homology 
in the -10 to -16 region.
CGTCAA
----- — . w ._> j. ui one a u u  v e cseq utJiiut: j'ev fcJeiXtiU l i v e
promoters with a 4/6 bp match to this sequence. These promoters could 
form a separate class based on this homology but no homology was 
detected between the relevant -35 sequences. The 6 consensus promoter 
sequences which are recognized by minor sigma factors in B.subtilis 
(Johnson et. al. 1983) show no homology to the above sequence. If 
CGTCAA is a meaningful consensus, no analogous class of promoters has 
been discovered in B.subtilis. There is good homology between the 
afsBp and aphpl promoters (Horinouchi et. al. 1 986) but this homology 
does not extend to any of the other promoter sequences in this group.
To clarify the nature of class 3 promoters further investigations are 
required. For some pairs of promoters e.g. pA3, pA4 and amvp2. amvp3. 
the transcriptional start sites are within 6-7bp of each other and 
there is no unequivocal proof that both start sites are used in vivo, 
they may be experimental artefacts. It is possible that some of these 
sequences should not be regarded as promoter sequences at all. The 
regulation of the majority of these promoters has not been studied and 
such data could identify common motifs between the promoters which in 
turn could lead to investigation of further sequences with regulatory 
roles. Run off transcription experiments with reconstituted RNAP 
containing only sigma-35 would indicate directly if elements in the 
promoter sequence are part of an E.coli type consensus sequence or if 
they are fortuitously similar to the consensus. The relevance of the 
6bp homology between hygp and orfp2 and the more extensive homology 
between afsBp and aphpl may be established by the publication of 
further promoter sequences and more directly by base substitution in 
in vitro mutagenesis experiments.
5.1.2 Expression of Promoter Sequences in Streptomvces and E.coli
17 of the 40 promoters in Table 5.1 have been tested for promoter 
activity in E.coli. All six of the class 1 promoters tested are 
expressed in E.coli. The transcription start sites of pIJ101A, and 
pIJ101 C are identical in Streptomvces and E.coli (Buttner and Brown 
1987* Deng jet al. 1986). These data suggest that the initiation of 
transcription at class 1 promoters is due to a species of RNAP 
holoenzyme in Streptomvces that recognizes similar sequence
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determinants to tne consensus promoter ox a . c o n . xne existence ox 
such a species has been demonstrated in S.coelicolor (V/estpheling et 
al 1985). The transcription start points of the three SEP were not 
detectable in Streptomvces and the promoters showed very low activity 
in Streptomvces (Jaurin and Cohen 1985). These promoters are highly 
expressed in E.coli and may be subject to regulation in Streptomvces. 
The SEP sequences have unusual features such as direct repeats and 
dyad symmetries, in the +10 to -60 region, which could be involved in 
the regulation of these promoters. Alternatively the SEP sequences, 
which were isolated in E.coli. may not have a functional role in 
Streptomvces. which would explain the low promoter activity.
Two of the class 2 promoters, voh and sta. have been tested in E.coli 
but are not expressed. The promoters of the genes in this group show 
no homology to the E.coli consensus sequence and are unlikely to be 
transcribed in E.coli. The B.subtilis etc gene is also not expressed 
in E.coli (Tatti and Moran 1984).
Nine of the class 3 promoters (.aphpl, aphp2. tsrol. tsro2. ajLY.p1, 
amvp2. amvp3 sphp and hvgp) have been tested but all were inactive in 
E.coli. Five of these promoters, aphpl, tsrpl, tsrp2, amvpl and .sphp, 
have some homology with the E.coli consensus sequence in the -10 
region, but all the promoters have little or no homology with the -35 
consensus sequence. However, as stated in Section 5.1.1 aphpl is 
likely to be recognized by E-sigma 35 in Streptomvces which appears to 
be functionally equivalent to E-sigma 70 in E.coli. Either this 
homology is too poor to be recognized by E.coli RNAP or the promoters 
require alternative sigma or other factors not present in E.coli. to 
be transcribed. However the non expressed phenotype in E.coli maybe
the result of other factors such as poor mRNA stability or poor
translation; the aphpl has no conventional ribosome binding site.
5.1-3 Expression of an E.coli promoter in S.lividans
The ampC B-lactamase gene of E.coli is expressed in S.lividans under
the control of the ampC promoter (Jaurin and Cohen 1984). Base
substitution up mutations ’of the promoter were made and the ampC gene 
was expressed in S.lividans at higher levels than from the wild type
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promoter in S.lividans (.Jaurin and Cohen I9b*u. Aitnougn ror tne 
three mutations studied there was increased levels of mRNA production 
in S.lividans and in E.coli. the relative effects varied between the 
two species (Fig 5.1). The evidence suggests that a species of 
Streptomvces RNAP, probably directed by sigraa-35 (Westpheling jet .al 
1985), recognizes the same promoter determinants as E.coli RNAP but 
the relative importance of these factors differ, reflected in the 
varying degrees of expression between S.lividans and E.coli.
5-1.4 Detailed analysis of the promoter regions of the 
erythromycin resistance gene (ermE), the neomycin 
phosphotransferase gene (aph)» the kanamycin resistance gene 
(kan) and the hydroxystreptomycin phosphotransferase (sph) gene.
All four genes have complex transcription patterns, involving multiple 
transcripts (Fig 5.2). The promoters responsible for the expression of 
the resistance genes have been identified, kanpl, kanp2, ermEpI, 
ermEp2. aphpl and sphp. The ermE1 and ermE2 transcripts which are 
expressed at the same level in S.ervthraeus and in the heterologous 
host S.lividans. were not affected by the presence or absence of 
erythromycin (Bibb e_t al 1.985). The kan1 transcript has been 
identified only in S.lividans and the kan2 transcript only in 
S.kanamvceticus cultured in antibiotic-producing medium (Nakano and 
Ogawara 1987). However kan2 transcripts have been identified before 
the onset of antibiotic production. The neomycin phosphotransferase 
gene is transcribed from only one promoter, aphpl, as the aph2 
transcript terminates before the beginning of the structural gene 
(Bibb and Janssen 1987). The sph transcript has been identified in 
S.glaucescens and also in S.lividans (Vogtli and Hutter 1987). For 
both aphpl and ermEnl initiation of transcription is at the 
translational start site and therefore translation apparently occurs 
in the absence of a conventional ribosome binding site (Bibb and 
Janssen 1987).
The transcriptional analysis of these genes is further complicated by 
divergent and sometimes overlapping transcriptional activity (Fig 
5.2). The function of these promoters is unknown but they may be 
coordinately regulated with promoters for the resistance genes.
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The kanpA transcript is transcribed divergently with respect to the 
kanpl and kanp2 transcripts. The kanpA transcript, like the kan.p1 
transcript, has been identified in S.lividans but not in 
S.kanamvceticus (Nakano and Ogawara 1987).
Five transcripts, pA1-5, have been identified around the aph.p1 
promoter (Bibb and Janssen 1987). The transcription start sites of 
pA2, pA3, and pA4 occur within 28bp of each other. The pA1 and pA2 
promoter regions overlap the aphpl promoter and produe more abundant 
transcripts than pA2, pA3 or pA4.
Three transcription start points have been identified for an open 
reading frame 185bp upstream of ermE (Bibb and Janssen 1987). orfpl 
has been identified in both S.lividans and S.ervthraeus and is 
expressed at marginally higher levels in S.lividans. orfp2 and orfp3 
have been investigated and identified only in S.lividans.
Two transcription start points, orflpl and orfIp2, have been 
identified for an open reading frame 150bp upstream of sph in 
S.glaucescens (Vogtli and Hutter 1987). It has been suggested that 
there is a third promoter for this orf, within the sph transcript 
because of the strong full length protection of the probe after S1 
nuclease protection (Vogtli and Hutter 1987).
The -10 and -35 regions of pA1-5, aphpl, aphp2, orfp2, orfp3, sphp. 
orflpl, orfIp2 and kanpl show little homology to the E.coli consensus 
sequence. Orflpl and kanpl have been assigned to the group 2 
promoters and all the others are assigned to the miscellaneous group 3 
promoters. The transcriptional control mechanisms of the majority of 
these promoters are unknown but the variety and number of promoter 
signals indicates that the expression of these genes is highly 
regulated. Many different factors may be involved such as unknown 
sigma factors, positive regulators, repressor proteins and anti-sense 
RNA regulators. Further studies on the regulation of these promoters 
are required to establish the control mechanisms involved and to 
understand how they relate to each other, if at all.
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Fig 5.3 The diagram indicates which end and strand of a probe is 
radioactively labelled.
Probe 1: 1251 bo BamHI/BstEII fragment, end labelled with kinase and
[&-32P]ATP.
Probe 2: 923bp BamHI/MluI fragment, end labelled with kinase and
[fc-32P]ATP.
Probe 3: 327bp 3amHI/DdeI fragment, end labelled with kinase and
[S-32P]ATP.
Probe 4: 1554bp MluI/SstI fragment, end labelled with Klenow and
[<*-32P]dCTP.
Probe 5: 327bp BamHI/Ddel fragment, end labelled with kinase and
[fc-32P]ATP.
Probe 6: 1212 BclI/SstI fragment, end labelled with Klenow and
[<^-32P]dCTP and [<x-32p]dATP.
B - BamHI Be - Bell 3s - BstEII D - Ddel
M - Eiul S - Sail St - SstI
5.1.5 Summary
Transcriptional studies on Streptomvces have revealed two consensus 
sequences. The first is analgous to the E.coli consensus and the 
second is typified by the B.subtilis etc promoter. Two independent 
sigma factors specify transcription from these consensus promoters. 
The class 1 promoters interact with RNAP in a predictable manner. For 
example substitution of the most highly conserved base in the 
sequence, T at position 6 in the -10 region, eliminates 
transcriptional activity (Bibb and Janssen 1987). Analysis of a 
mutagenized E.coli consensus promoter, at less highly conserved 
residues, in both E.coli and S.lividans produced similar trends of 
transcriptional efficency. The levels of expression differed between 
the two species (Jaurin and Cohen 1984) indicating that there may be 
more subtle differences in the interaction of RNAP with the E.coli 
consensus sequence between the two species. Nearly half of the 
promoters studied have no obvious consensus sequence and the role of 
alternative sigma factors and other positively regulating factors 
needs to be investigated further.
The transcription patterns of the resistance determinants discussed, 
indicates complex regulation of the antibiotic resistance genes. 
However the nature of these regulation mechanisms have not been 
studied but the differential expression of transcripts in heterologous 
and host strains and overlapping promoter control sequences indicate 
that regulation is occurring. This complexity is not restricted to 
genes involved in antibiotic pathways, the amylase gene and glycerol 
operon also have multiple promoters (Hoshiko e_t al 1987, Smith and 
Chater 1987).
5.2 Results
5.2.1 Low resolution S1 mapping of the 5* end of otcl
Probes 1 and 2 (Fig 5.3) were hybridised to RNA from S.rimosus 4018 
(cultured in TSB with exogenous OTC) at 70°C for 3hrs and treated with 
S1 nuclease according to the S1 mapping procedure in Section 2.15. 
The samples were run on a 1.2/S (w/v) alkaline agarose gel (Fig 5.4)
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Fig 5.4 Low resolution S1 mapping of'the start points and 
termination point of the otcl transcript
0.5pM of probe 4 (approx. 4 x 10^cpm/pM).was hybridised with samples 
in lanes 1 and 2 at 68°C
0.5pM of probe 1 (approx. 1 x 10^cpm/pM) was hybridised with samples
in lanes 3 and 4 at 68°C
0.1 pH of probe 2 (approx. 1 x 10°cpm/pM) was hybridised with samples
in lanes 5 and 6 at 70°C
Lane 1, 3 and 5: 40ug of tRNA
Lane 2f 4 and 6: 40ug of S.rimosus 4018 RNA (isolated from cells 
cultured in T.S.B. with exogenous OTC
60°C S7or. T V  ; 51 cC
1353 -  
1078 -  
872
603 -
310 -  
281 -  
234 -
Fig 5.5 Determination of the Tm [DNA/DNA] of probe 3 
A normal hybridisation reaction (section 2.15) was carried out in 
the presence of probe 3 and tRNA, at different temperatures
200-300bp to the right of the BamHI site. A second protected fragment
approximately 200bp longer, of lower intensity was identifedby probe— -----
2 (Fig 5.4). The specific activity of probe 1 was lower than probe 2, 
which explains why the intensity of the common protected fragment is 
weaker with probe 1. The reduced specific activity probably also 
explains why the less intense and longer protected fragment was not 
identfied with probe 1. No protected fragments were detected in the 
control tracks (Fig 5.4). These data indicated two transcription 
start sites separated by 200-300bp. The predicted promoters for these 
transcripts were named otclpl and otcIp2, short and long transcripts 
respectively.
5.2.2 High resolution S1 mapping of otclpl
The DNA/DNA melting temperature of probe 3 (Fig 5.3) was determined 
experimentally to be between 57°C and 60°C (Fig 5.5) using standard S1 
hybridisation conditions. The theoretical Tm [DNA/DNA] of probe 3> 
which is 327bp long and 66.6$ GC rich, is 58.6°C, in good agreement 
with the experimental value. Probe 3 was hybridised to RNA from 
S.lividans TK24 containing pDM131 and to RNA from S.rimosus 4018 
(cultures grown in TSB in the presence and absence of exogenous OTC) 
at 62°C (2-5°C above the Tm [DNA/DNA]) for 3hrs and digested with S1 
nuclease according to the procedure in Section 2.15. The samples were 
electrophoresed on a 6% (w/v) denaturing polyacrylamide gel. RNA from 
each source identified the same two transcriptional starts at nt 220 
and nt 221 identifying the transcription start points of otclpl (Fig 
5.6). RNA from S.rimosus 4018 identified a third transcriptional 
start at approximately nt 5-10, which defines the transcriptional 
start of otclP2 more precisely (Fig 5.6).
5.2.3 High resolution S1 mapping of divergent promoter activity in the 
BamHI/Sma1 fragment.
Probe 5 was hybridised to RNA from S.lividans TK24 containing pDM131 
and to RNA from S.rimosus (4018 cultures grown with exogenous OTC in 
TSB), at 62°C for 3hrs and digested with S1 nuclease according to 
section 2.15. The samples were electrophoresed on a 6% (w/v)
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Fig 5.6 High resolution .napping of otclpl and otcIp2
Arrows indicate the start points coincident with the bands
0.1pM of probe 3 (approx. 2.5 x 10^cpm/pM) was hybridised with
samples in lanes 1-4 at 62°C
Lane 1: 40ug of S.lividans TK24 (containng pDMI31) RNA
Lane 2: 40ug of S.riinosus 4018 RNA (isolated from cells cultured in
T.S.3.)
Lane 3: 40ug of S.rimosus 4018 RNA (isolated from cells cultured in 
T.S.3. with exogenous OTC)
Lane"4: 40ug of tRNA
C G 
♦ +
1 2 3 T A
Fig 5.7 High resolution S1 mapping of otcpA1-6
Arrows indicate the start point coincident with the bands
0.05pM of probe 5 (approx. 7 x 10 cpm/pM) was hybridised with
samples in lanes 1-3 at 59°C
Lane 1: 40ug of S.rimosus RNA (isolated from cells cultures in 
T.S.B. with exogenous OTC)
Lane 2: 40ug of S.lividans TK24 (containing pIJ487) RNA 
Lane 3: 40ug of S.lividans TK24 (containing pDM131) RNA
The hybridisation temperature was lowered to 59°C and the experiment
repeated as above. Six protected bands were identified within a 40bp----
region with mRNA from S.lividans TK24 containing pDM131 (Fig 5.7).
The most intense bands indicating transcriptional start sites were 
found at nt 211 and nt 225 (otcpAI and otcpA3 promoters respectively).
The protected band at nt 242 (otcpA5 promoter) was also relatively 
intense and the three weakest bands were at nt 222, nt 238 and nt 248 
(otcpA2, otcpA4 and otcpA6 promoters respectively). No protected 
bands corresponding to those above were identified with control RNA 
from S.lividans TK24 containing pIJ487 or from S.rimosus 4018 RNA even 
after a five day exposure of the gel. A seventh protected band at nt 
237 occurred with all RNA samples (Fig 5.7). The full length 
protection of the probe, caused by DNA/DNA hybrids, is particularly 
intense in the control track (Fig 5.7). However this was not a 
representative result because in all other experiments (data not 
shown) the full length protected band in control hybridizations was 
only as intense as the other samples.
5.2.4 Low Resolution S1 Mapping of the 3* end of the otcl transcript
Probes 4 and 6 (Fig 5.3) were used to map the 3* end of the otcl 
transcript. Probe 4 was hybridised to RNA from S.rimosus 4018 
(cultures grown in TSB with exogenous OTC) at 68°C for 3hrs, digested 
with S1 nuclease as described in Section 2.15 and the samples 
electrophoresed on a 1.255 (w/v) alkaline agarose gel. Probe 4 
protected a fragment of approximately 1300bp (Fig 5.4 a,b). Probe 6 
was hybridised to RNA from S.rimosus 4018 and S.rimosus M15883 
containing pPZ46 (Fig 1.4), at 68°C for 3hrs and digested with S1 
nuclease as described in Section 2.15. The products were 
electrophoresed on a 1.2$ (w/v) alkaline agarose gel and protected 
fragments of approximately 950bp were identified (Fig 5.8). The 
protected band from S.rimosus M15883 (pPZ46) sample was more 
intense, due to the high copy number of the plasmid in comparison to 
the single copy of otcl from S.rimosus 4018. These data indicated 
that the transcript terminates approximately 250bp before the SstI 
site.
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Fig 5-8 Low resolution S1 mapping of the termination point of the 
otcl transcript
Probe 6 was hybridised to samples in lane 2, 3 and 4 at 58°C 
Lane 1: Probe 6
Lane 2: 40ug of tRNA
Lane 3: 40ug of S.rimosus (containing pPZ46) RNA
Lane 4: 40ug of S.rimosus RNA
Divergent transcriptional start sites have been mapped upstream of the 
otcl structural gene. The promoters of the two start sites initiating 
transcription toward the otcl gene, have been named otclpl and otcIp2. 
6 start sites were identified initiating divergent transcription, in 
relation to otclpl and otclp2. and the potential promoters have been 
named otcpA1-6. Low resolution S1 mapping of the transcriptional 
termination site for otcl indicated a stop site approximately 250bp 
before the SstI site i.e. at approximately nt 2400. A translational 
stop codon within the otcl orf occurs at nt 2340 which is followed by 
a 23bp inverted repeat (Fig 3.5). The position of the inverted repeat 
in the DNA sequence coincides with the 31 end of the mRNA estimated 
from S1 mapping data. The transcription initiation pattern of this 
region is diagrammed in Fig 5.9.
otclpl and otcIp2 were initially identified by low resolution S1 
mapping which indicated the appropriate probes to be used in high 
resolution S1 mapping. High resolution mapping identified two 
transcription start points for otclpl i.e. at nt 220 and nt 221 with 
RNA from S.rimosus 4018 and S.lividans TK24 containing pDM131. The 
sequence of the otclpl promoter (Table 5.2) has been assigned to the 
class 1 promoters discussed in the introduction. The -10 region has 
the major conserved residues of the prokaryotic consensus i.e. A at 
position 2 and a T at position 6 of the consensus. The -35 region 
incorporates 4/6 residues of the prokaryotic consensus sequence - 
TTGACA. This promoter has not been tested in E.coli for activity but 
if it behaves similarly to other promoters assigned to class 1, one 
would expect the promoter to be functional in E.coli. The 
transcriptional start site of otclpl supports the data from promoter 
probe constructs pDM110 and pDM130, which are inhibited by equivalent 
levels of km, indicating that the promoter control sequences are 
located within the BamHI/BclI insert.
A transcriptional start point for otcIp2 has only been identified with 
RNA from S.rimosus 4018. The transcript appears to be less abundant 
than the .otclpl transcript. The start point maps within 5-1Obp of the 
BamHI site. A shorter probe will be required to resolve the actual
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otclpl
AGCCCTGACCCTC-CGTGGCCGCCCTTGCTACCGTGATCA
otcpAl
ATCCGCCCGGCGGGAACACACCCGCGGCATGATCACGGT
gatctggggaattcgagctcggtacccgggGATCACGGT
otcpA2
GTCGCTGTGATCCGCCCGGCGGGAACACACCCGCGGGGC
otcpA3
TGACGTCGCTGTGATCCGCCCGGCGGGAACACACCCGCG
otcpA4
GTTCCGCCCTCTCTGACGTCGCTGTGATCCGCCCGGCGG
otcpAG
ATCGTTCCGCCCTCTCTGACGTCGCTGTGATCCGCCCGG
otcpA6
TGCCGCATCGTTCCGCCCTCTCTGACGTCGCTGTGATCC
Table 5.2 The table displays potential promoter sequences upstream of 
the transcriptional start sites. The sequence upstream of otcIp3a is 
disrupted in pDM111, this sequence is diagrammed below otclola. 
Possible consensus sequences and the nt at the start site are 
underlined. Lower case letters denote vector sequence from pDM111.
D P A T T T V H D V L Q  R L N H G L  I R 
> GGATCCGGCCACCACGACGGTGCACGACGTACTGCAACGGCTCAACCACGGCCTCATCCG 
< CCTAGGCCGGTGGTGCTGCCACGTGCTGCATGACGTTGCCGAGTTGGTGCCGGAGTAGGC
otcIp2
G D T S S S S V E E Y R A E I  E E A G F  
> CGGCGACAGGTCGTCCAGCAGCGTCGAGGAGTACCGCGCGGAGATCGAGGAGGCCGGCTT 
< GCCGCTGTGCAGCAGGTCGTCGCAGCTCCTCATGGCGCGCCTCTAGCTCCTCCGGCCGAA
R V R Q A E R I  O N L L G D W L I!(V i A i(y 
> CCGGGTGCGGCAGGCGGAGCGCATCGACAACCTCCTCGGTGACTGGCTGATAGTCGCCGT 
< GGCCCACGCCGTCCGCCTCGCGTAGCTGTTGGAGGAGCCACTGACCGACTATCAGCGGCA
/K
otcpAI
t if ! t-10
> CAAGCCCTGAGCCTGGGTGGGGGCCCTTGCTACCG 
< GTTCGGGACTGGGACGCACCGGCGGGAACGA-TGGC
ofcpA2 ofcpA3 otcpM
- I - ■ : >' ' ■ ‘ ' •-
TGATC^TGCCCGCGGGTGTGTTCCC 
ACTAGTACGGGCGCCC?ACACAA&GG
HclT .
otclplotcpA5 otcpA6
 < r* <---•
> GCCGGGCGGATCACAGCGACGTCAGAGAGGGCGGAACGATGCGGCAGGCGACCACGAATC
< CGGCCCGCCTAGTGTCGCTGCAGTCTCTCCCGCCTTGCTACGCCGTCCGCTGGTGCTTAG
M N K L
> CGGCAGGAAAGGTCCGCATCACGACGCTAAGGAATCCGAACCCCCTCCATGAACAAGCTG 
< GCCGTCCTTTCCAGGCGTAGTGCTGCGATTCCTTAGGCTTGGGGGAGGTACTTGTTCGAC
N L G I L A H V D A G K  T S L T  E R L L  
> AATCTGGGCATCCTGGCCCACGTTGACGCCGGCAAGACCAGCCTCACCGAGCGCCTGCTG 
< TTAGACCCGTAGGACCGGGTGCAACTGCGGCCGTTCTGGTCGGAGTGGCTCGCGGACGAC
H R T G V  I D E V G S V D A G T T T T D  
> CACCGCACCGGTGTGATCGACGAGGTCGGCAGCGTGGACGCCGGCACCACGACGACCGAC 
< GTGGCGTGGCCACACTAGCTGCTCCAGCCGTCGCACCTGCGGCCGTGGTGCTGCTGGCTG
Fig 5.9 DMA sequence from nt 1 —480 (Fig 3.6)
Transcriptional start points are indicated by circles and the 
direction of transcription by associated arrows. Presumptive -10 
and -35 regions of otclpl and otcIp3a are underlined. An inverted 
repeat is indicated by converging arrows. The amino terminal a.a. 
sequence of otcl and carboxy terminal a.a. sequence of otcZ is 
indicated.
with RNA from S.lividans TK24 (pDM131) but the transcription start 
site is very close to the BamHI site and it is quite possible that the 
promoter signals have been lost or at least disrupted by subcloning 
using the BamHI site. The promoter probe constructs do not include 
any sequence beyond the BamHI site. Therefore to investigate the 
promoter activity of sequences 5* to this start site, it will be 
necessary to subclone a fragment from pPZ46, which incorporates some 
sequence on either side of the BamHI site but not the otclpl promoter. 
It will be interesting to see if RNA derived from S.lividans 
containing such a construct, identifies a transcriptional start point 
in S1 mapping experiments. There is no sequence data 5* to the BamHI 
site so it has not been possible to identify any sequences with 
potential promoter activity based on similarity to known consensus 
sequences. The preliminary S1 mapping of a transcriptional start site 
for otcIp2 suggests that promoter activity identified in constructs 
pDM110 and pDM130 is derived from otclpl.
No transcriptional terminator has been identified for the otcZ gene. 
If the otcZ transcript overlaps the otcl transcript one would have 
expected to have identified full length protection of the relevant 
probes. However the RNA was harvested from cells cultured in T.S.B. 
medium, which does not support antibiotic production. Therefore the 
absence of the otcZ transcript may be due to the fact that it is not 
being expressed.
The divergent transcriptional activity identified by S1 mapping is far 
more complex. Possible promoters for each start site have been named 
otcpAI-6. This experiment was conducted initially under the same 
conditions used for high resolution mapping of otclpl f because the 
probes were identical but differentially labelled. However no 
hydrids were identified and the hybridisation temperature was lowered 
by 3°C. Under these conditions the 6 protected bands were identified, 
suggesting that the BamHI/BclI DNA/RNA hybrid is less stable than the 
Bcll/Ddel DNA/RNA hybrid. No bands corresponding to the 6 protected 
bands were duplicated in the control sample, indicating that the 
hybrids were real RNA/DNA hybrids. A computer search for indirect 
repeats with the potential to form hairpin-loops and therefore
79
which could be digested by S1 nuclease to account for any of the six 
protected bands. There is one band present in all samples (Fig 5.8) 
which may be accounted for by an inverted repeat with the potential to 
form a hairpin-loop with a AG=-17kcal. The band occurs at base 235 
which is within the loop of this possible secondary structure. 
Because the band appeared in all tracks including the controls it has 
been disregarded.
Potential promoter sequences of all 6 transcription start sites have 
been displayed in Table 5.2. The sequence of otcpAI may be grouped 
with the class 2 promoters. The sequence from -13 to -20 has a 7/8bp 
match with the endoH and vph promoters. The promoter probe data 
indicates that jotcpAI retains some activity in pDM111, which contains 
only the BamHI/BclI insert. However in this construction, Bell cuts 
at the -9 base of otcpAI. Streptomycete DNA sequences upstream of the 
-9 region have been replaced by the polylinker DNA sequence which 
exhibits some similarity to the conserved group 2 sequence (4/8bp 
identical) (Table 5.2). This region of identity is located 3bp nearer 
to the transcriptional start site but the km resistance levels 
indicate that this fragment still retains promoter activity. The 
larger promoter probe construct pDM131> incorporates all the start 
sites identified and exhibits considerably increased promoter activity 
(Fig 5.1). It is impossible to discern if this increased promoter 
activity is due to transcription from the undisrupted otcpAI promoter 
or from the other 5 start sites or both.
The sequences upstream of the 5 other start sites show no homology to 
either the prokaryotic consensus or the class 2 consensus sequence and 
have been grouped with the class 3» miscellaneous promoters. They 
also show no homology to the tentative consensus sequences, 
established within the group between aphPl/afsBp and hygp/orfp2 (Table 
5.1). These start sites are very close to each other, similar to pA2, 
pA3 and pA4 which direct the divergent transcription associated with 
the aph gene (Bibb and Janssen 1987). The transcription start sites 
of otcpA2 and otjcpA3 are within 3hp of each other as are the start 
sites of otcpA4 and otcpA5 and these could be considered as 
alternative start sites from the same promoter. The other start sites
80
are suxiacenuxy spaceu apart to oe considered as separate entities. 
mRNA processing could result in the 6 transcription start sites 
identified (SI artefacts due to secondary structure have been ruled 
out) but one would not expect to find a class 2 type promoter 
sequence, otcpAI. upstream of the shortest transcript if it is simply 
the product of mRNA degradation. As discussed in the introduction 
and above, multiple closely spaced transcription starts have been 
observed previously but the function of such a complex arrangement of 
promoters is unknown. Multiple promoters may be useful in fine 
regulation of expression of a transcript. If further experiments 
demonstrate promoter activity associated with all or even some of 
these transcriptional start sites, at least two classes of promoter 
can be assumed to be regulating transcription. However otcpAI-6 
transcriptional start sites have not been identified in hybridization 
experiments with RNA from S.rimosus 4018 which contains otcl mRNA. 
This result is consistent with the data from promoter probe construct, 
PDM160, which exhibits no promoter activity and includes 45$ of the 
otcl polypeptide. A plausible explanation for these two results is 
that transcriptional activity from otcpAI-6 is repressed by factors 
within the otcl structural gene. This would introduce another level 
of complexity in the transcriptional control of this region. It is 
impossible to test, in promoter probe vectors, each potential promoter 
in isolation for promoter activity, because the sequences overlap 
extensively. However substitution of the bases at -13, -14 and -15 of 
jotcpAI should radically decrease the activity from this promoter 
(Craig Binnie pers. comm.) and it may then be possible to assay the 
contribution of otcpAI-6 to promoter activity in pDM131.
otclpl and atclp2 start sites have been identified with RNA from 
S.rimosus. which was cultured both in the presence and in the absence 
of exogenous OTC. otclpAI-6 start sites have not been identified with 
RNA from S.rimosus.which was cultured in the presence and absence of 
exogenous OTC (data not shown). OTC in the medium would appear to 
have little or no effect on the expression of the otcl gene. However, 
this is not a good test of the effect of intracellular levels of OTC 
because this level is unknown whether the cells are cultured in the 
presence or absence of OTC. The effect of OTC on the expression of 
otcl needs to be investigated further.
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The transcription pattern 5’ to otcl is similar in many respects to 
the transcription patterns of the resistance genes discussed in 
section 5.1.4.. Transcription of otcl is directed by two promoters 
separated by 210-215bp. otclpl is expressed in both the host strain 
and in S.lividans and otclp2 activity needs to be investigated in 
S.lividans. In addition divergent transcriptional activity from 
multiple transcriptional start sites occurs, overlapping with otclpl. 
One respect in which otcl transcription pattern differs from the other 
resistance genes, is the close proximity of otcZ, a production gene 
(Fig 5.9). This creates a situation of overlapping transcripts. The 
function of the ojtcpA transcript has yet to be determined but it is 
highly probable that it is involved in the regulation of the OTC 
production pathway. The data resulting from promoter probe constructs 
and S1 mapping have defined certain points of the regulation of these 
transcription units. Transcription from otcpAI-6 is repressed in both 
promoter probe construct PDM160 and in S.rimosus 4018 cultures which 
are expressing otcl. indicating that the otcl polypeptide possibly 
controls the expression of the otcpA transcript. The activity of 
otclpl in PDM161 is increased, which implies that transcription from 
overlapping promoters otcpAI-6 is partially repressing the activity of 
otclpl in pDM110 and pDM130. As suggested in Chapter 3 the otcpA 
transcript may be involved as an anti-sense regulator of the 
production pathway genes. Regulation at the level of promoter 
consensus sequences must also be considered because two promoters have 
been identified, otclpl and ojtcpA 1, which have the potential to be 
recognized by different sigma factors. The role of otc.Ip2 in the 
regulation of otcl expression needs to be investigated by the 
isolation and further S1 mapping of this promoter.
A more comprehensive understanding of the regulation of these genes 
requires consideration of the effect of OTC production on expression. 
It will be necessary to harvest RNA samples for S1 mapping experiments 
from different time points in the life cycle and to assay the cultures 
for OTC, in order to develop a clearer picture of this complex 
regulation mechanism.
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Chapter 6
Concluding Remarks
83
Sequencing of the BamHI/SstI fragment encoding otcl identified the 
otcl open reading frame with an initiation codon at nt 349-352. The 
sequence also indicated that the orf for the otcZ structural gene 
terminated at nt 190. The transcription initiation pattern of pattern 
of the otcl gene presented in chapter 5 is derived from high 
resolution S1 mapping and is consistent with activity from promoter 
probe constructs. Two transcription start points separated by 
approximately 215bp direct the transcription of otcl. The sequence 
upstream of the start site at nt 219-220 (the otclpl promoter) 
resembles a streptomycete class 1 promoter which is the counterpart of 
the E.coli consensus promoter in Streptomvces. The sequence upstream 
of the start site at nt 5-10 (otcIp2) is unknown because it lies 
outside the sequenced BamHI/SstI fragment. The otcIp2 transcrit was 
slightly less abundant than the otclpl. otclp2 needs to be 
investigated further to identify sequences 5T to the transcription 
start site and also in promoter probe vectors. The transcription 
start site was not identified with RNA from S.lividans TK24 containing 
pDM131, which suggests that none of the promoter probe constructs 
contain this promoter. It will be interesting to identify which class 
of promoter otclp2 resembles, in terms of the regulation of the otcl 
gene.
Divergent transcriptional activity was identified in promoter probe 
constructs and 6 clustered transcription start sites were identified 
at nt 211, 222, 225, 238, 242 and 248 (the otcpA1-6 promoters) with
RNA from S.lividans TK24 containing pDM131. No transcription start 
sites were identified with RNA from S.rimosus 4018 which is consistent 
with the km sensitive phenotype of pDMl60. It remains to be 
established that the transcription start sites jotcpA1-6, are all 
preceeded by functional promoters. Because the start sites are 
closely clustered it is difficult to study potential promoter 
sequences in isolation. However it is possible to mutagenize the 
conserved sequence of otcpAI and subsequently identify the effect on 
promoter activity from this region. The unusual, but not 
unprecedented, clustering of transcriptional start sites may play a 
role in the fine regulation of expression of this transcript. Two 
start sites within 5bp of each other, have been identified 51 to the
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gal operon in E.coli (Queen and Rosenberg 1981). Initiation from P1 
is activated by CRP-cAMP and initiation from P2 is induced by glycerol 
and inhibited by CRP-cAMP. The P2 transcript synthezises galE four 
times more efficiently than P1 mRNA and it has been suggested that the 
differential translation efficency of the P1 and P2 transcripts is 
directly related to the increase in size of the P2 transcript. The 
developmentally regulated gene, s p o V G  from B.subtilis. is also 
expressed from two overlapping promoters, which direct transcription 
from sites separated by 10bp (Johnson et al 1983). These promoters 
are recognized by two distinct sigma factors and in addition the 
expression of s p o V G is regulated by the s p o O  regulatory gene products. 
The complexities of this regulation system are not fully understood 
but they do show some similarity to the unusual transcription patterns 
which are being discoveed in Streptomvces species.
An incomplete picture of the regulation of the otcl gene has been 
established. The leftward divergent transcript is totally repressed 
in the presence of sequences within the N terminal end of otcl. most 
probably by the otcl polypeptide. When the leftward transcript is 
expressed it has a partially repressive affect on otclpl, which may be 
explained by the effect of promoter sequences and transcription start 
sites overlapping. The role of otcIp2 has yet to be established.
The function of the leftward divergent transcript is unknown, but the 
fact that it is regulated by otcl indicates it may be involved in the 
regulation of OTC biosynthesis. There is no evidence that the 
transcript is translated but a potential ribosome binding site occurs 
at nt 150-156, 6bp upstream of a translational initiation codon. 
Translation of this transcript would create a situation of overlapping 
polypeptides with otcZ. An in vitro transcription/translation system 
may be used to look for a potential polypeptide product from this 
transcript. The leftward transcript also has the potential to act as 
an anti-sense RNA regulator of the expression of ateZ. This would be 
an unusual anti-sense RNA regulation mechanism because no anti-sense 
RNA regulators have been found which mediate control at the 31 end of 
a mRNA or extend along the full length of a mRNA.
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To understand the regulation mechanisms it will be necessary first of 
all to identify the transcription end point of the leftward transcript 
and the transcription start site of otcZ. The role of the 6 
transcription start sites otcpAI-6 must also be elucidated. The 
sequence of .otcpAI suggests that it is likelt to be transcribed by E- 
sigma49, but the role of sigma 49 in the temporal expression of genes 
has yet to be established. The sequences upstream of the 5 other 
transcriptional start sites have been assigned to the class 3 
streptomycete promoters. Promoter probe constructs demonstrate in 
vivo promoter activity from this region, but further experiments are 
required to demonstrate if all or at least some of these start sites 
are preceeded by functional promoters. Clustered transcription start 
sites have been identified in other streptomycete species (Bibb and 
Janssen 1987) but these have also not been tested for activity in 
isolation and the function of clustered has yet to be determined.
All promoter probe constructs were analysed in S.lividans TK24 and S1 
mapping experiments used RNA from S.lividans TK24 containing promter 
probe constructs or RNA from S.rimosus 4018 cultured in T.S.B.. 
Regulatory control of the region may be altered in the heterologous 
host S. lividans TK24 and T.S.B. medium does not support OTC 
biosynthesis, so again regulation may be altered from the usual 
mechanisms. To get a better understanding of the regulation of 
expression of these transcripts it will be necessary to harvest RNA 
from S.rimosus under controlled conditions. RNA samples should be 
harvested from S.rimosus 4018 grown in production medium (where the 
onset of OTC biosynthesis will be monitored) at different time points 
in the life cycle.
The organization of the promoters 5f to the otcl structural gene is 
very similar to the examples discussed in section 5.1.4. The promoter 
probe data in conjunction with the S1 analysis have indicated that 
these transcripts are coordinately regulated and have developed a 
picture of possible mechanisms of control. Further investigations of
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concepts for the regulation of resistance genes and antibiotic 
biosynthetic genes in Streptomvces
The BamHI/SstI fragment has been sequenced. The predicted orf for
otcl encodes a protein of 71.329Kd. The predicted amino acid sequence
has been compared to the predicted amino acid sequence of tetM from
Streptococcus. The 130 a.a. at the N terminal ends of both proteins 
are 66$ homologous and three further small regions dispersed 
throughout the sequence show equivalent homology. A functional role 
has been proposed for these highly conserved regions. The overall 
homology between the two proteins contributes further evidence to the 
Benveniste and Davies (1973) hypothesis that antibiotic resistant 
determinants in non-producing species are derived from antibiotic 
producing species like the streptomycetes.
The highly conserved N terminal ends of otcl and tetM also exhibit
similarities to the N terminal end of Ef-Tu from E.coli. This region 
includes the GTP binding site of EF-Tu which occurs at a.a. 4-20 in 
otcl and tetM and a.a. 12-28 in EF-Tu. Ef-Tu and otcl are 48$ 
homologous over 150 a. a at the N terminal end when the chemical 
equivalence of amino acids is considered. This startling homology 
suggests that a functional relationship exists between these 3 
proteins. It is possible that the tetracycline resistance genes act 
as an alternative elongation factor which protects the translation 
machinery from the inhibitory effect of tetracycline. To test if the 
otcl gene product plays a functional role in protein synthesis it will 
be necessary to reconstitute ribosomes in vitro, replacing the normal 
EF-Tu with the otcl polypeptide.
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APPE!u)IZ: Restriction sites found in sequence of otc resistance gene
From 1 to 2657 there is/are 2 oeeurrence( s) of AatH 
Sequence(s): /GACGTC/
258/1 2128/1
From 1 to 2657 there is/are 1 occurrenceC s) of AccI 
Sequence^s): /GTATAC/GTAGAC/GTCTAC/GTCGAC/
1234/4
Fran 1 to 2657 there is/are 7 occurrence(s) o f Acyl
Sequencer s): /C-ACGCC/GACGTC/GGCGCC/GGCGTC/
258/2 385/1 457/1 658/4 826/1 2100/1 2123/2
Fran 1 to 2657 there is/are 0 oceurrenee(s) of Aflll 
Sequence(s): /CTTAAG/
Frau 1 to 2657 there is/are 4 occurrenceCs) of Afllil 
Sequence! s): /ACACGT/ACATGT/ACGCGT/ACGTC-T/
66/1 923/3 954/1 1103/3
From 1 to 2657 there is/are 0 occurrence(s) of AhalJLl 
Sequence!s): /TTTAAA/
From 1 to 2657 there is/are 7 occurrence!s) of Alul 
Sequence!s): /AGCT/
356/1 408/1 902/1 1700/1 2029/1 2542/1 2653/1
From 1 to 2657 there is/are 2 occurrence! s) of ilpal 
Sequencefs): /GGGCCC/
842/1 2284/1
From 1 to 2657 there is/are 7 occurrence!s) of ApaLI 
Sequence!s): /G7GCAC/
20/1 1015/1 1069/1 1099/1 1-349/1 2014/1 2167/1
From 1 to 2657 there is/are 5 occurrence!s) of Aval
Sequence!s): /CCCGAG/CCCGGG/CTCGAG/CTCGOG/
573/2 613/4 1319/2 2278/1 2375/2
From 1 to' 2657 there is/are 16 occurrence!s) of Avail 
Sequence!s): /GGACC/G0TCC/
311/2 518/2 633/2 539/1 1034/2 1059/1 1146/1 1399/2
1512/1 1563/2 1679/1 1755/1 1977/2 2350/1 2335/2 2423/1
From 1 to 2557 there is/are 0 occurrence! s) of Aval.TI
Sequence!s): /ATGCAT/
From 1 to 2657 there is/are 0 occurrence!s) of Avrll
Sequence!s): /CCTAGG/
Froiii 1 to 2657 there is/are 1 occurrence! s) of Ball 
Sequence!s): /TGGCCA/
527/1
From 1 to 2657 there is/are 1 occurrence!s) of BamHl 
Sequence! s): /GGATCC/
1/1
From 1 to 2657 there is/are 13 occurrence!s) of Bbvl 
Sequence!s): /GCAGC/GCTGC/
78/1 417/2 449/1 498/1 768/2 903/2 1089/2 1122/2
1224/2 1281/2 1479/2 1491/2 1601/1
From 1 to* 2657 there is/are 3 occurrence!s) of BbvII 
Sequence!s): /GAAGAC/GTCTTC/
721/2 1288/2 2131/2
Fra:i 1 to 2657 there is/are 2 occurrence! s) of Bell 
Sequence(s): /TGATCA/
216/1 1445/1
From 1 to 2657 there is/are 4 occurrence!s) of Bgll
Sequence! s): /CCC—  GGC/
799/1 2138/1 2262/1 2277/1
From 1 to 2657 there is/are 0 occurrence!s) of Bglli 
Sequence!s): /AGATC7/
From 1 to 2657 there is/are 7 occurrence!s) of BinI 
Sequence!s): /GGATC/GATCC/
1/1 2/2 248/1 777/2 1593/2 2409/1 2523/2
From 1 to 2657 there is/are 1 occurrence!s) of Bsmi 
Sequence! s): /GAATGC/GCATTC/
707/2
From 1 to 2657 there is/are 3 occurrence! s) of BspE-ii 
Sequence!s): /ACCTGC/GCAGGT/
1170/1 1526/1 1884/2
From 1 to 2657 there is/are 0 occurrenceCs) of Bspiin
Sequence* s): /TCCGGA/
From 1 to 2657 there is/are 6 occurrence/s) of BssBII
Sequence! s): /GCGCGC/
749/1 1003/1 1154/1 1156/1 1969/1 2628/1
From 1 to 2657 there is/are 3 occurrenceC s) of BstEII
Sequencers): /GOT-ACC/
1251/1 1375/1 1887/1 
From 1 to 2657 there is/are 0 occurrenceCs) of BstXI
From 1 to 2657 there is/are 28 occurrenceCs) of Cauii 
Sequencers): /CCCGG/CCCGG/
121/2 242/2 573/1 574/2 741/2 864/1 876/1 891/2
1020/1 1080/2 1248/2 1319/1 1320/2 1331/2 1380/2 1385/2
1461/1 1767/1 2057/1 2067/1 2104/1 2191/1 2232/2 2375/1
2375/2 2475/2 2526/2 2598/2
— ..
From 1 to 2657 there is/are 14 occurrenceCs) of CfrI 
Sequence(s): /CGGCCA/CGGCCG/TGGCCA/TGGCCG/
6/1 198/4 527/3 647/2 908/4 989/4 1245/2 1304/1
1550/2 1759/2 1943/2 2117/2 2222/4 2259/2
From 1 to 2657 there is/are 18 occurrenceCs) of CfrlOI
Sequencers): /ACCGGC/ACCGGT/GCCGGC/GCCGGT/
113/3 388/3 427/2 460/3 785/1 829/3 1045/1 1243/1
1552/3 1681/1 1757/1 1918/1 2002/4 2022/4 2240/1 2341/1
2403/3 2466/4
From 1 to 2657 there is/are 1 occurrenceCs) of Clal
Sequence(s): /ATCGAT/
2520/1
From 1 to 2657 there is/are 4 occurrenceCs) of Ddel
SequenceCs): /CT-AG/
327/1 2062/1 2427/1 2620/1
From 1 to 2557 there is/are 4 occurrenceCs) of DraJI
SequenceCs}: /AGG-CCC/AGG-CCT/GGG-CCC/GCG-CCT/
1052/2 1352/4 1511/1 2283/3
From 1 to 2657 there is/are 1 occurrenceC s) of Dralll
Sequence( s): /CAC~— C-TG/
1018/1
From 1 to 2657 there is/are 0 occurrenceCs) of EcoHI
Sequence(s): /GAATTC/
From 1 to 2657 there is/are 0 occurrenceC s) of EcoHI-
SequenceCs): /AATT/
From 1 to 2657 there is/are 11 occurrenceCs) of EcoRII 
Sequence(s): /CCAGG/CCTGG/
372/2 540/2 636/2 942/2 1055/2 1434/2 1818/2 2139/2
2202/1 2220/2 2414/2
From 1 to 2657 there is/are 0 occurrenceC s) of EcoRV
Sequence(s): /GATATC/
From 1 to 2657 there is/are 0 occurrenceCs) of Eco47II
SequenceCs): /AGCGCT/
From 1 to 2657 there is/are 2 occurrence^s) of EspI
SequenceCs): /GOT"AGO/
2061/1 2619/1
From 1 to 2657 there is/are 6 occurrence:'s) of FinI
SequenceCs): /GGGAC/C-TCCC/
755/2 1334/1 1400/2 1473/1 1678/1 2125/1
’rom 1 to 2657 there is/a 1'•e 40 0ccurrenoS(s) of Fnu4HI
Sequence (s): /GO-■GC/
60/1 78/1 127/1 200/1 281/1 417/1 449/1 495/1
498/1 503/1 666/1 746/1 768/1 799/1 837/1 903/1
991/1 1089/1 1119/1 1122/1 1160/1 1182/1 1224/1 1281/1
1407/1 1425/1 1479/1 1486/1 1491/1 1530/1 1549/1 1501/1
1863/1 1942/1 2053/1 2259/1 2268/1 2271/1 2274/1 2602/1
From 1 to 2657 there is/are 11 occurrence:'s) of Gdin
SequenceCs): /CGGCCG/TGGCCG/
198/2 647/1 908/2 989/2 1245/1 1550/1 1759/1 1943/1
2117/1 2222/2 2269/1
From 1 to 2657 there is/are 6 occurrence/s) of Gsul
SequenceCs): /CTCCAG/CTGGAG/
490/2 1435/2 2041/2 2140/2 2415/2. 2549/2
From 1 to 2657 there is/are 4 oc- : e 0 c..
SequenceCs): /AGGCCA/AGGCCT/TGGCCA/TGGCCT/
527/3 1820/^ 4 1832/1 1961/1
From 1 to 2657 there is/are 4 occurrenceCs) of Haeil
Sequence(s): /AGCGCT/AGCGCC/GGCGCT/GCCGCC/
410/2 609/3 1457/2 1689/3
From 1 to 2657 there is/are 36 occurrence/ s) of Haelll 
Sequence(s): /GGCC/
7/1 50/1 112/1 199/1 375/1 528/1 577/1 648/1
843/1 862/1 909/1 990/1 1054/1 1128/1 1167/1 1246/1
1305/1 1354/1 1383/1 1451/1 1551/1 1760/1 1821/1 1833/1
1944/1 1962/1 2001/1 2118/1 2223/1 2243/1 2270/1 2276/1
2285/1 2406/1 2431/1 2465/1
From 1 to 2657 there is/are 17 occurrence(s) of Heal
SequenceC s): /C-ACGC/GCGTC/
81/2 323/1 385/1 457/1 659/2 753/2 826/1 922/1
1105/2 1114/1 1221/1 1232/2 1268/1 1713/1 1750/2 1987/1
2100/1
From 1 to 2657 there is/are 13 occurrenceCs) of HgiAI
SequenceCs): /GAGCAC/GAGCTC/GTGCAC/GTGCTC/
20/3 619/4 1015/3 1069/3 1099/3 1258/1 1294/1 1849/3
2014/3 2167/3 2227/1 2323/4 2652/2
From 1 to 2657 there is/are 6 occurrenceCs) of HgiCI
SequenceCs): /GGCACC/GGCGCC/GGTACC/GGTGCC/
463/1 1204/1 1388/1 2046/4 2344/1 2400/4
From 1 to 2657 there is/are 1 occurrenceCs) of HgiEII
1000/1
From 1 to 2657 there is/are 5 occurrenceCs) of HgiJiI 
SequenceCs): /GAGCCC/GAGCTC/GGGCCC/GGGCTC/
842/3 1764/1 1806/4 2284/2 2652/2
From 1 to 2657 there is/are 45 occurrenceCs) of Hhal 
Sequence(s): /GCGC/
96/1 139/1 411/1 501/1 610/1 629/1 696/1 749/1
751/1 848/1 856/1 994/1 1003/1 1005/1 1039/1 1117/1
1154/1 1156/1 1158/1 1279/1 1342/1 1410/1 1423/1 1458/1
1409/1 1494/1 1556/1 1635/1 1690/1 1733/1 1748/1 1771/1
■1893/1 1940/1 1969/1 1971/1 1990/1 2096/1 2331/1 *j
2362/1 2381/1 2556/1 2628/1 2630/1
From 1 to 2657 there .is/are 4 occurrence! s) of Hindi!
Sequence! s): /GTTAAC/GTCAAC/GTTG/iC/GTCGAG/
382/3 556/2 727/2 1234/4
From 1 to 2657 there is/are 0 cccurrencei's) of Hindlll
Sequence!s): /AAGCTT/
From 1 to 2657 there is/are 7 occurrence! s) of Kinfl
Sequence(s): /GA-TC/
296/1 332/1 360/1 4?8/1 1213/1 1615/1 2431/1
Fran 1 to 2657 there is/are 6 occurrence! s) of HinGUII
Sequence!s): /GGATG/CATCC/
55/2 369/2 513/2 678/2 1077/2 2313/2
From 1 to 2657 there is/are 0 occurrence!s) of HpaJ
Sequence!s): /GTTAAC/
From 1 to 2657 there is/are 52. occurrence! s) of Hpall 
Sequence!s): /CCGG/
5/1 114/1 121/1 242/1 300/1 389/1 428/1 461/1
516/1 574/1 741/1 786/1 830/1 865/1 877/1 891/1
1021/1 1046/1 1080/1 1193/1 1244/1 1248/1 1265/1 1320/1
1331/1 1380/1 1335/1 1453/1 1462/1 1553/1 1632/1 1758/1
1760/1 1919/1 1933/1 2003/1 2023/1 2058/1 2068/1 2105/1
2192/1 2232/1 2241/1 2342/1 2348/1 2376/1 2388/1 2404/1
2467/1 2475/1 2526/1 2598/1
From 1 to 2657 there is/are 14 occurrence!s) of HphI 
Sequence!s): /GGTGA/TCACC/
158/1 404/2 509/2 791/2 893/1 932/2 1218/1 1253/2
1274/2 1375/1 1889/2 1904/2 2586/1 2592/1
From 1 to 2657 there is/are 0 occurrence!s) of Kpnl
Sequence!s): /GGTACC/
From 1 to 2657 there is/are 0 occurrence!s) of Mael
Sequence!s): /CTAG/
From 1 to 2657 there is/are 11 occurrence! s) of i-laell
Sequence!s): /ACC-T/
27/1 68/1 259/1 380/1 532/1 956/1 1364/1 1763/1
2129/1 2321/1 2635/1
From 1 to 2657 there is/are 6 occurrence! s) of ilaelll
Sequence! s): /GT-AC/
159/1 1219/1 1252/1 1376/1 1888/1 1903/1
From 1 to 2657 there is/are 4 occurrence(s) of Hbolj
Sequence(s): /GAAGA/TCTTC/
722/2 1289/2 1418/2 2132/2
From 1 to 2657 there is/are 2 occurrence(s) of Hlal
Sequence(s): /TTCGAA/
2035/1 2547/1
From 1 to 2657 there is/are 2 occurrence(s) of Hlul
Sequence/ s): /ACGCGT/
923/1 1103/1
Fran 1 to 2657 there is/are 3 occurrenceCs) of linel
SequenceC s): /TOOAAC/TCCG AC/GTTGGA/GTCGGA/
583/2 1752/4 2251/4
From 1 to 2657 there is/are 37 'occurrenceCs) of Hnll
SequenceCs): /CCTC/GAGG/
52/1 86/2 107/2 110/2 151/1 154/1 267/2 344/1
402/1 442/2 561/1 598/2 655/2 930/1 949/2 982/2
1051/2 1165/2 1392/1 1465/2 1517/1 1540/2 1569/1 1579/2
1596/1 1687/2 1840/2 2011/2 2044/2 2122/2 2143/2 2163/1
2209/2 2281/2 2418/2 2426/1 2487/2
From 1 to 2657 there is/are 2 occurrenceCs) of list I
SequenceCs): /TGCCCA/
695/1 1493/1
From 1 to 2657 there is/are 6 occurrenceC s) of Gael
SequenceCs): /GCCGGC/
113/1 338/1 460/1 829/1 1552/1 2403/1
From 1 to 2657 there is/are 0 occurrenceCs) of.Karl
SequenceC s): /GGCGCC/
From 1 to 2657 there is/are 0 occurrence(s) of IIcoI
SequenceCs): /CCATGG/
From 1 to 2657 there is/are 0 occurrenceCs) of Udel
SequenceCs): /CATATG/
From 1 to 2657 there is/are 0 occurrenceCs) of Fhel
SequenceC s): /GCTAGC/
From 1 to 2657 there is/are 4 occurrenceC s) of Hlalll
SequenceCs): /CATC/
220/1 348/1 1497/1 2496/1
From 1 to 2657 there is/are 17 occurrenceC s) of HlalV
Sequ.ence(s): /GO— CC/
1/1 463/1 689/1 842/1 1033/1 1204/1 1352/1 1388/1
1399/1 1512/1 1673/1 2046/1 2187/1 2283/1 2284/1 2344/1
2400/1
From 1 to 2657 there is/are 1 occurrenceCs) of TIotl
SequenceCs): /GCGGCCGC/
2268/1
From 1 to 2657 there is/are 0 occurrenceCs) of Urul
SequenceCs): /TCGCGA/
From 1 to 2657 there is/are 7 occurrenceCs) of KspBII
SequenceCs): /CAQCGG/CAGCTG/CCGCGG/CCGCTG/
58/3 225/3 800/3 838/3 1120/4 2182/1 2272/3
From 1 to 2657 there is/are 1 occurrenceCs) of I'spCl
SequenceCs): /ACATGC/ACATGT/GCATGC/GCATGT/
1496/3
From 1 to 2657 there is/are 1 occurrenceC s) of Pflr'I
SequenceC s): /CCA—  TGC/
2642/1
From 1 to 2657 there is/are 4 occurrenceCs) of Ppal
SequenceCs): /GAGACC/GGTCTC/
642/2 1188/2 1315/1 1438/1
From 1 to 2657 there is/are 1 occurrenceCs) of Ppulil
SequenceC s): /AGGACCC/AGGACCT/GGGACCC/GGGACCT/AGGTCCC/AGG7CCT/GGGTCCC/GGGTCCT/
1511/1
From 1 to 2657 there is/are 0 occurrenceCs) of PstI
SequenceCs): /CTGCAG/
From 1 to 2657 there is/are 2 occurrenceCs) of Pvul
SequenceCs): /CGATCG/
351/1 1520/1
From 1 to 2557 there is/are 0 oceurrence(s) of Pvuil
Sequence(s): /CAGCTG/
From 1 to 2657 there is/are 16 occurrenceCs) of Rsal
SequenceC s): /GTAC/
29/1 91/1 950/1 975/1 1026/1 1176/1 1366/1 1627/1
1652/1 1875/1 1916/1 2006/1 2071/1 2310/1 2in 1/1 2460/1
From 1 to 2657 there is/are 4 occurrenceCs) of ItsrII
Sequence(s): /0GGAC0G/CGGTCCG/
517/2 1754/1 2349/1 2384/2
From 1 to 2o57 there is/are 1 occurrenceCs) of Sail
SequenceC s): /GTCGAC/
1234/1
From 1 to 2657 there is/are 1 occurrenceCs) of Saul
SequenceCs): /CCT-AGG/
2426/1
From 1 to 2657 there is/are 17 occurrenceCs) of Sau3A 
SequenceCs): /GATC/
2/1 
852/1 
2607/1
103/1
1446/1
217/1
1521/1
249/1 
1593/1
435/1
1695/1
547/1
1779/1
735/1
2490/1
777/1
2523/1
'roia 1 to 
iequenceC s): /GG-
2657 there is/are 31 
-CC/
occurrenceCs) of Sau.961
311/1
862/1
1399/1
2276/1
375/1
1034/1
1512/1
2284/1
518/1
1053/1
1553/1
2285/1
576/1
1059/1
1679/1
2350/1
633/1
1127/1
1755/1
2385/1
689/1 
1146/1 
1977/1 
2423/1
842/1 
1353/1 
2000/1 
2464/1
843/1
1382/1
2243/1
From 1 to 2657 there is/are 0 occurrenceCs) of Seal
SequenceCs): /AGTACT/
From 1 to 2657 there is/are 39 occurrenceCs) of ScrFI
Sequence(s): /CC-GG/
121/1 242/1 372/1 540/1 573/1 574/1 635/1 741/1
864/1 876/1 891/1 942/1 1020/1 1056/1 1050/1 1248/1
1319/1 1320/1 1331/1 1380/1 1385/1 1434/1 1461/1 1767/1
1818/1 2057/1 2067/1 2104/1 2139/1 2191/1 2202/1 2220/1
2232/1 2375/1 2376/1 2414/1 2475/1 2.526/1 2596/1
From ■ 1 to 2657 there is/are 22 occurrenceCs) of Sciul
SequenceC s): /GGGCCC/GC-GCTC/GGGCAC/GAGCCC/GAGCTC/GAGCAC/GTGCCC/GTGCTC/GTGCAC/
20/9 619/8 842/1 1015/9 1069/9 1099/9 1203/3 1258/6
1294/6 13o7/3 1764/4 1806/2 1849/9 2014/9 2047/7 2110/7
2145/3 2167/9 2227/6 2284/1 2323/8 2652/5
From 1 to 2657 there is/are 30 occurrenceC s) of Seel
SequenceC s): /CC— GG/
46/1 58/1 154/1 225/1 524/1 572/1 573/1 596/1
741/1 800/1 818/1 838/1 1149/1 1319/1 1331/1 1596/1
1673/1 1733/1 1817/1 2114/1 2120/1 2201/1 2202/1 2232/1
2272/1 2279/1 2375/1 2376/1 2433/1 2485/1
From 1 to 2657 there is/are 12 occurrenceC s) of SfaJJI
SequenceCs): /GA7GC/GCATC/
141/2 278/1 316/2 363/2 506/2 677/2 684/1 1076/2
1271/2 1661/2 2151/1 2518/2
From 1 to’ 2657 there is/are 1 occurrenceCs) of Sfil
SequenceCs): /GGCC-— — GGCC/
2276/1
From 1 to 2657 there is/are 3 occurrenceCs) of Smal
SequenceC s): /CCCGGG/
573/1 1319/1 2375/1
From 1 to 2657 there is/are 0 occurrenceCs) of SnaEI
SequenceCs): /TACGTA/
From 1 to 2657 there is/are 0 occurrenceCs) of Snal
Sequence(s): /GTATAC/
From 1 to 2657 there is/are 0 occurrenceCs) of Spel
SequenceC s): /ACTAGT/
From 1 to 2657 there is/are 1 occurrenceCs)'of SphI
SequenceC s): /GCATGC/
1496/1
From 1 to 2657 there is/are 4 occurrenceCs) of SplI
SequenceCs): /CGTACG/
1365/1 1626/1 1651/1 2459/1
i-'rora 1 to 2657 there is/are 1 occurrenceC s) of SstI
SequenceC s): /GAGCTC/
2552/1
From 1 to 2657 there is/are 5 occurrenceC s) of Sstll
SequenceCs): /CCGCGG/
58/1 225/1 800/1 838/1 2272/1
From 1 to 2657 there is/are 0 occurrenceC s) of StuI
SequenceCs): /AGGCCT/
From 1 to 2657 there is/are 0 occurrenceCs) of StyI
SequenceCs): /CCAAGG/CCATGG/CCTAGG/CCTTGC-/
From 1 to 2657 there is/are 22 occurrenceCs) of Taql
SequenceCs): /TCGA/
84/1 105/1 1 W 1  437/1 481/1 566/1 602/1 623/1
653/1 737/1 1235/1 1292/1 1394/1 1519/1 1523/1 1640/1
1664/1 1697/1 * 1838/1 2036/1 2521/1 2543/1
From 1 to 2657 there is/are 13 occurrenceCs) of Taqll
SequenceC s) : /CACCCA/CACCGA/GACCCA/GACCGA/TGGGTG/TGGGTC/TCGGTG/TCGC-TC/
156/7 405/2 474/4 870/2 896/7 963/4 1216/7 1254/2
1373/7 1741/6 1390/2 2199/3 2584/7
From 1 to 2657 there is/are 56 occurrenceCs) of Thai
SequenceCs): /CGCC-/
59/1 95/1 97/1 226/1 502/1 630/1 750/1 752/1
781/1 801/1 839/1 847/1 849/1 855/1 924/1 978/1
993/1 1002/1 1004/1 1006/1 1038/1 1104/1 1116/1 1155/1
1157/1 1159/1 1173/1 1210/1 1231/1 1278/1 1341/1 1409/1
1422/1 1483/1 1548/1 1557/1 1611/1 1709/1 1749/1 1772/1
1941/1 196-8/1 1970/1 1959/1 2085/1 2097/1 2273/1 2302/1
2332/1 2354/1 2361/1 2363/1 2382/1 2535/1 2627/1 2629/1
From 1 to 2657 there is/are 1 occurrenceCs) of Tth_I
SequenceCs): /GAC— GTC/
439/1
From 1 to 2657 there is/are 0 occurrenceCs) of Tth_II
SequenceCs): /CAAACA/CAAGCA/TGTTTG/TGCTTG/
From 1 to 2657 there is/are 0 occurrenceCs) of Xbal
SequenceCs): /TCfAGA/
Fran 1 to 2557 there is/are 0 occurrenceCs) of Xhol
SequenceCs;: /CTCGAG/
From 1 to 2657 there is/are 3 occurrenceCs) of
SequenceCs): /AGATCC/AGATCT/GGATCC/GGATCT/
1/3 776/1 1592/1 .
From 1 to 2657 there is/are 7 occurrenceCs) of
SequenceCs): /CGGCCG/
647/1 1245/1 1550/1 1759/1 1943/1 2117/1 2269/1
From 1 to 2657 there is/are 0 occurrenceCs) of
SequenceCs): /GAA— *— TTC/
